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CHAPTER ONE 
1.0 Insomnia and physical activity 
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 1.1 Insomnia 
1.1.1 Classification for research and clinical practice 
There are established classification systems for diagnosing insomnia in clinical practice, the 
most widely used being the International Classification of Sleep Disorders -2 (ICSD-2; 2000) 
and the Diagnostic and Statistical Manual of Mental Disorders (DSM-5; 2013). Each of these 
nosologies historically listed sub-types of insomnia, essentially distinguishing between 
insomnia occurring independently of other known pathology (i.e. stand-alone insomnia, or 
primary insomnia); and insomnia temporally concurrent with other pathologies (i.e. co-morbid 
insomnia).  
DSM-IV-TR (2000) was current in clinical practice at the time of design of the present 
research programme1. It listed four sub-types of insomnia, and the one relevant to this work 
was primary insomnia. DSM-5 (2013) replaces the old classification, essentially reducing it to 
insomnia disorder, with concurrent comorbidities, if any. The new criteria recognises the fact 
that insomnia, regardless of its origin and comorbidities, should be diagnosed and treated on 
its own.  
                                                 
1 Insomnia is now explicitly defined in the second edition of the International Classification of Sleep Disorders 
(ICSD-2: American Academy of Sleep Medicine, 2005) and the fifth edition of the Diagnostic and Statistical 
Manual of Mental Disorders (DSM-5; American Psychiatric Association, 2013). While these nosologies largely 
agree on the symptoms of insomnia, there remain important differences both in terminology and emphasis. 
Importantly, during the course of the research described in this thesis, a profound ‘shift’ took place in the 
categorisation of insomnia in relation to comorbid conditions.  While the earlier (revised 4th edition) of the DSM 
(DSM-IV-TR: APA, 2000) and the ICSD-2 distinguish between insomnia occurring independently of other 
known pathology (i.e. ‘primary insomnia’); and insomnia concurrent with other pathologies (i.e. ‘co-morbid 
insomnia’), this distinction (and many of the causal assumptions which accompanied this distinction) have now 
been rejected in favour of the single classification of “insomnia disorder” as defined in DSM-5. This new 
classification recognises that insomnia, regardless of its origin and comorbidities, can be diagnosed, and 
effectively treated, as a ‘stand-alone’ condition.  The DSM-5 diagnostic criteria for Insomnia Disorder require 
predominant difficulty in initiating or maintaining sleep, or non-restorative sleep, despite adequate opportunity to 
sleep, accompanied by clinically significant distress or impairment in important areas of daily functioning, for at 
least one month.  
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The criteria requires predominant difficulty in initiating or maintaining sleep, or non-
restorative sleep, despite adequate opportunity to sleep, accompanied by clinically significant 
distress or impairment in important areas of daily functioning, for at least one month.  
The ICSD-2 consists of 11 sub-types, three of which are primary insomnia categories: 
psychophysiological insomnia, idiopathic insomnia, and paradoxical insomnia. The criteria 
requires complaints of difficulty in initiating or maintaining sleep, waking up earlier than the 
desired time, or non-restorative sleep, accompanied by specific daytime impairments related 
to these complaints; despite adequate opportunity and circumstances to sleep.  
The inter-rater reliability between the different classifications is modest (Buysse, Reynolds, 
Kupfer, & Thorpy, 1994). Most recent multi-trait analyses of the different nosologies of 
insomnia similarly show marginal reliability and validity for insomnia sub-types from DSM-
IV-TR and ICSD-2 (Edinger et al, 2011). Nonetheless, these criteria are nowadays 
increasingly being used in epidemiological and experimental research (Ohayon, 2002). 
In an effort to standardise research definition criteria, the Research Diagnostic Criteria (RDC) 
for insomnia was developed by the American Academy of Sleep Research (AASR) (Edinger 
et al, 2004). Drawing on the DSM-IV-TR and the ICSD-2, the AASR developed criteria for 
diagnosing primary insomnia, and several other overlapping ICSD-2 insomnia sub-types.  
Insomnia disorder is defined by listed nighttime and daytime symptoms; whereas primary 
insomnia is defined to subsume the disorder, as well as providing temporal conditions, and 
necessary exclusions. For primary insomnia, sleep complaints must be present for at least 1 
month; in addition, the sleep complaints must show temporal independency from current or 
past psychiatric disorder, other medical condition, or other sleep disorder.  
There is a need for further empirical evidence to refine the RDC criteria, to quantify insomnia 
symptoms. For example, sleep onset latency (the time it takes to fall asleep) inclusion criteria 
is disputed, with some researches considering 31 minutes or more is appropriate for insomnia 
criteria inclusion (Lichstein, Durrence, Taylor, Bush, & Riedel, 2003); whilst there is also the 
view that 21 minutes provides adequate sensitivity and specificity to capture insomnia 
symptoms (Lineberger, Carner, Edinger, & Means, 2006) .  
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Additional quantitative and qualitative elements, related to the non-restorative nature of sleep, 
or to the frequency of complaints, could aid in identifying the target population better 
(Buysse, Ancoli-Israel, Edinger, Lichstein, & Morin, 2006).  
The methods for assessing insomnia in research populations are also varied, as the symptoms 
of insomnia do not easily translate into objective evidence recorded using polysomnography 
(Edinger et al, 2000). In addition, self-reported daytime impairment accompanying insomnia 
does not always match objective evidence of sleep disturbance (Orff, Drummond, 
Nowakowski, & Perlis, 2007). The results is that different research groups adopted their own 
method of assessment, often consisting of structured clinical interviews, sleep diaries, or 
polysomnography (Buysse et al, 2006).  
The Research Assessment Criteria (RAC) for insomnia was developed in an effort to 
standardise the approach in research practice (Buysse et al, 2006). The RAC makes 
recommended and essential guidelines concerning the assessment of sleep and insomnia 
symptoms, measures and reporting standards. Although there is still great variability between 
criteria used for inclusion of participants in studies, there is a greater uniformity in the 
instruments used to report changes in sleep quality.  
The literature reviewed in this thesis reflects a wide range of definitions in relation to 
insomnia.  For the purpose of reviewing high quality experimental evidence, efforts were 
made to include randomised controlled studies which used definitions and assessments of 
insomnia as recommended by the RDC and RAC for insomnia (Edinger et al, 2004; Buysse et 
al, 2006).  However, in reviewing historical and epidemiological studies, many of which pre-
date the publication or adoption of such criteria, a wide range of insomnia definitions, and 
insomnia symptoms was accepted.    
1.1.2 Measures of sleep structure, quantity and quality 
There are a number of operational measures of sleep, encompassing physiological, 
behavioural and psychological approaches. The ‘gold standard’ physiological measure of 
sleep is polysomnography (PSG), usually performed in the laboratory, under the supervision 
of a qualified sleep expert. Sleep structure is classified based on various characteristics of 
scalp-recorded electroencephalogram EEG (waveform, amplitude, frequency), coupled with 
electrodes which detect muscle activity and eye movement related to sleep. 
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PSG standard scoring is used to then classify sleep into 4 distinct stages, as per ‘The AASM 
Manual for the Scoring of Sleep and Associated Events’ (2007): Stage N1 (a relative low 
voltage, mixed frequency EEG, also called ‘light sleep’); Stage N2 (relatively low voltage, 
mixed frequency EEG, with additional characteristics waveforms, such as spindles and K-
complexes); Stage N3 (large amounts of high amplitude, low frequency EEG activity, also 
called ‘slow wave’ sleep, or ‘deep’ sleep); and Stage REM – Rapid Eye Movement (low 
voltage, mixed frequency EEG, accompanied by muscle atonia and characteristic rapid ocular 
movement; also known as ‘dream sleep’).  
The EEG characteristics are also used to quantify indices of sleep, including length of sleep 
(total sleep time), time taken to fall asleep (sleep onset latency), time spent awake after the 
first episode of falling asleep (wake after sleep onset), or movement during sleep (sleep 
fragmentation index). In addition, sleep efficiency can be inferred from the amount of time 
spent asleep whilst in bed. Another method to quantify these indices of sleep is based on 
actigraphic measures, which describe patterns of movement/non movement. Actigraphy has 
the advantage of being less intrusive than EEG, and thus offer a reliable measure of sleep 
patterns over longer periods of time. 
Self-reported measures include daily sleep diaries, questionnaires, and momentarily-
assessment tools. They can be used to quantify sleep indices (as above); or to describe the 
experience of sleep, e.g. light, deep, restful, agitated, short.  
Most adults report sleeping around 6 to 8 hours per night (Ohayon & Vecchierini, 2005). 
There are individual variations in what is considered a 'normal' amount of sleep. These may be 
attributed to a preference of sleep time (an 'owl' type, preferring to sleep late at night; or a lark 
type, preferring to sleep early), while some people are naturally 'short' sleepers. For most 
people, normal sleep is self-reported good sleep, with sleep quality being reflected in 
continuity of sleep over night (i.e. unbroken sleep) (Akerstedt, Hume, Minors, & Waterhouse, 
1994), and feeling refreshed or alert the following day (Harvey, Stinson, Whitaker, 
Moskovitz, & Virk, 2008).  
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Subjective reports of ‘normal’ sleep do not always reflect in known physiological measures of 
sleep. There are people who report good sleep, but show a disturbed sleep pattern when 
physiologically monitored; and conversely there are people who report disturbed sleep, but 
show normal sleep patterns when objectively monitored (Edinger et al, 2000). The most 
reliable indicator of sleep disturbance is self-reported global sleep dissatisfaction (Ohayon, 
Riemann, Morin, & Reynolds, 2012). 
1.1.3 Insomnia: prevalence and personal impact   
Sleep complaints, which include problems getting to sleep, staying asleep or waking up too 
early, are the most commonly reported psychological symptoms in Britain (Office for 
National Statistics [ONS], 2001). When such complaints are chronic, and accompanied by 
daytime symptoms or impairments such as fatigue and sleepiness, mood dysregulation and 
psychomotor deficits, then the diagnosis of  insomnia can be made (DSM-5; Diagnostic and 
Statistical Manual of Mental Disorders, DSM-5, 2013). Applying diagnostic criteria 
(specifying the frequency, severity and duration of insomnia symptoms) the prevalence of 
insomnia in the adult population is estimated at about 10% (Morin, LeBlanc, Daley, Gregoire, 
& Mérette, 2006; Léger, Scheuermaier, Philip, Paillard, & Guilleminault, 2001; Morgan, 
2012). However, age-specific prevalence rates show a steady increase across the lifespan, 
from an estimated 3-5% among those aged 18 to 25, to  25-30%  among people aged 65 and 
over (Ohayon, 1996; Morgan, 2012). Amongst the older population, up to 57% report at least 
one chronic insomnia symptom in point prevalence surveys (Foley et al, 1995). Across all age 
groups, insomnia is more prevalent among women, and those of low socioeconomic and 
educational level (Ohayon, 2002).  
As to the incidence of insomnia, the proportion of people reporting symptoms of insomnia 
over two years duration also increases significantly with age, with older people also more 
likely to report taking benzodiazepine hypnotic medication (Stewart et al, 2006). Objectively, 
polysomnographic studies show that ageing is associated with a notable decline in ‘deep’ or 
slow-wave sleep, starting in midlife, and an increase in ‘lighter’ stages of sleep (stages 1 and 2 
or N1: Hoch et al, 1997;  Ohayon & Lemoine, 2004). Subjectively, older adults report more 
frequent awakening during the night, earlier awakening in the morning, and lighter overall 
sleep (Ancoli-Israel & Cooke, 2005). The impact of insomnia symptoms grows stronger with 
age, even when accounting for physical functioning status (Stewart et al, 2006). 
1.1.4 Daytime consequences of insomnia 
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Night-time symptoms of insomnia, described mainly as difficulties in getting to sleep at night, 
are often distressing and have daytime consequences. Daytime symptoms or impairments 
associated with insomnia include increased fatigue (Orff et al, 2007), impairment of sustained 
and shifting attention (Altena, Van Der, Ysbrand, Strijers, & Van Someren, 2008) and poorer 
working memory (Bonnet & Arand, 1995). It is this perceived overall dysfunction that mostly 
leads to people with insomnia to seek medical help (Stepanski et al, 1989).  
Daytime performance is consistently associated with sleep quality as perceived both by people 
with insomnia, and by people who are normal sleepers (Harvey et al, 2008).  
Fatigue and sleepiness 
People with insomnia commonly report experiences of fatigue. Fatigue seems to describe 
physical tiredness (Ream & Richardson, 1996). The concept is distinct from the experience of 
sleepiness, which is related to drowsiness, and a measurable propensity to fall asleep (George, 
2001). Insomnia has been independently associated with both fatigue, and daytime sleepiness. 
The prevalence of both conditions increases with age (Theorell-Haglöw, Lindberg, Janson, 
2006). People with insomnia report disrupted sleep patterns, with increased sleep onset 
latency and increased wake after sleep onset, resulting in less total sleep time and poorer sleep 
efficiency (Orff et al, 2007; Haimov et al, 1994). It might therefore be inferred that people 
with insomnia would report increased daytime sleepiness as a consequence. However, in 
experimental research depriving people with insomnia of sleep, the amount of fatigue reported 
went up with the percentage of sleep loss, whilst sleepiness levels remained stable (Bonnet & 
Arand, 1998). Only when totally deprived of sleep for a night did people with insomnia show 
daytime sleepiness (Stepanski, Zorick, Roehrs, & Roth, 2000). Even then the recovery process 
matched that of normal sleepers deprived of sleep (Edinger et al, 2000). Thus, research into 
the daytime consequences of insomnia indicates that fatigue is both a more likely 
consequence, and a more useful measurement, than is sleepiness.  
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Impairment of mood  
There is strong evidence showing that insomnia is a risk factor for psychiatric disorders, 
independently contributing to new onset of depression and anxiety (Ford & Kamerow, 1989; 
Breslau, Roth, Rosenthal, & Andreski, 1996; Riemann & Voderholzer, 2003). Furthermore, 
insomnia and fatigue are the only ‘universal’ symptoms present in most people reporting 
major depression around the world (Weissman et al, 1996). Ford & Kamerow (1989), using 
data from a large prospective community sample, concluded that insomnia develops in many 
cases prior to depression; and those people with insomnia at baseline had much higher odds 
ratio of reporting depression one year later. A recent meta-analysis of epidemiological 
evidence in this field found that people with insomnia have a twofold risk to develop 
depression, compared to people with good sleep (Baglioni et al, 2011). Affect-insomnia 
relationships, however, are not necessarily ‘one-way’.  In a prospective design study Jansson 
& Lindblom (2008) assessed anxiety, depression, and insomnia in a representative sample of 
the general Swedish population over a year and concluded that relationships between mood 
disturbance and insomnia are bi-directional.  
Such findings are important since the anxiety state is at the core of the current influential 
cognitive view of insomnia. Harvey (2002) proposed that people with insomnia selectively 
attend to and monitor the internal and external environment for sleep-related cues, and this 
process is precipitated by anxiety related to sleep. Research into psychophysiological 
mechanisms underpinning this relationship points to sleep processes being related to 
emotional regulation processes in people with insomnia (Baglioni, Spiegelhalder, Lombardo, 
& Riemann, 2010).  
Impairment of attention and working memory  
Recent meta-analyses of results of studies of people with insomnia have found evidence of 
mild to moderate cognitive impairment in specific functions such as episodic and working 
memory, and in decision making (Fortier-Brochu, Beaulieu-Bonneau, Ivers, & Morin, 2012).  
Nevertheless, an earlier review of neurocognitive tests used to elicit daytime cognitive deficits 
in people with insomnia found significant heterogeneity in the samples used, which led to 
difficulty in forming firm conclusions about the extent of impairment in different cognitive 
domains, or indeed the existence of any cognitive impairments in this clinical group 
(Shekleton, Rogers, & Rajaratnam, 2010).  
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It has been suggested that the limited published evidence of cognitive impairment in people 
with insomnia might indicate either the absence of such impairment (Riedel & Lichstein, 
2000); or an overestimation and exaggeration of symptoms by those reporting them, due to 
cognitive bias in their attention processes (Orff et al, 2007). Alternatively, the evidence might 
also suggest that the tests used are insufficiently specific to be able to elicit insomnia-related 
deficits. Many of the currently used cognitive tests were originally designed to detect and 
measure gross cognitive deficits, and subsequently adapted for people with insomnia (Fortier-
Brochu et al, 2012). While such tests are a useful starting point, the more we learn about the 
neurophysiological complexity of insomnia, the more it becomes apparent that neurocognitive 
tests required to detect deficits in people with insomnia need to be specifically refined and 
tuned (Riemann et al, 2010).  
It has been suggested that people with insomnia may appear to perform no differently in such 
tests than those with healthy sleep because, comparatively, they are able to recruit additional 
neurocognitive resources in order to match the demands of the task (Orff et al, 2007). Thus, 
the subjective impairment reported may be a reflection not of difficulties of performance, but 
of the additional neurophysiological effort needed to perform the task. This hypothesis is 
supported by evidence that people with obstructive sleep apnoea, a breathing disorder which 
leads to impaired sleep, show a compensatory neural activation mechanism, which increases 
with increased severity of the disorder (Archbold, Borghesani, Mahurin, Kapur, & Landis, 
2009). The hypothesis may explain why, as task complexity increases, and thus the demand on 
extra neurophysiological resources also increases, people with insomnia find it harder to keep 
the pace, and perform worse on these more complex tasks than normal controls (Altena et al, 
2008). The deficiency in performance in people with insomnia may reflect a trade-off between 
immediate response to presenting unambiguous stimuli (simple reaction time), and recruiting 
extra neurocognitive functions when the task difficulty increases (complex reaction time).  
The study by Altena et al (2008) makes this important distinction in attention deficits shown 
by people with insomnias. The authors used both a 'simple' reaction time task, and a 
‘complex’ vigilance task, which required participants to make a choice, rather than the same 
response to incoming stimuli. The insomnia group proved faster than the control group in the 
simple vigilance task, but slower than the control group in the complex vigilance task.  
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Following targeted intervention in respect of insomnia (including physical activity, light 
exposure, sleep hygiene), the ratio (or trade off) in performance between the simple and the 
complex task improved in the insomnia group, and their performance time 'normalised' near to 
the level of the control group.  
These results suggest that insomnia may affect simple cognitive functions required to monitor 
incoming stimuli, as well as higher cognitive functions required to monitor and decide on 
more ambiguous stimuli. Altena’s findings are consistent with those of other neurocognitive 
studies of people with insomnia, revealing the 'complexity cost' reflected in performance of 
tasks involving other more complex functions, such as working memory and decision-making 
processes (Edinger, Carney, & Wohlgemuth, 2008; Fortier-Brochu et al, 2012).  
Occupational impairment  
Linton & Bryngelsson (2000) assessed sleep problems and daytime work performance in a 
representative sample from the Swedish population, aged 20 to 60 years. The prevalence of 
sleep disturbance in the sample ranged from 35% (poor perceived sleep) to 8% (fulfilling 
DSM-IV diagnostic criteria). Just under 50% of the group with insomnia reported daytime 
impairments related to their sleep difficulties: poorer concentration and memory, headaches, 
problems making decisions; and feeling listless and ‘blue’. Poor sleep was reported to reduce 
work productivity and increase absenteeism and healthcare utilization, pointing to associated 
substantial indirect costs, added to those direct costs noted elsewhere in the literature (Leger, 
Levy & Paillard, 1999).  In a study of the occupational impact of sleep quality among 1054 
adults in England, Kucharczyk, Morgan and Hall (2012) found that 23% of workers reported 
that poorer quality of sleep affected their vitality throughout the day, and their ability to 
perform effectively in the workplace.  
Quality of life 
People with insomnia experience significantly poorer quality of life, both in physical and 
mental domains, compared to the general population. Comparing those with insomnia and 
without insomnia Bolge, Doan, Kannan, and Baran (2009), for example, found that the 
insomnia group had on average 10% lower scores on the physical and mental components of a 
quality of life measure. These significantly lower scores, which were adjusted for 
demographics and comorbid conditions, translated into significant lost work productivity, 
more than three times greater than the non-insomnia group.  
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Those people experiencing insomnia reported significantly more absenteeism, presenteeism 
(productivity impairment at work), and daytime activity impairment.  The health related 
quality of life of those people experiencing insomnia symptoms decreases with the increased 
severity of their sleep disorder (Schubert et al, 2002). This study found that insomnia 
symptoms had a negative impact on health related quality of life, with a significant decrease in 
every domain of quality of life with increasing number of insomnia traits. This effect 
remained significant even when adjusting for chronic disease, incontinence, smoking, alcohol 
use and impaired vision. In this large representative adult British sample, all categories of 
reported insomnia were significantly associated with lower health-related quality of life, after 
adjustment for physical health and common mental health disorders.  
1.1.5 Discussion of present treatment options for insomnia 
The NIH consensus statement on insomnia (Leshner, Baghdoyan, & Bennett, 2005) concluded 
that the main evidence-based current treatment options for insomnia are pharmacological and 
psychological. Pharmacological treatment aims to target the most obvious night-time 
symptoms, the inability to fall, or stay, asleep. Commonly used pharmalogical agents are 
benzodiazepines (such as temazepam). These have a long half-life, contributing to their 
efficacy in maintaining sleep throughout the night (Scharf, Roth, Dominguez, & Ware, 1990), 
but can also result in next day sedation and impaired next day cognitive functioning 
(Holbrook, Crowther, Lotter, Cheng, & King, 2000). Nonbenzodiazepine hypnotics, such as 
zolpidem, have proved less problematic in terms of next day consequences (Verster et al, 
2002). These seem to be effective to aid sleep onset, though they are less efficacious as sleep 
maintaining agents (Scharf, Mendels, Thorpy, & Weiss, 1994).  
Although a high proportion of people with insomnias use pharmacological agents long-term, 
(Mellinger, Balter, & Uhlenhuth, 1985), no currently approved insomnia agents have been 
evaluated in trials exceeding 12 weeks (Benca, 2005). Prolonged use of benzodiazepines, and 
of nonbenzodiazepine hypnotic agents, has been associated with both acute, and next day 
residual effects (Verster et al, 2002). People using pharmacological treatment for insomnia on 
a long term basis have higher mortality risk (Kripke et al, 1998).  
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Recent large longitudinal analyses of hypnotic medication use in relation to health and 
mortality outcomes show that people prescribed hypnotics (even in relatively small dosage of 
less than 18 pills a year) have significantly elevated hazards not only of mortality but of other 
adverse health outcomes (such as incident cancer), compared to people who were not 
prescribed hypnotics (Kripke, Langer, & Kline, 2012). In addition, pharmacological trials for 
insomnia treatment find that the placebo effect is a major contributor to the reported effect 
size of medication; it accounts for up to half of the effect size of the drugs response (Huedo-
Medina, Kirsch, Middlemass, Klonizakis, & Siriwardena, 2012.). 
Thus, overall, pharmacological treatment with hypnotic medication can be an effective short 
term solution for managing the symptoms of insomnia. Such treatment can give rapid relief in 
the short term from the most immediate night-time symptoms, of inability to get to, or to 
maintain sleep (Buscemi et al, 2005). There are serious adverse consequences of long term 
use, coupled with the large placebo effects accompanying such insomnia treatment; the 
remaining beneficial effect should be balanced against harmful effects set out above.  
The findings on the significant effect of placebo on the effectiveness of pharmaceutical 
treatment for insomnia point to the importance of psychological variables (Huedo-Medina et 
al, 2012). Nondrug alternatives for treating insomnia include cognitive and behavioural forms 
of therapy, such as CBT-I (Cognitive Behavioural Treatment for Insomnia), sleep hygiene, 
forms of meditation, and relaxation and mindfulness (Ong & Sholtes, 2010).  
CBT-I often consists of a combination of several techniques: cognitive restructuring, stimulus 
control, sleep restriction, sleep hygiene and relaxation (Morin & Espie, 2003). The efficacy 
and effectiveness of cognitive behaviour therapy for improving night-time symptoms of 
insomnia (CBT-I) is well established. The most recent American Academy of Sleep Medicine 
review of 85 clinical trials found 70% of people with insomnia who underwent CBT-I 
experienced enduring symptom reduction (Morin et al, 2006b).  
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Predictably, CBT-I shows longer term benefit in reducing the severity of insomnia symptoms 
and in improving sleep quality than pharmacological therapy for insomnia (Jacobs, Pace-
Schott, Stickgold, & Otto, 2004), and it is also effective in reducing the long-term use of sleep 
medication in people with insomnia (Morgan, Dixon, Mathers, Thompson, & Tomeny, 2004). 
CBT-I is also cost effective when compared to “treatment as usual” (i.e. prescription of 
hypnotics) in primary care settings (Morgan et al, 2004). Also, cognitive behavioural 
interventions contain the method of treatment preferred by patients with insomnia, when 
compared to medication (Vincent & Lionberg, 2001).  
As to reductions in daytime consequences of insomnia, such as fatigue, irritability and 
concentration difficulties, the evidence available of CBT-I’s efficacy is more sparse. One of 
the larger clinical trials comparing the effectiveness of CBT-I and pharmacological 
interventions in treatment of insomnia found no improvement in daytime insomnia-related 
variables (mood and fatigue) (Jacobs et al, 2004). More recent CBT-I trials found no 
significant treatment effect of CBT-I on daytime insomnia symptoms (sleepiness, fatigue, 
depression or anxiety) (Morin et al, 2006b; Bothelius, Kyle, Espie, & Broman, 2013).  
If CBT-I may have a direct effect only upon night-time symptoms of insomnia, this leaves 
open the possibility that a multi-therapeutic modality is necessary to improve daytime 
symptoms (Bothelius et al, 2013). Given the multi-factorial nature of insomnia, daytime 
related impairments may need targeting separately via specific behavioural and cognitive 
techniques. These techniques might address such difficulties sometimes related to chronic 
insomnia such as circadian rhythm desynchrony, excessively negatively toned cognitive 
functioning, or high anxiety levels.  
1.1.6 Summary 
Insomnia is a prevalent condition affecting not only night-time sleep, but also negatively 
impacting mood, cognitive performance, occupational efficiency and quality of life. Current 
pharmacological treatment for insomnia efficaciously addresses short-term nighttime 
insomnia symptoms. Cognitive and behavioural therapies for insomnia offer longer term relief 
of insomnia symptoms for a large proportion of sufferers, but do not always adequately 
address daytime insomnia-related symptoms. Current treatment options point to the multi-
factorial origins of insomnia, to include psychological variables.     
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1.2 Physical activity 
1.2.1 Definition of terms 
Physical activity, fitness, and exercise are terms which are often used interchangeably in the 
research literature, though they describe different concepts. Physical activity is any bodily 
movement produced by skeletal muscle that results in energy expenditure beyond the energy 
expended at rest. Exercise is a sub-set of physical activity, its defining features being 
structure, repetitiveness, planning, and having physical fitness as a motivational goal. Physical 
fitness comprises of a set of abilities which enable the ability to carry out physical activity, 
such as muscle strength, body composition, flexibility, and cardiovascular fitness.  
There is an important interrelationship between the amount of physical activity, and its 
intensity. Here,  amount  refers to the total energy expended in a given physical activity, and is 
usually described in minutes, while intensity refers to the rate of energy expenditure when 
engaged in physical activity (Pate et al, 1995). Intensity can be defined in absolute or relative 
terms. Absolute intensity is expressed in Metabolic Equivalents (METs), where 1 MET equals 
the resting metabolic rate (≈3.5 mL O2 x kg−1 x min−1). Relative intensity refers to the 
proportion of aerobic power used during exercise and is expressed as percent of the maximal 
heart rate (or VO2 max).  
Moderate intensity physical activity is considered the easiest achievable level for most strata 
of the general population, and is the intensity recommended by the current guidelines on 
physical activity and health (Chief Medical Officer [CMO], 2011). Moderate intensity 
activity, for example brisk walking, refers to an absolute energy rate of expenditure of 4 – 6 
METs, or a relative energy expenditure of 40-70% VO2 max. However, the relative intensity 
takes account of the maximal heart rate, which could vary depending on age, or health status.  
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Since physical activity is a complex behavioural construct, it poses specific measurement 
challenges in research and clinical practice. There are various measurement techniques 
available, from which activity-related energy expenditure can be calculated: self-report 
(through questionnaires and diaries), direct behavioural observation, physiological markers 
(such as heart rate, temperature), motion sensors (pedometers or accelerometers), and indirect 
calorimetry (Schutz, Weinsier, & Hunter, 2012). They each have advantages over others. For 
example, self-report questionnaires and diaries can offer type of activity performed and 
context, whilst motion sensors are more accurate and less burdensome for participants.  
Current physical activity guidelines for the UK, published by the Chief Medical Office (CMO, 
2011),  specify that adults should aim to be active daily and that, over a 1-week period, 
individuals should accrue at least 150 minutes (2½ hours) of moderate intensity activity in 
bouts of 10 minutes or more. This could be achieved by doing 30 minutes of moderate 
intensity activity on at least 5 days a week. 
1.2.2 Physical activity and health 
Increased physical activity levels are related to a host of physical and mental health indicators. 
Moderate physical activity using large muscle groups, such as brisk walking, produce 
cardiovascular adaptations that aid in increasing exercise capacity, endurance and skeletal 
muscle strength. Regular exercise is associated with a range of physical and mental health 
benefits. These include reduced risk of coronary heart disease (Sattelmair et al, 2011), non-
insulin dependent diabetes (Jeon, Lokken, Hu, & Van Dam, 2007), some cancers, particularly 
colon (Wolin, Yan, Colditz, & Lee, 2009) and breast cancer (Friedenreich, 2011), and 
neurodegenerative disorders (Hamer & Chida, 2009). An overall dose-response relationship 
between physical activity and all-cause mortality also exists (Samitz, Egger, & Zwahlen, 
2011), and a recent analysis suggested that physical inactivity accounts for 9% of premature 
deaths worldwide (Lee et al, 2012).   
In addition, exercise has been shown to have a role in the management of chronic conditions 
such as coronary heart disease (Leon et al, 2005), stroke (Gordon et al, 2004), diabetes 
(Colberg et al, 2010), obesity (Donnelly et al, 2009), and mental health problems, such as 
anxiety (Wipfli, Rethorst, & Landers, 2008) and depression (Rethorst, Wipfli, & Landers, 
2009).  
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More specifically, physical activity also contributes to the attenuation and reversal of 
symptoms in coronary heart disease (Taylor et al, 2004), benefits the glycaemic control in 
type 2 diabetes (Boule, Haddad, Kenny, Wells, & Sigal, 2001), and reduces the impact of 
existing mental health problems (Singh, Clements, & Fiatarone, 1997; Barton, Griffin, & 
Pretty, 2011). Evidence shows that the most benefit in mortality reduction is seen in those 
physically inactive people who take up regular physical activity (Myers et al, 2004), implying 
a role for physical activity in both the incidence and prevalence of chronic disease. Thus, 
adults who are physically active have lower rates of all-cause mortality and chronic disease, 
and exhibit higher levels of functional health than their less active peers (Morgan, 2003).  
1.2.3 Sleep and daytime activity levels 
Sleep is defined as an altered state of consciousness, characterized by immobility, reduced 
responsiveness and quick reversibility to the awake state, unlike anaesthesia or coma (Siegel, 
2004). Sleep behaviour, alternating periods of reduced activity and alertness, can be observed 
in virtually all animal species (Drucker-Colín, 1995); and in plants too (Covington et al, 
2008).  Many theories have been put forward on the function of sleep, contending that sleep 
relieves a deficit in body or brain tissue, fulfilling a physiological or psychological need 
accumulated during awaking periods. Of these, Horne (2006) holds that sleep varies in 
function with increasing complexity of the brain: in humans it serves the purpose of cerebral 
recovery; and in animals with less cerebral complexity, it serves the purpose of energy 
conservation. Others hold that sleep’s essential function is to reduce the energy expenditure 
below the level attainable by rest alone (Walker, Garber, Berger & Heller, 1979). Still others 
contend that sleep is serving to enforce rest and limit metabolic requirements (Zepelin & 
Rechtscaffen, 1974). 
The 2-process model of sleep regulation proposes that sleep results from the combined action 
of two independent processes: the sleep/wake homeostasis, which is dependent upon 
sleep/wake behaviour (process S); and the circadian biological clock, which runs 
independently of sleeping and waking (process C) (Borbely, 1982). By process S, sleep 
tendency (or sleepiness) increases with the duration of time one is awake. Thus, sleep is 
regulated in its intensity as a function of the duration of previous wakefulness. Process C, on 
the other hand, regulates the timing of alternating periods of sleep and wakefulness over 24 
hours.  
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The natural oscillation of the internal clock can be measures through temperature and 
hormonal changes over 24 hours. The ‘dips’ in the circadian rhythm result in the strongest 
sleep drive occurring in most adults between 2-4am and in the afternoon between 1-3pm. The 
sleepiness experienced during those times will be more intense if more awake time has been 
accumulated; and less intense if sufficient sleep occurred beforehand. Thus, the homeostatic 
drive for sleep is accumulated through the day, is then dissipated through adequate sleep, and 
the cycle begins again.  
Physical activity during the daytime can influence both the homeostatic drive, and the internal 
biological clock. Increased physical activity levels through the day will increase the energy 
expenditure, and metabolic requirements of the body, and potentially act upon process S by 
increasing the drive to sleep and restore energy. Under natural environments, the internal body 
clock is synchronized to the geophysical day/night cycle by environmental time cues 
(Zeitgebers). The most powerful zeitgeber for our bodies is the pattern of light exposure over 
24 hours. Other social zeitgebers are meal times, activity patterns, work schedule etc. Physical 
activity is one such zeitgeber, shown to have influence upon the entrainment of the circadian 
rhythm to the environmental time pattern, by contributing to effective temperature regulation 
maintenance (Youngstedt, 2002).  From this perspective, daytime activity behaviour serves to 
maintain the robustness of the sleep/wake circadian rhythm (van Someren & van der Lek, 
2007).   
1.3 Physical activity and sleep quality: epidemiological research 
1.3.1 Introduction 
The evidence suggests that, in general, people perceive physical activity as behaviour 
promoting better sleep quality. In a survey reported by Shapiro and Bachmayer (1988), for 
example, 83% of those participants who exercised at least twice a week reported the belief 
that exercise helped them fall asleep.  Just over a third of people randomly selected for a 
survey in Finland listed exercise as the best sleep-promoting practice (Urponen, Vuori, Hasan, 
& Partinen, 1988) while, in a large representative sample of the Japanese population, Ohida et 
al (2001) found that lack of regular exercise was associated with perceived insufficient sleep 
duration.  
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Similarly, in a study reported by Gerber, Brand, Holsboer-Trachsler, and Puehse (2010) it was 
found that those participants with a perceived lack of physical activity also reported prolonged 
sleep onset latencies.  
1.3.2 Summary of literature 
Large population datasets have consistently shown significant associations between increased 
physical activity levels and better sleep quality, as evidenced by comprehensive data reviews 
(Youngstedt & Kline, 2006; Buman & King, 2010). Epidemiological studies in which activity 
and insomnia outcomes have been assessed (and in which physical activity was clearly 
quantified) are presented in Table 1.   
Sherrill, Kotchou, and Quan (1998) analysed data from a cross section of 722 American adults 
randomly sampled, aged 40 years or over, obtained using structured questionnaires. The level 
of physical activity was categorised according to its frequency, intensity and duration, 
distinguishing between those subjects who engaged in physical activity vigorously, for more 
than one hour per day; those who walked at least 6 blocks per day for less than one hour per 
day, at a brisk pace (moderate intensity); and those who walked at least 6 blocks a day for less 
than one hour a day, at a low pace (low intensity).  
Insomnia was identified where subjects reported current difficulties in initiating and 
maintaining sleep. Sherrill et al’s study identified an optimal threshold level of physical 
activity required for identifiable sleep quality benefits as being “regular activity at least once a 
week, participating regularly in an exercise program, and walking at a normal pace for more 
than 6 blocks per day” (95% CI, ORs=0.47 to 0.71). This level of physical activity may be 
below the level of the current public health guidelines (6 blocks is the equivalent of 0.5 miles, 
which one could walk in 10 minutes, at a brisk pace). The authors also noted that there may be 
an inverted ‘U’ shaped relationship between physical activity and sleep, with women who 
exercised more vigorously, and women with insufficient exercise, having worse sleep than 
those men and women who had the ‘optimal’ amount of physical activity. This is supported by 
recent observational data in athletes’ sleep, which suggest athletes have poorer sleep quality 
markers compared to non-athlete controls, presumably due to high levels of exercise/training 
(Leeder, Glaister, Pizzoferro, Dawson, & Pedlar, 2012).  
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Janson, Lindberg, Gislason, Elmasry, & Boman (2001) analysed longitudinal data obtained 
from 2,602 men, randomly sampled, aged between 30 and 69 years of age, using the authors’ 
own questionnaire on the severity of sleep disturbance. Two groups of subjects were 
identified: being those who were physically active (defined as carrying out physical activity of 
at least moderate intensity, such as walking, cycling, gardening) for at least 240 minutes per 
week; and those who were sedentary (defined as almost completely inactive, engaging mostly 
in sitting, watching TV). Insomnia was classified according to the authors’ own questionnaire 
on severity of sleep disturbance. Janson et al’s study found that being physically inactive 
significantly increased the risk of reporting insomnia 10 years later (CI 95%, OR=1.4). 
However, the threshold definition used for being physically active (of at least 240 minutes per 
week), was higher than the current recommended public health guidelines (of at least 150 
minutes per week).  
Morgan’s longitudinal study (2003) analysed data from a random sample of 1042 people aged 
65 years or more. Physical activity was assessed using a structured detailed interview, where 
activities likely to promote health benefits were categorised according to their type, frequency 
and duration. These were then divided into quintile ranges, from a very low level, through to a 
high level of customary physical activity (CPA). Insomnia was classified if self-reported 
symptoms were present often, or always, during the preceding week. Insomnia prevalence in 
the sample was 21%. Morgan’s study (2003) found that walking for less than 11 minutes per 
day was significantly associated with prevalence of insomnia. In unadjusted bivariate 
analyses, there was also a marked activity gradient present, with lower levels of CPA 
associated with higher prevalence of insomnia. In final adjusted models, low or intermediate 
CPA levels were significantly associated with prevalent and incident insomnia. Thus, lower 
physical activity levels were associated with a significant higher risk for insomnia persistence, 
and insomnia incidence (CI 95%, ORs=2.0-2.2).  
The National Sleep Foundation Poll (2003) analysed data from a cross-sectional random 
sample of 1506 American adults aged between 55 and 84 years. Levels of physical activity 
were assessed according to frequency, based on how many times each week participants 
engaged in exercise of sufficient intensity to elicit health benefits. Using DSM-IV criteria, the 
poll assessed detailed sleep profiles, including sleep duration, quality, and insomnia 
symptoms.  
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The National Sleep Foundation Poll 2003 found that those adults who exercised less than once 
a week were significantly more likely to report experiencing symptoms of insomnia, than 
those adults who exercised three or more times per week. A dose response pattern was 
observed, with increased exercise accompanying decreased reported insomnia symptoms. In 
this sample, exercising to at least moderate intensity, for at least three times a week, delivered 
significant sleep benefits. The more recent National Sleep Foundation Poll 2013 delivered 
similar results: those who reported carrying out no physical exercise experienced more sleep 
problems, and lower sleep quality, than those who reported that they were physically active. 
There was an apparent dose-response relationship present, with those exercising at higher 
intensity reporting fewer sleeping problems, and better sleep quality (National Sleep 
Foundation, 2013).  
Kim et al’s longitudinal study (2009) analysed data from 1204 adults aged at least 65 years. 
Participants were divided into those who were active or inactive based on a structured 
assessment of both work and leisure activity, and validated measure of insomnia were used 
(i.e. DSM-IV criteria). Kim et al found that a lack of habitual physical exercise was 
significantly associated with prevalent and incident insomnia (95% CI, OR=1.8, and OR=1.6, 
respectively).  
Another recent epidemiological study, by Paparrigopoulos et al (2010a), analysed data from a 
cross section of 1005 adults aged between 18 and 99 years. Participants were divided 
according to the International Physical Activity Questionnaire (IPAQ) into two groups: those 
carrying out light, moderate or vigorous physical activity, and those who were sedentary. 
Insomnia was assessed on the Athens Insomnia Scale, a standardised validated questionnaire.  
In adjusted analyses, sedentary participants were found to have a significantly increased risk 
of reporting insomnia, as compared to those participants engaging in light, moderate or 
vigorous physical activity  (95% CI, OR=1.4). In a separate analysis of data from the same 
sample, based only of those participants who reported cardiac problems, physical activity was 
found to be a significant protective factor against reporting insomnia (95% CI, OR=0.69) 
(Paparrigopoulos, Tzavara, Theleritis, Soldatos, & Tountas, 2010b).   
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Table 1 
Selection of epidemiological studies of insomnia symptoms and physical activity 
Author and year Design Sample 
characteristics 
Insomnia assessment Physical activity assessment 
Sherrill et al, 
1998 
Cross-sectional 
Random 
sample 
N=722 
>40 years 
 
 
Self-reported current 
difficulties in initiating 
and maintaining sleep 
Three groups, according to intensity and duration: 
1: walked > 6 blocks/day at a brisk pace, < 1 h/day  
2: walked > 6 blocks/day at a low pace, < 1 h/day;  
3: vigorous physical activity, > 1 h/day. 
Janson et al, 
2001 
Longitudinal  
Random 
sample 
N=2,602 men,  
30-69 years 
Authors’ own 
questionnaire on 
severity of sleep 
disturbance 
Two groups (validated questionnaire): 
1: sedentary-almost completely inactive: sitting, watching TV 
2: physically active-at least medium intensity physical 
activity (walking, gardening, riding a bicycle), at least 4 
h/week. 
Morgan, K. 
2003 
Longitudinal  
Random 
sample 
N=1042  
>65 years 
Self-reported current 
sleep difficulties  
Two groups, by duration: 
1: walking > 11 min/day 
2: walking < 11 min/day 
Also, quintile ranges, from very low customary physical 
activity level (CAP), through to high CAP level. 
National Sleep 
Foundation, 
2003 
Cross-sectional 
Random 
sample 
N=1506 
55-84 years 
DSM-IV criteria Four groups, by frequency: 
 < 1 time/week 
1-2 times/week 
3-5 times/week 
> 5 times/week 
Kim et al, 
2009 
Longitudinal  N=1204 
>65 
DSM-IV criteria Dichotomous variable: 
Active 
Inactive 
Paparrigopoulos 
et al, 2010a 
Cross-sectional 
Random 
sample  
N=1005  
18-99 years 
Athens Insomnia Scale International Physical Activity Questionnaire (IPAQ) 2 
groups: 
1. Sedentary 
2. Light, moderate, vigorous 
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1.3.3 Summary 
The epidemiological studies reviewed above support the view that lower levels of physical 
activity are a significant risk factor both for present insomnia, and for the development of 
insomnia in the future (Janson et al, 2001; Morgan, 2003). Furthermore, the evidence shows a 
consistent trend of improved sleep quality with increased duration and intensity of physical 
activity (Morgan, 2003; National Sleep Foundation, 2003). All the above studies assessed 
physical activity in different ways, mostly clustered in intensity and duration, and frequency 
(Table 1). Though earlier studies use unvalidated questionnaires for assessing both insomnia 
and physical activity, later studies used validated instruments with known reliability (e.g. 
Paparrigopoulos et al, 2010a). Even with this variety of assessment instruments, the effects 
shown in these studies, while modest, are broadly similar.  
1.3.4 Limitations identified in the reviewed literature 
Nevertheless, there are limitations to the inferences which can be drawn from this research. 
The causal ordering of sleep-activity relationships reported in cross sectional epidemiological 
studies, for example, remains unclear. People with poor sleep quality feel more fatigued, 
sleepy and cognitively impaired during the daytime, which in turn reduces the energy and 
motivation necessary to exercise (Suskin, Ryan, Fardy, Clarke, & McKelvie, 1998).  The 
pathways which mediate possible sleep-activity inter-relationships are also unclear from the 
epidemiological research.  Light exposure, for example, is known to influence circadian 
rhythm indicators (Gordijn, Korte, & Van den Hoofdakker, 1998) and sleep quality 
(Guilleminault et al, 1995). Both light and physical activity have chronobiotic properties 
(Atkinson, Drust, Reilly, & Waterhouse, 2003; Knight, Thompson, Raboud, & Hoffman, 
2005; Buxton, Lee, L'Hermite-Balériaux, Turek, & Van Cauter, 2003). The effects on sleep 
quality could vary significantly depending on the timing of light exposure, and exercise 
intensity and duration (Youngstedt, Kripke, & Elliott, 2002).  
Youngstedt et al (2003), in an observational study of sleep quality and exercise, found that the 
mean reported time spent outdoors was almost three times higher (142 minutes) on days when 
participants were active, than on days when they were not active. Disentangling the effects, of 
light exposure and exercise cannot be reliably achieved in the present epidemiological 
research. In the absence of recorded data in time spent outdoors, or the amount of daily light 
exposure, it is difficult to estimate the confounding effect of light on sleep quality.  
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A further important issue which is not addressed in the sleep-activity epidemiological 
literature concerns the practical identification of a level of activity (expressed in terms of 
intensity, frequency and duration) necessary to positively impact sleep quality.  This is in 
marked contrast to the emphasis now placed in public health on the identification of precise 
minimum levels of physical activity likely to deliver a range of health benefits.  Thus, the 
amount, frequency, intensity and type of physical activity required to achieve mental and 
physical health benefits have all been examined in systematic reviews, and translated into 
international public health messages. These reviews have consistently found that moderate 
intensity physical activity levels at or above a threshold value of 150 minutes per week 
reliably deliver cardiovascular, metabolic and musculo-skeletal health benefits (Warburton, 
Charlesworth, Ivey, Nettlefold, & Bredin, 2010).  This overall weekly volume of engagement 
appears beneficial irrespective of the type of activity performed (Warburton et al, 2010), 
though walking has been identified as the most convenient and achievable form of exercise for 
a high proportion of the adult population (Department for Transport, 2012).  While promoting 
this level of activity is now a public health priority for reducing levels of stroke, heart-disease, 
cancers, diabetes and obesity, the evidence base does not yet allow such precision in 
predicting activity-related sleep benefits.  Rather, the sleep-activity literature presents a range 
of possibly effective activity levels which might reduce insomnia symptoms and improve 
sleep quality, ranging from high intensity exercise regimes (see Driver & Taylor, 2000) to 
above-average levels of customary physical activity (Morgan, 2003).    
1.4 Activity and Insomnia: a research agenda 
Establishing a minimum level of activity likely to impact sleep quality could have 
implications for both public health generally, and behavioural sleep medicine specifically.  
Behavioural approaches to the management of insomnia include cognitive and behavioural 
forms of therapy, such as Cognitive Behavioural Treatment for Insomnia (CBT-I), sleep 
hygiene, and relaxation and mindfulness approaches (Ong & Sholtes, 2010). CBT-I often 
consists of a ‘package’ of techniques, typically cognitive restructuring, stimulus control, sleep 
restriction, sleep hygiene and relaxation (Morin & Espie, 2003).    
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While the American Academy of Sleep Medicine’s recommendation for behavioural and 
psychological treatment approaches to insomnia is based on the evidence of their high degree 
of clinical effectiveness (see Morgenthaler et al, 2006), it is also the case that CBT-I does not 
benefit all patients.  In reviews prepared by the Task Force of the American Academy of Sleep 
Medicine, Morin and colleagues (1999; 2006b) concluded that CBT-I delivers lasting benefits 
to 80% of treated patients.  Similarly, Montserrat Sanchez-Ortuno and Edinger (2010) note 
that not all people with insomnia benefit equally from standardised forms of CBT-I, and that 
responses vary along psychological and behavioural dimensions, including daytime 
sleepiness, anxiety and depression. Some of these variables may be modifiable by other 
behavioural or psychological interventions, augmenting the CBT-I treatments.  Physical 
activity presents as a strong candidate for behavioural intervention for insomnia; few other 
daytime behaviours are more linked to subsequent night-time sleep. However, before physical 
activity can be offered as a practical and effective adjunct to CBT-I, two important scientific 
objectives need to be met. First, an appropriate minimal level of activity intervention should 
be empirically established.  This would introduce clarity for practitioners, and avoid the 
unnecessary exclusion and attrition from treatment programmes which would result if the 
level was set too high, and beyond that achievable by many patients.  And second, any such 
minimal level should be subjected to a randomised and appropriately controlled clinical trial, 
in order to establish effectiveness independent of confounders like light exposure, and the 
methodological issue of causal ordering.     
The programme of research presented in this thesis was designed to address both of these 
needs.  Since a level of  ≥150 minutes of moderate intensity physical activity per week has 
already:  a) proved sufficient to deliver a range of health benefits; and b) been adopted by 
agencies around the world as an ‘aspirational’ public health goal, it would seem reasonable to 
initially adopt this threshold value in preliminary explorations of a minimal level of activity 
likely to impact sleep quality and insomnia symptoms.  In order to test proof of concept, 
secondary analyses of existing longitudinal data were conducted to assess whether walking to 
current WHO guideline levels of physical activity (≥150 minutes/week) was associated with 
sleep quality benefits in a representative sample of UK older people. The rationale, method, 
analysis, results and conclusion from these assessments are presented in Chapter 2.   
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CHAPTER TWO 
2.0 Proof of concept: physical activity and insomnia in the Nottingham 
Longitudinal Study of Active Ageing  
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2.1 Background 
Systematic reviews have consistently found that moderate intensity physical activity levels at 
or above a threshold value of 150 minutes per week reliably deliver health benefits (See 
Chapter 1).  This overall weekly volume of engagement appears beneficial irrespective of the 
type of activity performed (Warburton et al, 2010), though walking has been identified as the 
most convenient and achievable form of exercise for a high proportion of the adult population 
(Department for Transport, 2012).  Whether a minimum of 150 minutes per week of walking 
can also impact sleep quality has not previously been investigated.  None of the major UK 
surveys which include measures of physical activity (e.g. the Health Survey for England; the 
Time Use Survey; the General Household Survey; the Active People Survey) also include 
suitable measures of sleep quality.  However, the opportunity to explore relationships between 
sleep quality and precise levels of walking is presented by the Nottingham Longitudinal Study 
of Activity and Ageing (NLSAA), an ongoing study of physical activity and health outcomes 
which has already delivered epidemiological profiles of insomnia and activity levels in 
England (Morgan, 2003).  While it could be argued that results from a sample of older adults 
may not necessarily generalise to the whole adult population, the utility and validity of the 
present approach is supported by four counter-arguments: first, the NLSAA provides the only 
accessible nationally representative sample on which such analyses are possible;  second, 
since the aim of the proposed analyses is to test proof of concept, the demographic 
composition of the sample is less relevant; third, the dose-response relationship between sleep 
quality and activity level reported from the National Sleep Foundation Poll (2003) was found 
to be age independent; and fourth, levels of physical activity show a significant degree of 
‘tracking’ across the lifespan, with individuals showing a strong tendency to maintain their 
activity rank positions within the population (see Armstrong and Morgan, 1998; Malina, 
2001). 
2.2 Aim of present analyses   
Using models controlling for appropriate confounders, the analyses reported in this chapter 
assess whether older adults who report habitual walking levels at or above a threshold value of 
150 minutes per week: i) show a significantly lower risk of all-cause mortality over a 27 year 
period (these analyses were conducted in order to assess the validity of the walking measure); 
and ii) demonstrate a reduced risk of insomnia symptoms. 
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2.3 The Nottingham Longitudinal Study of Activity and Ageing (NLSAA) 
description 
The NLSAA commenced in 1985 with the aim of meeting three core objectives: i) to quantify 
customary physical activity (CPA) and physical capabilities within a representative sample of 
elderly people living at home; ii) to quantify physical and psychological wellbeing within a 
representative sample of elderly people living at home; and iii) to examine, cross-sectionally 
and longitudinally, inter-relationships between CPA, health, and psychological wellbeing. 
Within the structure of a panel study with repeated survey measurements (but without sample 
replacement) data were collected in three waves: baseline measurement (T1: 1985); the first 
follow-up (T2: 1989); and the second follow-up (T3: 1993).  In order to preserve numbers for 
longitudinal analyses, yet allow for change in the variables of interest, 4-year follow-up 
periods were considered optimal.   To control for possible seasonal variations in CPA, all 
three interview waves were conducted in the summer period May-September.  Data were 
collected by lay interviewers recruited at each survey phase (n = 10, 8 and 8 for T1, T2 and T3 
respectively).  All interviewers were women, with ages ranging from 27-68.  Information on 
mortality within the baseline sample continues to be provided by the UK Medical Research 
Information Service, allowing for ongoing survival analyses.  
2.4 The sample 
Using electoral ward-level statistics from the 1981 census, three areas of greater Nottingham 
were combined to provide a study population whose demographic composition (as regards 
age, sex, social class, ethnicity and proportion of elderly people living alone) reflected the 
average national pattern for England and Wales (Table 2). The resulting area included a total 
of 48 733 individuals served by 25 general practitioners. With the consent and cooperation of 
these general practitioners, NHS age-sex lists were used to identify all patients aged 65 years 
and over within the survey areas. Since the aim was to identify a representative community 
sample, those living in institutions (i.e. those whose permanent address was a residential or 
nursing homes) were excluded. A total of 8409 elderly people were identified, from which 
1299 eligible individuals (those alive and still living at the address provided) were randomly 
selected for interview. At sampling those aged 75 years or older were intentionally over-
represented in order to admit sufficient numbers for subsequent longitudinal analyses.  
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Accordingly, while the ratio of "old" (65-74 years) to "very old" (75+ years) people in the 
1985 British population was approximately 1.62:1 [4] a baseline ratio of 1:1 was the target for 
this study.  
The baseline (T1) survey was conducted between May and September 1985. All potential 
respondents were first sent a letter inviting them to participate in the survey. After a minimum 
of three clear days, each respondent was then visited by an interviewer. Of the 1299 
individuals approached, 1042 were interviewed, a response rate of 80% (Table 2). 
2.5 Survey assessments 
The structured questionnaire contained a total of 318 items, and was designed to take 45-90 
minutes to administer.  Assessments directly related to the present analyses are described 
below. 
Walking  Levels of customary physical activity likely to promote muscle strength, joint 
flexibility, or stamina were assessed using detailed activity inventories administered in the 
single face-to-face interview. These activities were divided into five mutually exclusive 
functional categories: outdoor productive activities (e.g. gardening, house and car 
maintenance); indoor productive activities (e.g. housework, decorating, indoor maintenance); 
walking (purposeful walking outside the house or garden); shopping (i.e. continuous 
ambulatory behaviour associated with shopping); and leisure activities (e.g. cycling, 
swimming - walking was included as a leisure activity only if it was described as such).  
‘Customary’ defined those activities with a probable minimum energy cost of 2kcal/min, 
performed continuously for a minimum of three minutes, at least weekly, for at least the 
previous six weeks. In administering the questionnaire on outdoor, indoor, and leisure 
activities the interviewer first determined whether the respondent's participation in the activity 
met the criteria for 'customary', and then asked in detail about the frequency and duration of 
participation. Each reported activity was scored as minutes per week. Non-participation was 
scored as zero.   
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In the assessment of walking, the interviewer asked in detail about walking done on a typical 
day, selecting preferentially the day prior to interview.  If, however, this day had been 
atypical, then another was selected (up to a maximum of six days previously).   For the 
purposes of the interview, the selected day was divided into hours, and the amount of walking 
(purposeful walking, shopping, and recreational walking) in each hour was coded in minutes, 
and finally expressed as minutes per typical day. These were then aggregated in minutes per 
week.  
Sleep Subjectively estimated sleep quantity was assessed using the items: 1) “At what time do 
you usually go to bed?”; 2) “At what time do you usually settle down in bed to go to sleep?”; 
3) How long does it normally take you to fall asleep?”; 4) “At what time do you finally wake 
up?”; and 5) “At what time do you usually get up?”. Responses were then used to estimate 
time in bed (TIB = time elapsed between going to bed and getting up); sleep latency (SOL = 
time taken to fall asleep); and total sleep time (TST = TIB minus all non-sleep time in bed).   
Quality of sleep was assessed using the item "Do you ever have problems sleeping (i.e. 
problems getting to sleep and/or staying asleep and/or waking too early?)", with five 
response categories (never, seldom, sometimes, often, all the time).  Positive responses 
were followed with the question “Have you had this problem (or these problems) in the 
past week?”.  Insomnia symptoms were considered present if the respondent reported a 
sleep problem "often" or "all the time", and if that problem had been experienced within 
the previous week. 
Two sleep outcome variables were calculated for the present analyses: sleep efficiency 
(the percentage of time spent asleep in bed: SE = (TST/TIB) x 100)) and the presence of 
insomnia symptoms.  While separately reflecting quantitative and qualitative estimates, 
these measures are not unrelated, since sleep efficiencies below 85% typically indicate 
poor quality sleep (Perlis, McCall, Jungquist, Pigeon, & Matteson, 2005). 
General health was assessed using a health index scored from zero (no health problems) to 
13 (multiple health problems) covering the presence or absence of: heart, stomach, eyesight, 
or foot problems; giddiness, headaches, urinary incontinence, arthritis, falls, and chronic 
disease; drug and walking aid use, and recent (1 month) contact with (primary and secondary 
care) medical services. The scale showed full activity across its score range (0-13) and 
acceptable reliability (Cronbach’s alpha = 0.7).  
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Weight and skeletal size   At interview weight measurements (fully clothed with shoes 
removed) were made using calibrated analogue scales. To reduce error arising from kyphotic 
changes in measuring the height of older people, skeletal size was assessed using demispan 
(Bassey, 1986), the distance between the finger roots and the sternal notch (with the arm 
laterally outstretched). Body mass was then estimated using the Quetelet Index (BMI) based 
on weight and predicted height (Lehmann, Bassey, Morgan, & Dallosso, 1991).  Those with a 
BMI >25 were classified as overweight. 
Mental health status  Affective status was assessed using the separate anxiety and depression 
subscales from the Symptoms of Anxiety and Depression (SAD) Scale (Bedford, Foulds, & 
Sheffield, 1976) which focuses exclusively on recent symptoms. Clinically significant levels 
of either anxiety or depression are indicated by subscale scores of ≥4.   In validation trials 
conducted at baseline, scores at or above these cutpoints showed high levels of concordance 
with clinical diagnostic ratings (Morgan, 1998).  
Cognitive functioning  At the beginning of the interview all respondents were initially 
screened for cognitive impairment using the 12-item Information/Orientation (I/O) scale 
from the Clifton Assessment Procedures for the Elderly (Pattie & Gilleard, 1979). If, after 
appropriate prompting, the respondent failed to achieve a maximum I/O score of 8 and, in 
the opinion of the interviewer, was unlikely to respond reliably to the remaining 
questionnaire items, the interview was discontinued.  In validation trials conducted at 
baseline, scores at or above this cutpoint showed high levels of concordance with clinical 
diagnostic ratings of dementia (kappa coefficient = 0.83, p<0.001; Morgan, 1998).  
2.6 Statistical analyses 
Data were appropriately weighted to compensate for oversampling of the age group 75+ at 
baseline.  Initial examination of the log-minus-log plot of the survival function showed no 
departure from the assumption of proportional hazards.  
To investigate relationships between physical activity (as walking) and mortality, baseline 
walking durations were categorized as below guidelines (<150 minutes/week) or equal to, 
or above guidelines (≥150 minutes/week).  
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Two Cox regression models were employed: a partially adjusted model (Model 1) and a 
fully adjusted model (Model 2).  In Model 1 survival (period from baseline assessment in 
1985 to death or censorship in March 2012) was the dependent variable, and walking 
category (<150 minutes/week or ≥150 minutes/week), chronological age at baseline, and 
sex were covariates.  To improve the interpretability of results, chronological age was 
entered as a 4-category variable (65-69; 70-74; 75-79; 80+).  Model 2 was similar to 
Model 1, but also included baseline measures of physical health (above and below median 
value), BMI, the presence/absence of clinically significant levels of anxiety and 
depression, and social class as covariates. A forced entry approach to model selection was 
used.   
To assess the consistency of physical activity-survival relationships over the duration of 
study, the fully adjusted Cox regression model (Model 2) was repeated for the data 
collected at the 1989 and 1993 study measuring points.  
To assess cross sectional relationships between walking category and sleep quality at 
baseline, logistic regression models were fitted separately for insomnia symptoms 
(present/absent) and sleep efficiency (<85%/≥85%).  In both cases models were adjusted 
for age (65-70; 70-74; 75-7; 80+), sex, physical health status (above and below median 
Health Index value), BMI, the presence/absence of clinically significant levels of anxiety 
and depression, and social class.  Where appropriate, means were compared using 
independent samples t-tests, and the chi-square test was used to analyse contingency 
tables.  All data were analysed using SPSS for Windows v 19.0.     
2.7 Results 
2.7.1 Descriptives 
From the original baseline survey 1042 respondents provided information at interview.  
Information on both physical activity and sleep quantity and quality was available from 926 
respondents (with omissions due primarily to cognitive impairment or physical disability at 
baseline).   
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Sample characteristics and attrition are shown in Table 2. Overall, 21.6% of the sample 
reported insomnia symptoms, with 49% reporting sleep efficiencies below 85%. The 
prevalence of insomnia symptoms was also relatively stable over time, with rates of 25% and 
22% respectively reported in the 1985 and 1993 follow-ups. The prevalence was higher in 
women than men (Figure 1).  
Table 2 
Sample characteristics and attrition in the study sample between 1985 to 2012 
Variable 
Total analysed 
N (%) 
Women 
N (%) 
Men 
N (%) 
Baseline respondents (1985)  926 557 (60) 369 (40) 
 Walking to guidelines: 
             ≥150 walking minutes/week 
345 (37) 197 (21) 148 (16) 
 Walking below guidelines:  
 <150 walking minutes/week 
581 (63) 360 (39) 221 (24) 
BMI  > 25 (Overweight & Obese):  366 (39) 233 (25) 133 (14) 
Follow-up respondents(1989):  609 363 (60) 246 (40) 
 Walking to guidelines:    
             ≥150 walking minutes/week 
272 (44) 147 (24) 125 (21) 
Follow-up respondents(1993):   383 250 (65) 133 (35) 
 Walking to guidelines:   
             ≥150 walking minutes/week 
142 (37) 84 (22) 58 (15) 
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Figure 1. Prevalence of insomnia symptoms in each walking category. 
 
The activity threshold of ≥150 walking minutes/week divided the sample at baseline into 37% 
above, and 63% below the recommended guidelines.   Overall, 42% of women and 36% of 
men were classified as overweight/obese at baseline (Table 2).   
2.7.2 Physical activity and sleep outcomes 
In bivariate analyses lower levels of walking were significantly associated with higher levels 
of reported insomnia symptoms for the sample overall (X2= 17.1; df = 1; p<0.001), and for 
women (X2= 7.3; df = 1; p<0.01) and men (X2= 7.9; df = 1; p<0.01) separately.  
Results from the fully adjusted logistic regression models examining relationships between 
walking levels and the sleep outcomes of insomnia symptom prevalence, and sleep efficiency 
are shown in Tables 3 and 4, respectively.  The analyses show that higher levels of walking 
were significantly and independently associated with a lower likelihood of either reporting 
insomnia symptoms (OR = 0.67 (95% CI = 0.45 – 0.91), p=0.04), or experiencing poor sleep 
efficiency (OR = 0.70 (95% CI = 0.52 – 0.94, p=0.02). 
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Table 3 
 
Odds ratios and 95% confidence intervals for insomnia outcomes in walking categories 
Model & Variables B(SE) Odds Ratio 95% CI P* 
Included in the model:      
        Constant 
 
       Walking category (lower) 
-1.86(0.54) 
 
-0.40(0.20) 
 
 
0.67 
 
 
0.45 – 0.91 
 
 
=0.04 
 Physical Health Status    
(higher category) 
0.97(0.19) 2.64 1.79 – 3.88  <0.001 
 Anxiety 1.28(0.23) 3.61 2.26 – 5.77  <0.001 
 Age †  1.26 N/S =0.39 
 Sex (male)  1.42 N/S =0.07 
 Depression  1.33 N/S =0.30 
 Social Class (Class I & II)  0.96 N/S =0.88 
 BMI         1.02 N/S =0.22 
*2 tailed significance of regression coefficients. 
†As 4 categories: 65-69;70-74;75-79;80+ 
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Table 4 
 
Odds ratios and 95% confidence intervals for sleep efficiency outcomes in walking categories 
 
Model & Variables 
 
B(SE) 
 
Odds Ratio 
 
95% CI 
 
p* 
Included in the model:     
        Constant 
 
        Walking category (lower) 
  -0.05(0.04) 
 
-0.35 (0.15) 
 
 
0.70 
 
 
0.52 – 0.94 
 
 
=0.02 
 Physical Health Status    
(higher category) 
-0.52 (0.15) 0.58 0.43 – 0.78 <0.01 
 Anxiety -0.06 (0.25) 0.54 0.33 – 0.86 <0.01 
 Age †  0.81 N/S =0.31 
 Sex (male)  0.75 N/S =0.06 
 Depression  0.75 N/S =0.30 
 Social Class (Class I & II)  1.05 N/S =0.79 
 BMI  0.99 N/S =0.78 
*2 tailed significance of regression coefficients. 
†As 4 categories: 65-69;70-74;75-79;80+ 
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2.7.3 Physical activity and mortality outcomes 
In the 27-year period 1985-2012 the project received notification of 878 deaths within this 
subgroup (Table 2). Results from Cox regression analyses are shown in Table 5. 
In Model 1, the higher level of walking at baseline was significantly associated with a 
decreased mortality hazard (HR = 0.75 (95% CI = 0.65 - 0.86) p<0.01), after controlling for 
age and sex.  
Hazard outcomes were similar in Model 2 after controlling for age, sex, and baseline measures 
of physical health, anxiety, depression, and social class  (HR =0.78 (95% CI = 0.68-0.84) 
p<0.01).   
To assess data consistency, we repeated the fully adjusted survival model for the 1989 (T2) 
and 1993 (T3) follow-ups. The results again showed a significant association between higher 
levels of walking and decreased mortality (1989: HR = 0.80 (95% CI = 0.67 - 0.95) p=0.01; 
1993: HR = 0.78 (95% CI = 0.62 - 0.98) p=0.04).  
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Table 5 
 
Hazard ratios and 95% confidence intervals for 27-year mortality 
 
Model & Variables 
 
Hazard Ratio 
 
95% CI 
 
p* 
    
Model 1 (Partially adjusted)    
      
        Walking category 
(lower) 
 
0.75 
 
0.65 – 0.86 
 
<0.001 
 Age b 1.48 1.18 – 1.75  <0.001 
 Sex (male) 0.72 0.63 – 0.83   <0.001 
    
Model 2 ( Fully adjusted)    
         
        Walking category (lower 
 
0.78 
 
0.68 – 0.90  
 
<0.01 
 Age † 1.41 1.15 – 1.73  <0.001 
 Sex (male) 0.70 0.62 – 0.81  <0.001 
 Physical Health Status  
(higher category)   
1.30 1.11 – 1.51  <0.001 
        BMI            0.86 0.74 – 0.99 =0.04 
 Anxiety 1.12 N/S =0.29  
 Depression 0.92 N/S =0.58 
 Social Class (Class I & 
II) 
1.04 N/S =0.63 
*2 tailed significance of regression coefficients. 
† As 4 categories: 65-69;70-74;75-79;80+ 
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2.8 Discussion 
Given the representativeness of the original NLSAA survey sample, the relatively high 
response rates obtained at baseline, and the known reliability and validity of the survey 
measures used, the present analyses offer a robust test of the hypothesis that levels of physical 
activity consistent with being at or above the recommended threshold, positively impact sleep 
outcomes independent of concomitant health status.   
Insomnia was assessed using questions which evaluated the frequency of the sleeping 
problems (whether often or all the time), and the period over which those sleeping problems 
were reported (if symptoms had been present over the last week). Even though these criteria 
do not map onto the present DSM-5 diagnostic insomnia criteria, a balance between brevity of 
assessment and accuracy of diagnosis must be reached within large epidemiological surveys. 
The prevalence of insomnia symptoms reported in the baseline survey (21.6%) is within the 
range seen in more recent samples, and is also consistent with epidemiological trends over the 
past 30 years (Morgan, 2012). In addition, the characteristics of the identified sub-section of 
people with insomnia within the whole sample follow those noted in other major population 
surveys: most people with insomnia are women, the odds of reporting insomnia increase with 
age, and prevalence of chronic disease is higher in this sub-group, compared to the rest of the 
sample.  
In contrast, for all age and gender groups, levels of walking at or above the recommended 
threshold were greater among NLSAA respondents than in contemporary samples. For 
example, using data from the 2008 Health Survey for England, Craig, Mindell & Hirani 
(2009) found that only 13% of adults over the age of 65 reported walking levels at or above 
150 minutes/week. While some of this difference may be explained by methodological 
factors, the results are also consistent with evidence of an overall reduction in certain physical 
activity types throughout the 1990s (e.g. Brownson, Boehmer, & Luke, 2005).  Brownson et al 
(2005) reviewed long-term trends in physical activity over the past 50 years, and noted 
declines in work-related activity, transportation activity, and activity in the home, coupled 
with an increase in sedentary behaviour (e.g. television watching).   
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Further support for the validity of the activity measure used in the NLSAA survey is provided 
by the survival outcomes.  The results indicate that walking over 150 minutes (2.5 hours) a 
week at was associated with increased survival at 27-year follow up, amounting to a 22% 
(0.78) decrease in hazard rate. This is consistent with findings of other studies examining 
survival risks associated with physical activity generally (e.g., Hamer & Chida, 2009) or 
walking specifically (Samitz et al, 2011: 0.93 (0.87–0.97); Woodcock, Franco, Orsini, & 
Roberts, 2011: 0.89 (0.82-0.96)). Woodcock et al (2011) reported a very similar decrease in 
mortality risk ratio (0.76) was associated with physical activity of light or moderate intensity, 
of at least 7 hours per week. This level of physical activity – 7 hours per week – is close to the 
median duration of walking time shown in those walking ≥150 minutes/week in the present 
analyses.  
2.9 Conclusions   
Using activity measures validated by longitudinal follow-up, the present analyses show that 
walking at or above the threshold of 150 minutes/week was associated with a significantly 
lower likelihood of reporting insomnia symptoms.  It would appear, then, that in general, 
those who walked more, slept better.  Since the models took into account age, gender, mood, 
body mass and health status, it is unlikely that walking was simply a proxy for superior health 
status, leading to less sleep disruption. Rather, the evidence presented here strongly suggests 
that walking mediated the sleep benefit.   
Indicative of a dose-response relationship, the present results also show a more modest odds 
reduction than that shown when higher levels of habitual physical activity are examined in 
relation to sleep outcomes (e.g. Hublin, Kaprio, Partinen, & Koskenvuo, 2001; Kim et al, 
2009). The limitations of secondary analyses performed on data collected from an earlier 
generation of older people are self-evident. Changes in physical activity and in general health 
trends during the  past 27 years, coupled with an increase in overweight/obesity trends over 
the same period, could have introduced generational or cohort effects which impacted the key 
variables reported here.  Yet while these trends may be reflected in overall levels of physical 
activity - such as walking - in the contemporary older population aged 65+, it is less clear how 
secular change would impact on relationships between walking and health and wellbeing 
outcomes.   
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That the relationships identified in these analyses accord with contemporary findings supports 
the validity of the conclusions drawn and, at the very least, offers ‘proof of concept’ that 
physical activity-sleep relationships operate on a continuum, even at relatively low levels of 
activity. A major implication of the present findings, therefore, is that significant 
improvements in both the structure and quality of sleep may be added to those health benefits 
already demonstrated for those meeting recommended guidelines for physical activity. The 
next step is the identification and assessment of experimental evidence attesting to the 
causality of this relationship.  
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CHAPTER 3 
3.0 The effects of physical activity on sleep outcomes: reviews of 
experimental and controlled trials  
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3.1 Introduction 
In Chapter 1, sleep quality and physical activity relationships were introduced, and reviewed 
at the epidemiological (population) level.  The conclusion, that the literature suggests a dose-
response relationship between levels of physical activity and reported sleep quality, led to the 
proposition that a ‘minimal threshold’ of activity, similar to that associated with a range of 
non-sleep health benefits, may operate for insomnia symptoms.  This proposition was 
formally tested in the secondary analyses reported in Chapter 2, which showed that, among 
older people, levels of activity (as walking) at or above the currently recommended threshold 
of 150 minutes/week were associated with a significantly lower odds of reporting insomnia 
symptoms.  
Epidemiological data are useful in identifying patterns, associations and interactions among 
variables within the general population. While such cross-sectional data can establish risk, it 
cannot definitively establish causal links between factors. Levels of physical activity and sleep 
quality show consistent associations, but one cannot be certain of the directionality of (i.e. the 
causal ordering within) this relationship. Randomised controlled trials, on the other hand, are 
considered the 'gold standard' methodology of research designed to evaluate whether, and to 
what extent, a given intervention impacts a nominated outcome (Jadad, 1998). This type of 
methodology is considered robust enough to establish causality between factors, and it is 
suited to situations where the effect sizes might be small to medium.  In order to contextualise 
the further study of ‘minimal’ activity thresholds in the management of insomnia (in Chapter 
4), the present chapter will review experimental evidence examining the impact of 
activity/exercise on sleep outcomes.  This relatively small literature broadly divides into 3: 
studies of the acute effects of exercise on sleep; studies of the impact of activity/exercise on 
the experience of chronic conditions related to insomnia; and clinical trials (RCTs) which 
have assessed the impact of physical activity interventions on sleep outcomes.  
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3.2 Method  
Experimental studies and trials of the acute effects of exercise/activity on sleep outcomes, or 
the effects of exercise interventions on sleep outcomes in the context of chronic conditions, 
were identified using a range of appropriate search terms including: insomnia; sleep; activity; 
physical activity; exercise; comorbid insomnia; chronic conditions; and aerobic activity. 
Identified studies were then screened for relevance.   In order to identify clinical trials 
evidence in relation to at least insomnia symptoms, a literature search was first conducted  
using the search terms: insomnia; sleep; poor sleep; RCT/Randomised Controlled Trial; 
pragmatic trial; activity; physical activity; exercise; and aerobic activity.  Additional papers 
were identified using citation maps. Only papers which: i) qualified as randomised controlled 
trials; ii) characterised insomnia in line with RDC and RAC recommendations (Edinger et al, 
2004; Buysse et al, 2006) or explicitly defined insomnia complaints/symptoms independent of 
comorbidity; iii) utilised outcome measures in line with RDC and RAC recommendations 
(Edinger et al, 2004; Buysse et al, 2006); and iv) quantified levels of the physical activity 
intervention were included.   
3.3 Findings of studies of the acute effects of exercise on sleep outcomes 
Several studies have documented positive results of acute physical activity (i.e. one session 
only) over sleep during the subsequent night. These are summarised in a review by 
Youngstedt (2005). The effects of acute exercise on sleep are generally modest, with a linear 
trend of increased total sleep time with exercise duration (Youngstedt, O’Connor, & Dishman, 
1997). However, the findings show very modest effect size, and they present clinically 
insignificant results (for example, increase of total sleep time of 10 minutes) (Youngstedt, 
2005). In addition, these studies have been performed mostly in young healthy adults, leading 
to ceiling effects (Youngstedt et al, 2003).  
In the only study identified in the published literature of the impact of physical activity on 
participants with insomnia, by Passos et al (2011), the findings are clinically more significant. 
The randomised controlled trial examined the effect of different intensity and type of physical 
activity on sleep parameters and anxiety in middle aged people with chronic insomnia. The 
effect sizes were large, with significant reduction in sleep onset latency (36%), increase in 
total sleep time (26%) and decrease in pre-sleep state anxiety in the moderate intensity 
exercise group (treadmill for 50 minutes).  
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3.3.1 Summary and limitations 
There is very limited evidence looking at the more immediate effects of exercise on sleep 
quality of people with disturbed sleep. The evidence suggests the same trend of increased 
sleep quality with increased exercise duration, as well as a significant role of psychological 
factors, which may moderate this relationship.  
3.4 Findings of studies of the effect of physical activity on the sleep quality 
of people with chronic illnesses other than insomnia 
Sleep disturbances and, more specifically, insomnia symptoms, accompany a host of chronic 
conditions including multiple sclerosis (Stanton, Barnes, & Silber,  2006), Alzheimer's disease 
(Stepanski & Rybarczyk, 2006), Parkinson's disease (Gjerstad,  Wentzel-Larsen,  Aarsland, & 
Larsen, 2006), heart disease, stroke, diabetes (Taylor et al, 2007) and cancer. Amongst some 
of these clinical groups, behavioural interventions for improving sleep quality, including 
physical activity repeated over a substantial period of time, have been successful. McCurry, 
Gibbons, Logsdon, Vitiello, and Teri (2005), for example, randomised Alzheimer's disease 
patients and their caregivers to a sleep hygiene behavioural intervention group, which 
included physical activity (walking) and light exposure, for two months; or to a general 
Alzeheimer's disease education control group. The intervention group significantly improved 
their sleep quality, with less awakenings during the night, improved depression scores, and 
less daytime sleepiness.  
Some randomised controlled trials have been conducted on sleep disturbance, or insomnia, 
associated with cancer, and physical activity. Payne, Held, Thorpe, and Shaw (2008) 
randomised older women receiving hormonal treatment for breast cancer to a home exercise 
intervention (walking) or control usual care group for 12 weeks.  
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The intervention group significantly improved global sleep quality, had shorter wake time, 
and less movement during sleep.  Tang, Liou, and Lin (2010) tested the effects of a home-
based walking intervention, for eight weeks, on patients diagnosed with cancer, with sleeping 
difficulties. The walking intervention group reported significantly improved sleep quality, and 
improved quality of life, compared to the inactive control group. Both these studies are small, 
and the uptake and adherence to physical activity intervention was very poor, due to the nature 
of the illness.  
However, these examples show the potential of physical activity interventions as effective 
treatment for improving sleep quality in people whose sleep disturbance is closely associated 
with another chronic disease.  
3.4.1 Summary and limitations  
There are limitations in inferring wider benefits of physical activity for other chronic illnesses. 
Specific physiological consequences of these other chronic diseases, or the treatment 
accompanying them, may have direct consequences on the biological mechanisms influencing 
sleep processes. Therefore, the above studies inform generally on how usual sleep pattern, 
structure and behaviour may deviate, and how symptoms of sleep disorder may be improved 
with physical activity interventions within other chronic specific disease stages; they cannot 
be generalized to other clinical groups. Separate studies are needed testing the intervention on 
those with insomnia.  
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Table 6 
 
Randomised controlled studies on physical activity and sleep quality, using populations with mild to severe (insomnia) sleep complaints 
No Authors, 
year 
Duration Participants Intervention 
characteristics 
Control group  Sleep 
outcomes 
Other 
reported 
outcomes 
Results reported Jadad Scale 
Score 
1 Reid et 
al, 2010 
16 
weeks 
N = 17  
chronic people 
with insomnias 
100 min/week  
walking or 
jogging 
Recreational 
activities 
Self-reported 
PSQIa, sleep 
diary 
ESSb, SF-36c, 
CES-Dd 
Improved sleep 
quality, TST, SE, 
SOL, QoL 
2 
2 King et 
al, 1997 
16 
weeks 
N = 43  
moderate sleep 
complaints 
200 min/week  
mainly walking 
Waiting list Self-reported 
PSQI, sleep 
diary 
 Improved sleep 
quality, TST, SOL 
3 
3 Li et al, 
2004 
24 
weeks 
N = 118  
moderate sleep 
complaints 
180 min/week  
tai chi 
Low impact 
exercise 
(stretching) 
Self-reported 
PSQI 
ESS, SF-12, 
physical 
functioning 
Improved sleep 
quality, TST, SOL, 
sleepiness, OoL, 
physical functioning 
5 
4 Irwin et 
al, 2008 
25 
weeks 
N = 112  
moderate sleep 
complaints 
120 min/week  
tai chi 
Health 
education 
Self-reported 
PSQI 
BDIe Improved sleep 
quality, SE, TST 
 
5 
5 King et 
al, 2008 
54 
weeks 
N = 66  
mild to moderate 
sleep complaints 
210 min/week  
mainly 
endurance 
exercise 
Health 
education 
PSG, PSQI, 
sleep diary 
 PSG: Decreased 
Stage 1, increased 
Stage 2, fewer 
awakenings 
PSQI: decrease 
sleep disturbance 
Sleep diary:  less 
SOL, more rested 
4 
a PSQI – Pittsburgh Sleep Quality Index: 19-item self-reported questionnaire assessing sleep quality and disturbances over the last month.  
b ESS – Epworth Sleepiness Scale: self-administered sleepiness questionnaire 
c SF-12/36 – Medical Outcome Study Short Form – 12/36: Health-related Quality of Life self-administered questionnaire 
d CES-D – Self-reported questionnaire measuring depression symptoms 
e BDI – Beck Depression Inventory- Self-reported questionnaire measuring depression symptoms †  §
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3.5 Findings of randomised controlled trials (RCTs) on effect of physical 
activity interventions on sleep outcomes in populations with insomnia 
3.5.1 Methodology 
A wide range of databases were searched to identify peer-reviewed articles, published in 
English from 1990 to May 2012, describing randomised controlled trials of the effects of 
regular physical activity or exercise on sleep. The inclusion criteria are described below: 
- Intervention: randomised OR non-randomised and controlled design; 
- Sample size > 15; 
- Treatment: chronic physical activity, exercise (to include yoga and tai chi, when 
intensity of physical activity specified); 
- Duration of treatment: > 4 weeks; 
- Main outcome: sleep quality (SE, TST, SOL); and 
- Study population: >18 years, mild to severe sleep disturbance. 
No pre-defined frequency or intensity was selected in order to be more inclusive of studies. 
Physical activity/exercise included all types of such activities e.g. walking, yoga. The 
databases searched were PsycINFO, PubMed, Embase, Science Direct, Medline (the full 
search criteria are attached in Appendix 1).  The search resulted in 1246 citations from which 
relevant studies were selected for the review. Their potential relevance was examined by title 
and abstract first, and 1099 citations were excluded as irrelevant. The full papers of the 
remaining 147 citations were assessed to select those studies employing the required 
methodology. This criterion excluded 142 studies and left 5 in the review.  
The methodological quality of the selected randomised controlled trials was assessed using the 
Jadad Scale for reporting randomised controlled trials (Jadad et al, 1996), which offers 
excellent reliability and validity psychometric properties in assessing evidence of treatment 
effects in healthcare (Olivo et al, 2008). The scale includes three items assessing the control of 
bias: randomisation (maximum 2 points awarded), blinding (maximum 2 points), and 
accounting of all participants in the trial (maximum 1 point) (Appendix 1). Thus, scores range 
from 0 to 5, with higher scores indicating higher methodological quality.  
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3.5.2 Summary of findings 
Thus, the search identified a total of 5 studies, published in the United States between 1997 
and 2010 (see Table 6).   The full methodology quality assessment itemised score is presented 
in Appendix 1.  Reid et al (2010) randomised 17 people with chronic insomnia either to an 
intervention group treated with an aerobic activity condition and sleep hygiene; or to a control 
group treated only with sleep hygiene. The period of the intervention was 16 weeks. The 
intervention group exercised on average for 100 minutes per week, mainly through walking or 
jogging, whilst the control group engaged in recreational and educational activities (e.g. 
museum lectures). The main outcome measure was self-reported Pittsburgh Sleep Quality 
Index (PSQI) questionnaire. The findings included significantly better sleep quality, sleep 
efficiency, sleep onset latency and longer sleep duration for the intervention group (1.25 hours 
per night more sleep than at baseline, for the PA group). Post intervention, the PA group 
reported improved mood and quality of life. Although the authors used objective measures of 
sleep indexes at baseline (actigraphy and polysomnography), no follow up data from those 
measures was reported.   
King, Oman, Brassington, Bliwise, and Haskell (1997) randomised 43 men and women over 
50, with moderate sleep complaints, to a physical activity intervention group, or to a control 
list. The period of intervention was 16 weeks. The intervention consisted of 200 minutes per 
week of moderate intensity physical activity, mainly walking. Effects were seen at 8 weeks 
after the intervention started. Post-intervention, the intervention group reported significantly 
better sleep quality, longer sleep duration (approximately 42 minutes increase), and reduced 
sleep onset latency.  
Li et al (2004) and Irwin, Olmstead and Motivala (2008) used large samples (118 and 112 
participants respectively). Both employed Tai chi as the physical intervention type, using 
thresholds of 180 minutes, and 120 minutes per week respectively. Li’s control group carried 
out low impact exercise (stretching) and Irwin’s control group received health education. The 
period of intervention was 24 weeks, and 25 weeks, respectively. Both showed significant 
results for self-reported sleep quality. Irwin et al (2008) reported that the intervention group 
increased their sleep duration by 48 minutes, whilst the sleep onset latency decreased by 18 
minutes.   
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King et al (2008) randomised 66 participants aged 55 and over, with mild to moderate sleep 
complaints, to a physical intervention group, or to a health education control group. The 
intervention consisted of 210 minutes a week of mainly endurance exercise. The period of 
intervention was 12 months. The study employed objective measures of sleep indexes both at 
baseline and follow up. Standard polysomnography, and self-reported sleep measures were 
used as outcomes, though the authors reported only ‘selected variables’. The authors found 
those in the intervention group showed significant changes in sleep stages duration, and 
significantly less awakenings. In self-reported sleep measures, exercisers reported 
significantly lower sleep disturbance, reduced sleep onset latency, and feeling more rested in 
the morning. 
3.5.3 Discussion 
Period of intervention 
The period of the physical activity intervention differed amongst these studies, ranging from 
16 to 54 weeks. Whilst there are some sleep benefits of acute exercise on sleep, these are 
small and not clinically significant (Kubitz, Landers, Petruzzello, & Han, 1996). King et al 
(1997) noted that the effects of physical activity on sleep quality in their trial were apparent 
after 8 weeks. Buman and King (2010) reported on unpublished data from King et al’s (2008) 
trial, and found that increased sleep efficiency in participants at 12 months was greater on 
nights following physical activity, than on nights with no physical activity. This trend was 
marginal at 6 months, and statistically significant at 12 months.  
Taken together these findings suggest that there is a minimum period of about 8 weeks before 
the effects of a physical activity intervention can be detected in the self-reported sleep quality 
of people with moderate sleep complaints. These findings also suggest that changes in sleep 
structure may take longer time, i.e. up to one year or more; and that the maintenance of such 
changes is dependent on continuous maintenance and monitoring of the physical activity 
intervention.   
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Level of intervention  
The weekly duration of the physical activity in these intervention trials varied from 100 
minutes to 210 minutes, all showing significant effects on sleep quality.  The intensity, 
uniformly chosen, was moderate intensity physical activity. This is consistent with 
experimental evidence showing that the key health benefits of physical activity mostly occur 
within this achievable intensity range (CMO, 2011). The two trials with the lowest amount of 
weekly physical activity (Reid et al, 2010; Irwin et al, 2008) failed to show a significant 
impact on mood outcomes (however, they were the only two trials to report formal mood 
assessments, see Table 6). None of the trials tested the minimum recommended level of 150 
minutes per week of moderate intensity activity. 
It was not established whether increasing the amount of weekly physical activity would result 
in improved mood outcomes in people with insomnia. A meta-analysis of the effects of 
exercise on mood outcomes in the general population, and clinical groups with elevated mood 
dysfunction indicators, showed that the optimal amount of physical activity is around 150 
minutes per week, in order to find significant improvement in mood (Guszkowska, 2003). 
Similarly, the threshold of a minimum of 150 minutes per week has been identified as 
effecting significant positive changes in mental and physical health of those with chronic 
disease (CMO, 2011).  
The most recent narrative review of evidence of physical activity and sleep quality addresses 
the question of whether the duration of physical activity, above and below the guidelines, 
would deliver sleep benefits (Buman & King, 2010). The authors note that in those studies 
employing the current guideline threshold, there are small to moderate effects on sleep quality. 
The authors draw their evidence from acute, and chronic physical activity studies, which used 
a mixture of participants (healthy sleepers, people with primary insomnia, and people with co-
morbid insomnia).  
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Nature and context of the intervention  
There were no notable differences in outcomes based on modality of physical activity 
intervention. The modality of interventions in these trials varied between ambulatory 
movement (walking/jogging) to more static activities (tai chi); some were delivered in 
supervised classes, and some were performed by participants in their own time, unsupervised. 
A recent review of exercise effects on depressive symptoms in people with cancer found that 
wholly or partially supervised exercise interventions showed larger effect sizes of physical 
activity interventions (Craft, VanIterson, Helenowski, Rademaker, & Courneya, 2012). 
Supervision and settings of the exercise may also play a significant role in exercise adherence 
and compliance in randomised clinical trials (Kelley & Kelley, 2013).  
Participants  
All of the trials discussed above, apart from Reid et al (2010), use samples of participants with 
self-reported mild to moderate sleep complaints. They may have well captured some 
participants with insomnia disorder, but the inclusion criteria were not stringent enough to 
allow for such inferences to be drawn. Irwin et al (2008) screened out people with insomnia.  
The impact of insomnia symptoms on daytime outcomes (such as health-related quality of 
life) increases with the severity of insomnia (Leger et al, 2001). People with more severe 
insomnia symptoms have higher comorbidity of chronic mood-related disorders, higher degree 
of daytime impairment, and have a higher prevalence of hypnotic daily use, compared to 
people with mild insomnia symptoms (Hohagen et al, 1993). In addition, people with severe 
insomnia symptoms differ on psychological variables, such as sleep-related expectations, from 
people with mild to moderate insomnia symptoms (Montserrat Sanchez-Ortuno, & Edinger, 
2010). These findings suggest people with persistent severe symptoms of insomnia (i.e. 
chronic insomnia disorder) have specific characteristics which may respond differently to 
treatment, compared to those people with mild or moderate sleep complaints. There is merit in 
investigating interventions aimed at sub-clinical sleep complaints. As noted in the first 
chapter, observational data shows people who are physically active are less likely to suffer 
from insomnia. This suggests a preventative role of physical activity for developing insomnia. 
Equally, it may be that physical activity may be efficient in preventing the progression of mild 
to moderate sleep complaints to more severe chronic insomnia. There is a need to test these 
hypotheses.  
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However, studies with participants with mild to moderate sleep complaints may mask more 
significant effects of physical activity in people with insomnia. People with mild to moderate 
sleep complaints may present ‘ceiling effects’ in their sleep quality improvement. Such 
assertion is warranted given that Reid et al (2010), who use an insomnia sample, report the 
lowest amount of weekly physical activity, yet the most dramatic effects on sleep quality. 
Sleep outcome measures  
As the main outcome measure, all studies reviewed here used the Pittsburgh Sleep Quality 
Index (PSQI), a self-reported questionnaire, which assesses the quality of sleep over the last 
month (Buysse, Reynolds, Monk, Berman, & Kupfer, 1989). A PSQI global score higher than 
5 shows enough sensitivity and specificity to indicate insomnia (Backhaus, Junghanns, 
Broocks, Riemann, & Hohagen, 2002). However, the use of a single retrospective measure 
such as the PSQI would seem more appropriate for estimating prevalence of insomnia, whilst 
repeated administration of multi-angle measures of insomnia may provide more useful for 
assessing treatment outcomes (Buysse et al, 2006).  
King et al (2008) study also used an objective measure of sleep structure, polysomnography 
(PSG) as a main outcome measure. However, the use of PSG is not recommended in routine 
investigation of insomnia (Littner et al, 2003). More convenient, less intrusive and more 
reliable objective data may be captured through the use of actigraphy: this is recommended for 
the assessment of treatment effect in insomnia by the American Academy of Sleep Medicine 
[AASM] (Littner et al, 2003). A multi-instrument assessment approach is recommended, with 
a mixture of objective and subjective sleep measurements (Buysse et al, 2006).  
Assessment of daytime impairments related to sleep problems 
When diagnosing insomnia, an essential part of the diagnosis is daytime impairment 
associated with it (DSM-IV-TR, 2000). Yet the emphasis in each of the trials reviewed here 
was on the night-time characteristics of sleep. A recent NIH consensus statement noted that 
the importance of insomnia for public health lies in its daytime consequences (Leshner et al, 
2005).  
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In the trials where daytime outcomes related to insomnia/sleep disturbance were measured, 
physical activity interventions significantly improved the vitality sub-scale of quality of life; 
whereas the other seven sub-scales of quality of life were not significantly affected by the 
physical activity intervention (Reid et al, 2010).  Li et al (2004) noted significant 
improvements in the physical sub-scale of quality of life measure used in their trial, but no 
significant improvement in the mental quality of life sub-scale.  Irwin et al (2008) found no 
significant reduction in depression scores following a physical activity intervention based on 
their sample of people with mild or moderate sleep disturbance; and nor did Reid et al (2010) 
in their sample of people with insomnia. These findings suggest that that the daytime benefits 
of the physical activity interventions were primarily physiological. This view is further 
supported by the significant improvements noted in physical performance indicators, where 
these were measured (Li et al, 2004). Reid et al (2010) also showed a trend of improved 
physical fitness in the group undertaking the physical activity intervention. King et al (1997) 
noted that the improvement in sleep quality in their experimental group undertaking physical 
activity was mediated by changes in fitness levels.  
None of these studies assessed fatigue, and its response to the physical activity intervention. 
Where tiredness or fatigue are ‘implied’ in measures (such as vitality, or daytime dysfunction 
sub-scales of quality of life measures), there were significant improvements noted (as above). 
Daytime sleepiness was assessed in two of the trials. Li et al (2004) found a significant 
improvement in their physical activity intervention group; Reid et al (2010) found a trend of 
improvement in their sample.  
None of the studies tested cognitive processes of attention pre and post intervention, for 
example via psychomotor tests.  
Confounders 
None of these studies controlled for the role of light exposure in improving sleep quality, 
though other experimental evidence suggests that increased light exposure arising from 
physical activity may by itself improve sleep quality (Guilleminault et al, 1995).  
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The suprachiasmatic nucleus (SCN), the body’s internal pacemaker, is a structure in the 
hypothalamus which regulates the human biological rhythms. The SCN can be entrained to 
the geophysical 24 hour day/night cycles by zeitgebers. Research has identified entrainment 
effects of the light/dark cycle, ambient temperature, time of meals, social interactions, and 
physical activity (Wever, 1989; Aschoff, 1979; Aschoff et al, 1971; Buxton et al, 2003). The 
SCN integrates these photic and non-photic zeitgebers and produces output signals which 
regulate the circadian rhythms of the body, such as temperature, hormone levels, metabolic 
functions, and sleep (Monk et al, 1991).  
Light is the most powerful physical zeitgeber (Czeisler, 1995). The availability of sufficient 
environmental light is critical in the entrainment of the circadian rhythms to the dark/light 
cycle; most blind people with no, or little, conscious light perception exhibit disturbed 
circadian rhythms (Skene, Lockley, & Arendt, 1999). The effects of light on the entrainment 
process depend on its intensity, duration, spectrum, and timing of exposure, relative to the 
phase of the circadian rhythm (Turner & Mainster, 2008).  
The light intensities of most indoor environments are generally below 500 lux. In contrast, 
midday light intensities outdoors range from 10,000 on an overcast day to 100,000 in bright 
sunlight (Turner, Van Someren, & Mainster, 2010). In humans, light intensity exposure must 
probably exceed 1000 lux to optimise circadian rhythms synchronisation of rest/activity over 
the 24 hours (Middleton, Stone, & Arendt, 2002). In the general population, it is also 
estimated that middle aged adults receive on average of 58 minutes of daily light exceeding 
1000 lux (around 6% of the waking day) (Espiritu et al, 1994).  
In terms of light spectrum composition, there is evidence that the blue portion wavelength of 
light is optimal for photoreception in humans (Provencio et al, 2000). Outdoor daylight has a 
dominant wavelength in the shorter (blue) spectrum (Gallagher, Beasley, & Gohren, 1996). 
Indoor lighting is mostly at longer wavelengths (Thorington, 1985), which are less effective 
for photoreception. Timed optimal light exposure, usually in sessions lasting from 15 minutes 
to 4 hours, and with light intensities ranging from 2500 lux or 10000 lux has been successfully 
used for therapeutic purposes in people with circadian rhythm dysfunctions, such as delayed 
phase sleep syndrome (Terman et al, 1995).  
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Light supplementation is also useful in improving sleep efficiency in older people with 
insomnia (Murphy & Campbell, 1996), and in improving sleep duration and continuity in 
middle aged people with insomnia (Lack, Wright, Kemp, & Gibbon, 2005). Increased duration 
of exposure, from 20 minutes daily to 45 minutes daily, has been found to lead to long lasting 
improvement in total sleep duration in older people with insomnia (Kirisoglu & Guilleminault, 
2004).  Furthermore, early morning light exposure induces immediate changes in alertness 
levels, underscored by an increase in over 50% in cortisol levels (Leproult, Colecchia, 
L'Hermite Balériaux, & Van Cauter, 2000). It also induces daytime functioning changes, with 
shift workers reporting decreases in fatigue and sleepiness when exposed to daylight (Dawson 
& Campbell, 1991).  
The beneficial effects of light therapy on the mood of people with seasonal affective disorder  
are also well documented (see Glickman, Byrne, Pineda, Hauck, & Brainard, 2006), though 
evidence for the efficacy of light to improve non-seasonal depression is equivocal (Even, 
Schröder, Friedman, & Rouillon, 2008).  Long term exposure to increased light intensity may 
improve the ability of the SCN to synchronise hormonal, metabolic and peripheral oscillatory 
rhythms, which together contribute to an individual’s good functioning. However, the re-
synchronisation process may be slow, with studies showing that it takes months until effects 
of increased light exposure on day/night rhythms are observed (Van Someren & Riemersma-
Van Der Lek, 2007).  
Alternatively, light may act as a mood enhancer, improving subjective alertness and vitality, 
and leading in turn to a better outlook on the coming day and night (Kirisoglu & 
Guilleminault, 2004). This in turn may decrease rumination and anxiety over night-time 
insomnia and its daytime consequences in people with insomnia. 
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3.5.4 Conclusions 
All of the above studies have methodological limitations. A recent systematic review of 
physical activity interventions in people with sleeping problems (to include sleeping problems 
due to menopause, and mental health problems, alongside insomnia), found a small number of 
studies, comprising a small number of participants (Yang, Ho, Chen, & Chien, 2012). A 
Cochrane review, assessing the effects of physical activity on sleep quality in older adults, 
found only one study which had rigorous enough methodology for inclusion [King et al’s 
(1997) study reviewed above] (Montgomery & Dennis, 2009). The authors of the review 
noted the need for future trials with appropriate methodology for inferring causal 
relationships, able to show durable effects of physical activity on sleep. Coupled with the 
Montgomery and Dennis (2009) conclusions and the findings presented in Chapter 2, the 
present review provides clear guidance on both the direction and the design of such research.  
In summary: 
1. Trials of relatively low levels (but not ‘minimal recommended levels’) of physical 
activity have consistently reported improved sleep outcomes.  Since the 
epidemiological evidence shows that the minimum recommended level of 150 minutes 
moderate activity/week is significantly associated with a reduced risk of insomnia 
symptoms (Chapter 2), and since these levels of activity are now widely promoted by 
public health agencies throughout the world, there is a practical need to investigate the 
impact of these ‘guideline’ levels of activity on sleep outcomes. 
2. In designing such a study there is an important need to: recognise the confounding 
impact of light exposure; appropriately characterise participant insomnia using 
Research Diagnostic/Assessment Criteria; assess both the nighttime (using 
recommended sleep outcome measures) and daytime (using appropriate assessments of 
psychomotor performance, cognition and fatigue) consequences of insomnia; assess, 
and appropriately control for, changes in mood; extend the trial over a period sufficient 
to allow for the assessment of outcomes at post-treatment and longer-term follow-up;  
and validate levels of activity change, using instrumental measures. 
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3.6 Research questions for a randomised controlled trial 
The trial presented in the next chapter was conceptualised in response to these needs, and was 
designed specifically to address the following research questions: 
When undertaken by previously inactive people reporting symptoms of chronic insomnia, is 
physical activity which meets the current minimum recommended threshold: 
1. Associated with significant improvements in subjective sleep quality? 
2. Associated with significant improvement in objective sleep structure indicators? 
3. Associated with significant increases in light exposure? 
4. Associated with significant improvement in mood indicators? 
5. Associated with improvement in psychomotor performance? and 
6. Associated with significant improvement in daytime sleepiness, fatigue, and quality of 
life? 
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CHAPTER FOUR 
4.0 A randomised controlled trial assessing the impact of moderate physical 
activity (increased to the recommended level of 150 min/week) on sleep, 
mood and performance outcomes among sedentary people with insomnia 
59 
 
4.1 Introduction 
The epidemiological studies reviewed in Chapter 1 gave a clear indication that while physical 
inactivity was a risk factor for insomnia symptoms, higher levels of physical activity were 
associated with higher levels of sleep quality.  However, a minimum level of physical activity 
likely to mitigate insomnia risk (and which could serve as a target for public health and 
therapeutic interventions in sleep medicine) had not been evaluated.  As a result, it remained 
unclear whether the internationally recommended level of activity known to be associated 
with a range of health benefits (≥ 150 minutes of moderate physical activity per week) could 
also impact insomnia symptoms. This proposition was tested in the secondary analyses 
reported in Chapter 2, which provided evidence that, independent of comorbid health status, 
activity at or above the recommended threshold was significantly associated with a reduced 
risk of reporting insomnia symptoms.  The reviews presented in Chapter 3 examined the 
strengths and weaknesses of the experimental evidence base for a positive impact of physical 
activity interventions on sleep and insomnia outcomes.  The clinical trials included in these 
reviews showed a variety of limitations, with only a single study qualifying for inclusion in a 
Cochrane review.  This literature then used to inform the research questions presented in the 
previous chapter, and the trial methodology presented below.   
4.2 Methods 
4.2.1 Objective and design  
The objective of this study was to assess, in previously inactive people, the impact of 
increasing activity (to at least the recommended level of 150 minutes of moderate intensity 
activity/week) on sleep, wellbeing and daytime performance. 
The study was designed as a two-arm (activity intervention versus waiting list control) 
randomised controlled trial.  The activity intervention lasted for 6 months, with assessments 
collected at baseline, 3 months, 6 months, and 12 months (i.e. 6 months after the end of the 
intervention). Figure 2 shows an overview of the trial procedure.  
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At baseline, at 3 months, 6 months, and at 12-month follow up, participants were assessed via 
a battery of standardised self-report questionnaires. In addition, at the baseline and 6 month 
time points, participants were administered a battery of cognitive (psychomotor) tests.  
Separate actigraphic measures of sleep (using wrist worn actigraphs) and physical activity 
(using waist-worn actigraphs) were also initiated for 2-week periods at the baseline, 3 month 
and 6 month time points. 
4.2.2 Outcomes and sample size estimation 
The primary outcome was self-reported severity of insomnia symptoms, as measured by the 
Insomnia Severity Index (ISI). Secondary outcomes were changes in depressive symptoms 
(assessed using the Beck Depression Inventory II), anxiety (using the Spielberger State Trait 
Anxiety Inventory), and psychomotor performance. Sample size estimation was performed 
using GPower v.2 (Kiel University, Germany), and adopted the mean treatment effect for 
behavioural interventions on sleep quality of 0.76 reported from Irwin, Cole, & Nicassio’s 
(2006) meta-analysis of behavioural interventions outcomes for people with insomnia.  Setting 
beta at 80%, and alpha at 0.05, a minimum of 19 persons per group was required in order to 
detect significant reductions in the severity of insomnia symptoms with adequate power.  In 
order to allow for an attrition rate of approximately 20%, it was intended to recruit 23 
participants per arm (though to minimise loss of participants, an attrition management strategy 
was devised and applied throughout the study period; see Appendix 7).  
Ethical approval for the trial was granted by Loughborough University Ethical Advisory 
Committee (reference number R-11 P67 of 16 May 2011). Recruitment and screening began 
on 1st June 2011, and ended on 31st March 2012. Data collection was organised so that 
participants started the trial at intervals, with the last participant ending her 12 month follow 
up in June 2013. The research programme was staggered in order to optimise quality control 
and maximise the available research resources.  Recruitment, screening and data collection 
were executed by the author (IH) and involved an average of eight home visits per participant.  
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Trial stages 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Overview of trial procedure 
Initial screening by telephone/email  
• Volunteers were initially screened for two main inclusion criteria: 
sedentary behaviour and the presence of sleeping problems 
 
First home visit 
• Trial design and procedure explained, and questions invited 
• Participants return signed consent form by post 
 
 
Pre-intervention  (home visit) 
• Participants were randomised to intervention or control group 
• Completed baseline measures 
• Walking plan devised with members of the intervention group  
 
 
Intervention period 
• From immediate post-baseline to 6 months 
• Intervention group: 150 minutes moderate to vigorous physical 
activity per week as walking 
• Control group: continued life as usual 
 
 
6-month post-intervention assessment (home visit) 
• Self-report, psychomotor and actigraphy measures 
• Intervention group debriefed (no further activity monitoring) 
 
 
 
Detailed screening 
• Those included were sent trial information sheet/questionnaire 
• On return of questionnaires, detailed eligibility was established 
 
 
3 month measures (home visit) 
• Self-reported measures  
• Actigraphy measures 
12-month follow-up assessment  
• Follow up self-reported measures 
END OF TRIAL 
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4.2.3 Participants 
Eligibility 
Participants were inactive2 men and women who were 40 years or older, who were living in 
the community and who fulfilled the Research Diagnostic Criteria for insomnia (Edinger et al, 
2004; Table 7). The full eligibility criteria are presented in Table 8.  
                                                 
2 Inclusion criteria  In line with public health research and practice, the initial selection criteria should now be defined in 
terms of 'physically inactivity', rather than 'sedentary behaviour'. This is because since the design of the study in 2010-2011, 
research evidence has rapidly evolved to differentiate between concepts of ‘sedentary behaviour’ and ‘physical inactivity’. It 
is now generally accepted within the research community that sleep, sedentary behaviour, physical inactivity, and physical 
activity are on a continuum of increasing energy expenditure (Pate, O’Neil, & Lobelo, 2008), with accompanying postural 
specifics to sedentary behaviours (watching TV, lying down etc).  
During 2012, the Sedentary Behaviour Research Network (SBRN) published a definition of ‘sedentary behaviour’, in contrast 
to the concept of physical inactivity. According to the SBRN, sedentary behaviour is  “…any waking behaviour characterized 
by an energy expenditure ≤1.5 METs while in a sitting or reclining posture". The group went on to suggest that the term 
“inactive” is used instead to describe ‘those who are performing insufficient amounts of MVPA (i.e., not meeting specified 
physical activity guidelines) (SBRN, 2012).  
The drive to separate these two concepts resulted from accumulating evidence as to the independent predictive role of 
sedentary behaviours (such as TV viewing) of higher morbidity, even when controlled for daytime levels of physical activity 
(Wijndaele et al, 2010). Detrimental associations between sedentary time and morbidity outcomes are significant in those 
adults who are otherwise meeting the recommended physical activity guidelines (the ‘active couch potato' phenomenon) 
(Healy et al, 2008). Going further on energy expenditure continuum, there is evidence that points to incidental, non-
purposeful physical activity being beneficial for health (Donahoo et al, 2004; Matthews et al, 2007). 
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Table 7 
 
Criteria for establishing insomnia diagnosis for the participants in the present randomised 
controlled trial* 
Insomnia diagnosis for participants in the RCT 
A. The individual reports one or more of the following sleep related complaints: 
1. difficulty initiating sleep, 
2. difficulty maintaining sleep, 
3. waking up too early, or 
4. sleep that is chronically nonrestorative or poor in quality. 
B. The above sleep difficulty occurs despite adequate opportunity and circumstances for sleep. 
C. Significant daytime impairment and distress related to the nighttime sleep difficulty is 
reported by the individual. 
D. Insomnia has been present for at least six months. 
E. If there is a current or past mental or psychiatric disorder, the temporal course of the 
insomnia shows some independence from the temporal course of the mental or psychiatric 
condition. 
F. If there is no current or past sleep-disruptive medical condition, the temporal course of the 
insomnia shows some independence from the temporal course of the medical condition. 
G. The insomnia cannot be attributed exclusively to another primary sleep disorder (e.g., sleep 
apnoea, narcolepsy, or parasomnia) or to an unusual sleep/wake schedule or circadian rhythm 
disorder. 
H. The insomnia cannot be attributed to a pattern of substance abuse or to use or withdrawal 
of psychoactive medications. 
 
*Based on the Research Diagnostic Criteria for Insomnia Disorder/Primary Insomnia 
(American Academy of Sleep Research [AASM] 2004; Edinger et al, 2004) 
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Table 8 
 
Eligibility criteria for participants in the present randomised controlled trial 
Inclusion Exclusion 
40+ years 
Diagnosis of insomnia; or presenting 
persistent insomnia symptoms (using the 
ICD and DSM-IV-TR criteria) 
Inactive behaviour: 
• Amount: ≤ 60 min/week of 
moderate/vigorous exercise; and 
• Frequency: ≤  twice a week, 
during the preceding 6 months  
Stable on all taken medication for at least 
3 months 
Able to speak and understand English 
sufficiently to provide informed consent 
Willing to accept random assignment to 
one of two groups 
Living within 50 miles of Loughborough 
University 
 
Presence of other clinically significant sleep 
disorder e.g. sleep apnoea, Restless Legs 
Syndrome 
Shift work 
Present diagnosed psychiatric or cognitive 
disorder 
Severe chronic disease for which moderate-
intensity physical activity would be 
contraindicated 
Presence or history of myocardial infarct or 
stroke 
Taking anti-hypertensive  or hypolipidaemic  
medication 
Presence of musculo-skeletal  impairment  
which  would  prevent  participation  in  
moderate  levels  of  physical  activity 
Body Mass Index  > 35 
Undergone surgery in the previous 6 months 
Excessive daily use of tobacco, alcohol, and 
coffee 
(for women) Pre-  or  peri-menopausal  status  
and/or oestrogen  replacement  therapy (or on 
such therapy for less than 6 months) 
Participation in another randomised trial 
involving an intervention 
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Recruitment 
Participants were recruited by advertising through the local commercial press (Loughborough 
Echo, Leicester Mercury, East Midlands Gazette); radio stations (BBC Radio Leicester); 
national TV (BBC community news); local government organisations (the library, 
neighbourhood offices); local GP and dental practices; local community organisations (U3A, 
art groups, reading groups); and local major employers (Loughborough University; Brush). A 
sample of the advertisement used for recruitment is presented in Figure 3.  
 
Figure 3.  Sample of advert used for trial recruitment 
4.2.4 Procedures 
Screening 
Initial telephone/email screening 
Interested members of the public initially contacted the research office by telephone or by 
email. They were briefed on the study following a standardised script (Appendix 3), and 
screened to ensure that they were presenting a sleep problem, and that they were inactive.  
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Detailed screening 
If they agreed, volunteers were then sent a screening pack in the post, which contained the 
brief Participant Information Sheet, detailing the study, and the Health Assessment Screening 
Questionnaire (Appendix 4), to be returned in a pre-paid envelope. All volunteers who were 
sent the screening questionnaires were allocated a unique identification number, which then 
remained unchanged through the course of the study.  
The Health Assessment Screening Questionnaire included: 
a. General health screening questionnaire (Figure 4) 
 
 
 
Figure 4. Example items from the general health screening questionnaire 
b. Physical activity status (Figure 5) 
 
Figure 5. Example item from the physical activity status screening questionnaire 
c. Insomnia symptoms screening (DSM-IV criteria) (Figure 6) 
 
Figure 6. Example item from insomnia screening questionnaire 
  
How many 
nights/week 
Q3. Do you have problems falling alseep? ......................   Yes  No    
 
8. How many minutes a week do you spend doing exercise/physical activity (such as brisk walking, 
swimming, jogging etc)? 
………………………………………… minutes/week 
 
2. Have you ever had any of the following: 
(a) Convulsions/epilepsy  ......................................................... Yes 
 
No  
(b) Asthma  .............................................................................. Yes  No  
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d. Symptoms of Restless Leg Syndrome (Figure 7) 
 
Figure 7. Example item from Restless Legs Syndrome screening questionnaire 
 
e. Delayed Phase Sleep Syndrome questionnaire: 4-item questionnaire used to identify 
symptoms of Delayed Phase Sleep Syndrome (Figure 8) 
 
Figure 8. Example item from the Delayed Phase Sleep Syndrome screening questionnaire 
 
f. The Epworth Sleepiness Scale (ESS, Johns, 1991: This 8-item measure assesses the 
likelihood the individual will fall asleep during different situations (e.g., passenger in a 
car, sitting quietly after lunch) (Figure 9) 
 
Figure 9. Example item from Epworth Sleepiness Scale screening questionnaire 
 
Upon return of the completed screening questionnaire eligibility for the study was checked 
against the full inclusion/exclusion criteria. If necessary, the volunteer was contacted to clarify 
information.  If ineligible for inclusion in the study, volunteers were informed by means of a 
standardised letter. The letter also invited them to give separate consent for inclusion in a 
database to be notified of future studies in the Clinical Sleep Research Unit (Appendix 5).  
 I would 
never doze 
I would have a slight 
chance of dozing 
I would have a 
moderate chance of 
dozing 
I would have a 
high chance of 
dozing 
Sitting & reading     
 
    
 
How many 
nights/week 
Q16. Do you have problems waking up at the desired time? ..  Yes  No    
 
Q11. Have you ever had unpleasant sensations in your legs, combined with an urge to move 
your legs? 
 Yes  No  
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Randomisation procedure 
Participants were randomised to a moderate-intensity physical activity condition, or a waiting-
list control condition (Figure 10). The algorithm for randomisation was stratified by gender 
(male/female) and age (± 2 years in each group), as these two variables are consistently 
associated with prevalence and incidence of insomnia symptoms. The randomization was 
performed by an independent researcher within the University department, who had no 
involvement in the study, ensuring adequate allocation concealment for the study.  
 
Figure 10. Screenshot of Randomization procedure 
 
4.2.5 Assessment home visits 
First home visit 
Eligible volunteers were contacted to arrange a home visit by the researcher. The purpose of 
the visit was to explain the study in more detail, answer any questions, and fully explain the 
randomization procedure, the consent form, and the University's ethical and legal obligations 
to study participants. The Researcher left the detailed Participant Information Sheet and 
Consent Forms (Appendix 6) with the volunteer, to allow them to fully consider the 
information, before returning the signed Consent Form to the research office (in the pre-paid 
envelope provided).  
If the Consent Form was not received within 10-14 days of the home visit, the researcher 
contacted the volunteer initially by telephone, or by standardised follow-up letter (if 
telephoning proved unsuccessful). If the volunteer did not want to take part in the study, they 
were given the option of being included in the volunteer database for future studies.  
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If the Consent Form was returned to the Research Office, the participant was entered into the 
main database against the original identification number given. No identifiable features were 
included in the main database (name, date of birth, address).  
Second home visit – Administration of baseline measures 
Following randomization, participants were contacted to arrange a home visit for the baseline 
measures. The visit included: informing of the randomization outcome; explaining group 
membership procedure; obtaining consent to inform the participant’s general practitioner (GP) 
of study involvement (standard letter to GP enclosed in Appendix 8); administration of 
objective measures of physical activity and sleep, assessment of subjective measures through 
the booklet of self-reported questionnaires, and providing all relevant material for the 
allocated group membership.  
In a separate session, the participants were administered the battery of cognitive tests.  
Third home visit – Administration of 3-month measures 
The visit included: administration of objective measures of physical activity and sleep; and 
assessment of subjective measures through the booklet of self-reported questionnaires.  
Fourth home visit – Administration of 6-month measures (end of intervention period) 
The visit included: administration of objective measures of physical activity and sleep; and 
assessment of subjective measures through the booklet of self-reported questionnaires.  
Separately, the participants were administered the battery of cognitive tests.  
Assessment by postal questionnaire only – Administration of 12-month measures (end of 
trial) 
At 12 months, all participants were sent the booklet of self-reported questionnaires, to 
complete and return in the pre-paid envelopes provided.  
4.2.6 Assessment measures 
Data were collected on: 1) participants characteristics; 2) measures of insomnia symptom 
severity, and sleep quality; 3) sleep structure and light exposure; 4) quality of life and health 
status; 5) mood, fatigue and daytime sleepiness; and 5) physical activity status.  
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The self-report questionnaires were administered by a booklet, which participants were asked 
to complete at baseline (before the intervention), at 3 months, at 6 months (at the end of the 
intervention) (Appendix 9). And at 12 months (i.e. 6 months after the end of the intervention). 
Participants were given two weeks to complete the booklet on each occasion.  
Actigraphy devices for measuring sleep and levels of physical activity were administered for a 
period of 14 days at baseline; again at 3 months; and again at 6 months (see Footnote3 for an 
explanation of the selection process for these devices).  
The cognitive tests were administered separately from the other tests at baseline and 6 months, 
using a portable laptop. All tasks were administered in participants' home, in a quiet room, in 
the afternoon (after 1pm and before 7pm). 
                                                 
3 Consideration was given to streamlining the objective outcome measures to be used in the trial. Both devices 
(Actiwatch 2 for measuring sleep, and GTX3+ for measuring physical activity) incorporate accelerometers. Thus 
the question was as to whether a single device could be used.  
The devices sample at different frequency (32Hz v 30Hz). The data output (counts per minute) from each device 
uses different equations to summarise movement. No published evidence is currently available as to the 
comparability of the output data from ActiGraph GTX3+ and Actiwatch 2 accelerometers when used to measure 
daytime physical activity in adults. Upon investigation, it became apparent that these two devices could not yet 
accurately measure both daytime physical activity and night-time sleep outcomes (Philips, 2011, email 
communication).  
The manufacturer of the GTX3+ (Actigraph Inc., US) is now in the process of developing a new device, worn at 
the wrist, which could accurately detect and classify both daytime and night-time movement (Actigraph, 2013, 
personal communication). Recently (2013), the NHANES study, one of the largest-scale population surveillance 
programmes, began to use GTX3 at the wrist in order to measure physical activity over 24 hours, on the 
understanding that equations are currently being developed to validate and accurately classify such movement. 
Within the research community, work is in progress to use GTX3+ data retrospectively in order to predict sleep 
variables (Hartescu et al, 2013, conference proceedings). Although it was not possible to streamline the objective 
measures used in our trial, sleep and physical activity researchers should be able to use a single device for 
accurate objective measurements over time, in the near future.   
Insomnia diagnosis is based on self-reported sleep quality evaluation. The use of self-reported measures of sleep 
quality was considered essential to capture any meaningful change over time. A combination of self-report and 
objective measures was used in the trial, for completeness, and accuracy, as recommended in insomnia research 
(Buysse et al, 2006).  
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Physical Activity 
Physical activity was assessed using GTX3+ accelerometer (Actigraph; Figure 11), which 
measures body accelerations, in epochs of 30 seconds. These are converted into outputs of 
counts per epoch, then further processed with specialist software (ActiLife 6, 2013) to be 
expressed as intensity activity per minute. Accelerometers are recognized as a valid and 
objective tool to assess free-living physical activity. They are worn on a belt at the hip. The 
GTX accelerometer has been validated against the gold-standard physical activity energy 
expenditure measures (room calorimetry and doubly-labelled water) (Rothney, Brychta, 
Meade, Chen, & Buchowski, 2010).  
 
Figure 11. Image of GTX3+ accelerometer (Image from 
http://www.actigraphcorp.com/products/) 
 
Self-reported physical activity was measured with the International Physical Activity 
Questionnaire-Short Form (IPAQ), a 7-item questionnaire assessing physical activity and 
sedentary behaviour in adults (Figure 12; Craig et al, 2003). The questionnaire has acceptable 
concurrent and construct validity, and reliability, when measuring physical activity patterns in 
the general population (Hagstromer, Oja, & Sjostrom, 2006; Craig et al, 2003).  
 
Figure 12. Example item from the IPAQ-Short Form 
3. During the last 7 days, on how many days did you do moderate physical activities like 
carrying light loads, bicycling at a regular pace, or doubles tennis?  Do not include walking. 
 
_____ days per week 
  No moderate physical activities Skip to question 5 
 
 
4.5cm 
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Primary  outcome – severity of insomnia symptoms - Insomnia Severity Index (ISI) 
The Insomnia Severity Index (ISI) is a 7-item self-report questionnaire, designed to assess the 
nature, severity, and impact of symptoms of insomnia (Morin, Barlow, & Dement, 1993). The 
usual recall period is ‘the last two weeks’ prior to administration. The seven dimensions 
evaluated are: sleep onset, sleep maintenance, and early morning awakening problems, sleep 
dissatisfaction, interference of sleep difficulties with daytime functioning, noticeability of 
sleep problems by others, and distress caused by sleep difficulties. A 5-point Likert scale is 
used to rate responses to each of the 7 items (0 = no problem; 4 = very severe problem), 
yielding a total score of 0 to 28 points (Figure 13). The total score is interpreted as follows: 
absence of insomnia (0–7); sub-threshold insomnia (8–14); moderate insomnia (15–21); and 
severe insomnia (22–28). Three versions of the questionnaire are available - patient, clinician, 
and others – the present trial used the patient version only. Previous studies have found that 
the ISI exhibits adequate psychometric properties, both as a screening tool, and as an outcome 
measure (Bastien, Vallieres, & Morin, 2001).  
Recent research shows that internal consistency of the scale is excellent for community and 
clinical samples (Cronbach α of 0.90, and 0.91, respectively) (Morin, Belleville, Bélanger, & 
Ivers, 2011). Item response analyses indicate adequate discriminatory capacity for 5 of the 7 
items. Convergent validity is demonstrated by significant correlations between the total ISI 
score, and other measures of daytime impairments associated with insomnia such as fatigue; 
quality of life; anxiety, and depression. For purposes of detecting cases of insomnia in a 
community sample, a cut-off score of 10 on ISI is optimal (86.1% sensitivity and 87.7% 
specificity). In clinical samples, a change in score of -6 to -8 ISI points has been associated 
with moderately significant clinical improvements in insomnia, as associated with clinically 
meaningful changes in other health indicators, or as rated by an independent assessor after 
intervention (Yang, Morin, Schaefer, & Wallenstein, 2009; Morin et al, 2011). 
 
Figure 13. Example item from Insomnia Severity Index (ISI) 
  
Insomnia problem None Mild Moderate Severe Very severe 
1) Difficulty falling asleep 0 1 2 3 4 
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Secondary outcomes 
Sleep quality - Pittsburgh Sleep Quality Index (PSQI) 
The PSQI is a 19-item self-report questionnaire evaluating sleep quality and disturbances. The 
usual recall period is over the past month (Buysse et al, 1989). Of the 19 items, the first 4 
items are open questions, whereas items 5 to 19 are rated on a 4-point Likert scale (Figure 14). 
Scores obtained from individual items yield 7 components. A global score, ranging from 0 to 
21, is obtained by adding the 7 component scores. Scores higher than 5 suggest poor sleep 
quality, and this cut-off score has been used to discriminate people with sleeping problems 
from good sleepers (Backhaus, Junghanns, Broocks, Riemann, & Hohagen, 2002).  
The PSQI has excellent psychometric properties in British samples, and distinguishes people 
with insomnia from normal sleepers (e.g. Backhouse et al, 2002). The PSQI was used in the 
present trial because it measures a construct (sleep quality) that is related to insomnia. In 
addition, the PSQI has previously shown sensitivity to physical activity treatment in people 
with sleep disturbance (King et al, 1997).  
 
Figure 14. Example item from Pittsburgh Sleep Quality index (PSQI) 
Sleep structure / Light exposure  
Sleep structure was assessed using wrist-worn actigraphs (Actiwatch 2, Phillips Corporation) 
(Figure 15). Comparison of actigraphy with the 'gold standard' assessment of sleep research - 
polysomnography (PSG) - typically yields agreement rates in the range of 78 to 95% in both 
community and clinical samples (Sadeh, Hauri, Kripke, & Lavie, 1995). Actigraph devices 
have been validated to use in insomnia populations (Lichstein et al, 2006), and are sensitive to 
changes in sleep quality following physical activity (Van Someren, Lijzenga, Mirmiran, & 
Swaab, 1997).  
All participants wore the actiwatches on the wrist continuously for a period of 2 weeks at 
baseline and 6 months. In addition to measuring movement, the Actiwatch 2 incorporates a 
light sensor, which records daily photopic whitelight illuminance.  
3.  During the past month, when have you usually got up in the morning?  
  
   usual getting up time    _____________ 
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Figure 15. Image displaying Actiwatch 2, with the light sensor apparent on its front surface 
(Image from 
http://www.healthcare.philips.com/main/homehealth/sleep/actiwatch/default.wpd) 
Quality of life and health status 
The EQ5D-5L (EuroQoL Group, 1990) is a 5-item scale, with an additional visual assessment 
scale item, which assesses health related quality of life. Self-reported health status captured by 
EQ-5D-5L relates to participant’s quality of life status at the time of completion. The scale 
contains items on mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, 
which are used to sum up a health profile index value (Figure 16). The additional VAS item 
rates self-reported health on a scale from 0-100 (worst to best health), and the rates number on 
the scale is used separately. The EQ-5D-5L has recently been validated in diverse patient 
populations, including patients with chronic disease: cardiovascular disease, respiratory 
disease, depression, diabetes, liver disease, personality disorders, arthritis, stroke (Janssen et 
al, 2012). 
 
Figure 16. Example item from the EQ5D-5L scale 
  
MOBILITY 
I have no problems in walking about      
I have slight problems in walking about      
I have moderate problems in walking about      
I have severe problems in walking about      
I am unable to walk about        
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Health service utilisation, as an index of health behaviour, was assessed using 6 independent 
items developed for economic analyses in previously reported randomised controlled trials 
(Morgan et al 2004; 2012).  Items included the frequency of consuming ‘over the counter’ 
sleep aids and the frequency of contact with primary care clinical services (Figure 17).   
 
Figure 17. Example item from Healthcare Utilization Index 
Body mass index (BMI) was calculated from self-reported height and weight measures, using 
the NHS BMI Healthy weight calculator for adults, available at 
http://www.nhs.uk/Tools/Pages/Healthyweightcalculator.aspx. The formula used to calculate 
it is: BMI=body mass (kg)/(height (m))2.  
Mood, fatigue and daytime sleepiness 
Depression was measured with Beck Depression Inventory-II, a 21-item self-report inventory 
assessing the intensity of typical symptoms of depression on a 4-point Likert scale, over the 
past two weeks (Beck, Steer, & Brown, 1996) (Figure 18). The total score ranges from 0 to 
63, with a higher score suggesting more severe depressive symptoms. The psychometric 
properties of the scale show adequate validity and reliability in clinical and non-clinical 
populations (Beck, Steer, & Carbin, 1988). The scale shows sensitivity to treatment in people 
with insomnia (Isaac & Greenwood, 2011). The proposed thresholds for clinical severity of 
depression are below 20 for mild depression, below 29 for moderate, and 30 and up for severe 
(Beck et al, 1996). 
 
Figure 18. Example item from Beck Depression Inventory (BDI) 
1. Sadness 
I do not feel sad  
I feel sad much of the time  
I am sad all of the time  
I am so sad or unhappy that I can’t 
stand it  
 
  How often? (enter number 
of times) 
i Visited your local surgery for a consultation with a doctor (include 
‘out-of hours’ consultations at special centres)? 
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Anxiety was assessed using the State-Trait Anxiety Inventory (STAI – State/Trait), a two part 
instrument assessing trait (in general), and state (situational), anxiety (Spielberger, Gorsuch, 
Lushene, Vagg, & Jacobs, 1983). Each part contains 20 items, rated on a 4-point Likert scale, 
indicating the situational intensity of the symptoms (state), or frequency of symptoms (trait) 
(Figure 19). The scores are summed up separately for each scale, with higher scores indicating 
greater anxiety. Internal consistency coefficients for the scale range from .86 to .95; test-retest 
reliability coefficients range from .65 to .75 over a 2-month interval (Spielberger et al, 1983).  
The construct and concurrent validity of the scale has been thoroughly tested and evidenced 
(Spielberger, 1989). Sesti (2000) proposed two cut-off scores: 40 for moderate anxiety, and 60 
for clinical anxiety; with scores below 40 being categorised as low anxiety. However, other 
studies have suggested a higher cut score of 54–55 for older adults, aged 64 and over (Kvaal, 
Ulstein, Nordhus, & Engedal, 2005).  
 
 
 
Figure 19. Example items from STAI-Trait (upper table), and STAI-State (lower table) 
  
  Not at all Somewhat Moderately 
Very much 
so 
1. 
 
I feel calm 
 
    
 
  
Almost 
never 
Sometimes Often 
Almost 
always 
1.  I feel pleasant     
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Fatigue was assessed with Fatigue Severity Scale (FSS; Krupp, LaRocca, Muir-Nash, & 
Steinberg, 1989), a 9-item questionnaire assessing symptoms of fatigue over the last 7 days 
(Figure 20). Scale is a 7-point Likert scale where 1 represents ‘Strongly disagree’ and 7 
‘Strongly agree’. The responses are summed up, and the mean of the scale calculated, with a 
score range from 1-7, with a higher score indicating more fatigue severity. Reliability has 
proven excellent in both clinical and non-clinical populations, Cronbach’s alpha 0.81-0.89 
(Krupp et al, 1989), and both construct and concurrent validity are considered very high 
(Krupp et al, 1995).  
A published review of measurements of fatigue in chronic illnesses rated FSS as the highest 
scorer on robust psychometric properties among other 18 fatigue measurements evaluated 
(Whitehead, 2009). The mean fatigue severity in normal adults is 2.3 (SD=0.7) (Krupp et al, 
1989).  
In sleep disordered patients, the FSS averages 4.8 (SD=1.5), whilst specifically in insomnia 
patients the average score is higher, at an average of 6 (SD=0.5), which is comparable to 
scores in clinical populations with multiple sclerosis (5.1) and Chronic Fatigue Syndrome 
(6.1) (Lichstein, Means, Noe, & Aguillard, 1997).  
 
Figure 20. Example item from Fatigue Severity Scale (FSS) 
Daytime sleepiness was assessed with the Epworth Sleepiness Scale (ESS, Johns, 1991). The 
ESS is a self-administered questionnaire that measures daytime propensity (i.e. the likelihood) 
to fall asleep, in eight real-life scenarios i.e. whilst reading, whilst in a car, etc (Figure 9, 
above), rating the likelihood on a scale of 0 (unlikely) to 3 (very likely). A total score from 0 
to 24 is calculated, with values over 10–11 indicating abnormal or pathological sleepiness 
(Johns, 2000). The ESS has been shown to have high level of internal consistency and test-
retest reliability in healthy subjects (Johns, 1994; Johns, 1992). Patients with insomnia have 
lower scores on ESS than other sleep disordered patients (Johns, 1991). A recent study found 
patients with chronic insomnia ESS scores ranging from 4.90-5.91 (above and below age 65), 
compared to 4.74-4.19 (above and below 65) in normal sleepers (Kim et al, 2013).  
My motivation is lower when I am fatigued.  1  2  3  4  5  6  7  
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Cognitive Task Design 
Several factors were considered when selecting measures for psychomotor performance. The 
first criteria was to include a task that would reveal the cognitive challenges faced by people 
with insomnia, and which has proven effective in distinguishing people with insomnia from 
people with satisfactory sleep. The Simple Vigilance Task was chosen, as protracted reaction 
time tasks have been reported to differentiate people with insomnia from good sleepers 
(Shekleton et al, 2010). Vigilance tasks test sustained attention, which is one of the cognitive 
domains most likely to be affected by daytime insomnia-related impairments.  
Second, a comparator task within the same domain was needed, which required, and therefore 
tested, functions of higher cognitive order, in order to establish whether the complexity as 
such was driving any observed effect. Thus the Complex Vigilance Task was chosen: this 
required the use of decision-making and response inhibition cognitive processes. Complex 
vigilance tasks have been used to show that both lower and higher cognitive load produce 
observable deficits in people with insomnia (Altena et al, 2008).  
Finally, having considered the inclusion of attentional measures, it was then required to 
control for the possibility of any general gross cognitive differences being responsible for the 
potential observed effects. A standard working memory task was chosen: this was a forward 
Digit Span Task. For this task, participants were required to remember a list of numbers that 
are presented on the screen. The list of numbers was presented for a few seconds before 
disappearing from view. Participants were required to type on a keyboard the sequence of 
numbers in the order it previously appeared. The list of numbers increased by one number on 
every second trial. In the general population, the norm is a maximum digit span of 5 to 7, with 
a digit span of 3 or lower indicative of gross cognitive deficiency.   
The two psychomotor vigilance tasks were obtained from Professor Eus van Someren (Sleep 
and Cognition Group, Netherlands Institute for Neuroscience), and were the same as those 
used in the Altena et al (2008) study of effects of chronic insomnia and sleep therapy on 
vigilance.  
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The full description of the tasks is quoted from the original paper in full below: 
"For the first ‘simple’ vigilance task, 110 asterisks would sequentially appear on the screen on 
the same location but with variable and random time intervals of between 1 and 10 s. Prior to 
the task, there was a brief training session of five targets, allowing the subjects to get 
acquainted with the task and the screen layout. Subjects were instructed to press the left of the 
two mouse buttons with their dominant hand as quickly as possible whenever they saw the 
target. They were told that the task had a duration of approximately 13 min and were asked to 
maintain their concentration as well as they could throughout the task. 
In the second task, the ‘complex’ vigilance task, either the target letter ‘p’ or the distracter 
letter ‘d’ would appear in the middle of the screen. The stimuli were drawn randomly from a 
list of 10 targets and 10 distracters without replacement, such that the maximum (though very 
unlikely) number of targets or non-targets appearing consecutively would be 10.  
The time intervals between successive stimuli changed randomly between 0.5 and 5 s. This 
ensured that the average interval between targets, the number of targets and the duration of the 
task would be the same as for the ‘simple’ vigilance task. The target and distracter letters ‘p’ 
and ‘d’ were chosen because the shape and size of the letters were the same, whereas they 
differed only in their orientation. There was a brief training session of 10 stimuli (five targets) 
preceding the task. Subjects were instructed to respond as accurately and as quickly as 
possible to the targets while ignoring the distracters. A total of 220 stimuli were presented on 
the screen, of which 110 were target stimuli." (Altena et al, 2008, p.338).  
The Digit Span task was obtained from Dr Stephan Bandelow (Applied Cognitive Research 
Group, Loughborough University). During this task, a sequence of numbers would appear on 
the screen, one number at a time. The participant was then asked to enter the number sequence 
using the keyboard, in the order it appeared on the screen. Digits were randomly sampled 
without replacement up to list lengths of 9 digits in a row (with single digit duplications when 
participants’ spans surpassed  9), with the additional constraints that successive digits could 
not occur in regular ascending or descending sequences with equal consecutive step sizes 
(e.g., 123, 876, 357, 864, or 369). The sequence span length was increased following correct 
answers and repeated following an incorrect response, up to maximum of 12 trials.  
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4.2.7 Intervention procedure 
Intervention group 
Participants were instructed to engage in brisk walking of moderate intensity. Brisk walking 
was described for these purposes as: ‘walking hard enough to make one breathe more heavily 
than  normal and to become  slightly warmer, but not so hard that one is unable to talk and 
walk at the same time, or become exhausted’. The duration of physical activity was defined as 
a minimum of 30 minutes of moderate intensity physical activity (PA) on 5 or more days of 
the week. By the end of the week, participants should have accumulated a minimum of 150 
minutes of physical activity. 
Prior to the start of the trial, each individual participant had a session with the researcher, in 
order to discuss present lifestyle, and opportunities for fitting the PA programme within it. 
During that session, each individual participant was issued with: (i) walking advice booklet, 
which contained advice on how to begin and sustain moderate intensity walking, (ii) support 
telephone number for the Research office, to call and text for advice and support (Contact 
card), (iii) a pedometer with accelerometer (New Lifestyles NL- 2000, New Lifestyles Inc.) 
for the entire duration of the study, as a monitoring and motivational tool; (iv) pedometer 
diary for recording daily/weekly steps and moderate-intensity minutes, readings from the 
pedometer with accelerometer (all in Appendix 2). 
The intervention started with a conditioning period of 4 weeks. This started with 10-15 
minutes per day of walking on at least 5 days of the week (Weeks 1 and 2), and increased to 
20 minutes per day walking on at least 5 days of the week (Week 3), and increased to 25-30 
minutes per day walking on at least 5 days of the week (Week 4). After the end of the 
conditioning period, participants were required to engage in walking on at least 30 minutes per 
day, on at least 5 days of the week, totalling at least 150 minutes of moderate intensity 
physical activity at the end of each week. Walking was monitored through readings from the 
pedometer with accelerometer of minutes in moderate intensity physical activity accumulated 
at the end of the day/week, self-monitored and noted by participants in the PA diary. 
Participants engaged in the physical activity programme in their chosen setting in their own 
time.  
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Researcher-led contact with participants was effected, on average, on a weekly basis, either by 
telephone or by email. During the weekly contact, the physical activity target achievement for 
the current week was discussed. In addition, any adverse reports of physical activity were 
noted. If the target for the current week had not been achieved, then the discussion included 
identification of further opportunities to engage in physical activity the following week, e.g. 
switching mode of transport to work to include more walking, signing up for a local walking 
group, identifying a supporting friend/relative to engage in the walking programme. 
Participants were also asked to wear an accelerometer with display screen for the duration of 
the intervention (see below section on monitoring of adherence for full technical details of the 
devices worn). Self-monitoring and goal setting have been employed successfully as strategies 
in increasing physical activity in clinical populations with chronic disease (van Achterberg et 
al, 2011). The provision of tailored feedback has also been proven successful in adherence to 
physical activity interventions (de Vries et al, 2008). It was considered that a combination of 
these strategies to develop a tailored intervention approach would prove successful in ensuring 
adherence and fidelity of the physical activity intervention for the present trial.  
Control group 
Participants were asked to continue their lifestyle as usual, and maintain their existing levels 
of physical activity. After 6 months, participants in the control group were offered the same 
material as had been provided to the intervention group at the start, containing detailed advice 
on engaging in moderate intensity physical activity.  
Monitoring of adherence during the intervention period  
The participants were asked to wear a pedometer with accelerometer for the duration of the 
intervention (6 months), in order to monitor adherence to the condition assigned. All 
participants in the intervention group wore a NewLife NL-1000 Activity Monitor (New 
Lifestyles Inc., US) (Figure 21), a small hip-worn device which measures vertical acceleration 
to count steps and accumulate total activity time spent at or above moderate intensity. The 
participants were asked to record their readings, both in steps and accumulated moderate to 
vigorous physical activity minutes, in a physical activity daily diary.  
  
 82 
 
To monitor and account for the motivational effect of wearing a physical activity monitoring 
device, all the participants in the control group were also randomised to wear the same activity 
monitor, by rotation, for 3 months. The procedure ensured that all participants in the control 
group wore the activity monitor for at least 3 months during the intervention period.  
The research office contacted all participants on a weekly or fortnightly basis, to obtain the 
readings, and updates on health, physical activity and sleep.  
 
Figure 21. Image of New Lifestyles NL-1000 activity monitor 
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4.2.8 Data management 
Data processing 
Data were entered into SPSS version 20.0 (SPSS Statistics v. 20.0, IBM, US). Data were 
analysed using pre-planned descriptive statistics, t-tests for independent means, analyses of 
variance and covariance, Pearson correlation and logistic regression. Data were checked for 
outliers, distribution variance, and missing data. Statistical assumptions of variables’ 
distribution were checked visually and with normality tests. Statistical significance was 
defined as p < .05 using two tailed tests.  
The process for handling missing data was set in two stages. Stage 1 included separate bias 
analyses for data missing from participants who were randomised, but dropped out before the 
first follow up period, so whole cases were missing. If the analyses revealed no bias effect of 
the missing data on the outcomes of the trial, analyses proceeded on the remaining data, and 
no data imputation would be performed. If the analyses at Stage 1 revealed that missing data 
biased the outcomes of the trial, then Stage 2 would be employed. In Stage 2, statistical 
procedures for inputting missing data would be used (multiple imputation or last observation 
carried forward methods). All data was analysed per group allocation, regardless of adherence 
to intervention, as per ‘intent to treat’ principles.  
Processing of data from accelerometers 
ActiLife (v.6.5.3 Actigraph, US) software was used for processing the data from GTX3+ 
accelerometers.  
  
 84 
 
Based on published protocol (Troiano et al, 2008), the following threshold and criteria were 
used when cleaning up and managing accelerometer data:  
- All accelerometers were checked on calibration voltage status before and after being 
used; 
- A valid day was considered a day of 10 or more hours of valid recording; 
- Non-wear was defined as a continuous period of at least 60 minutes of 0 counts, with 
allowance of 2 minutes of counts between 0-100; 
- A valid recording unit was considered a minimum of 7 days continuous recording (out 
of 14 possible days); 
- 2020 and above counts was the threshold for moderate to vigorous physical activity 
(MVPA);  
- Time spent in physical activity is presented for every minute where the respective 
intensity threshold has been met.  
The statistical variable resulted from processing accelerometer data is moderate to vigorous 
physical activity (MVPA) minutes per week. 
Processing of data from Actiwatches 
Respironics Actiware 5 (v.5.71, Phillips Electronics, US) software was used for processing 
data from Actiwatch 2 monitors.  
The statistical variables resulting from processing Actiwatch 2 data were:  
- Total sleep time (TST) in minutes per night;  
- Time in bed (TIB) in minutes per night;  
- Sleep onset latency (SOL) in minutes per night;  
- Sleep efficiency (SE) percentage, calculated from TST/TIB x 100;  
- Sleep fragmentation index (SFI) which quantifies the degree of fragmentation of sleep-
awake pattern during the night. It is calculated as follows: 100 × the number of groups 
of consecutive immobile 30-s epochs/by the total number of immobile epochs. 
- Wake after sleep onset (WASO) in minutes per night.  
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Processing of data from psychomotor tests 
The psychomotor tasks were administered using E-prime 1.1, with service pack 3 (Psychology 
Software Tools, Pittsburgh, PA, USA). All testing was performed on an HP-compatible laptop 
running Windows XP. During the tasks, stimuli (Courier New bold font size 45) appeared in 
the middle of a 30.5 × 23cm LCD screen (screen resolution 640 × 480) against a light grey 
background.  
For the attention tasks, for all analyses, the first three target stimuli were discarded, in order to 
eliminate start-up problems (Altena et al, 2008). Thus, there were 107 target stimuli, for each 
test, included in the analyses.  
As dependent variables for the two vigilance tasks, reaction times (in milliseconds [ms]), 
lapses and false-positive responses, were used, defined as follows: 
- Reaction times (RTs) – these consisted of a single trial RTs to the target stimuli. For 
purposes of calculating mean RT and all other statistical analyses, the responses scored 
as lapses were ignored.  
- Lapses – the error of omission was scored as a lapse; a lapse was defined as a non-
response, or a response slower than 500ms on the ‘simple’ task (Altena et al, 2008); 
and slower than 637ms for the ‘complex’ vigilance task. The complex vigilance task 
required on average 137ms more than the simple vigilance task.  
- False-positive responses – on the complex vigilance task, the errors of commission to 
the distractor stimuli were scored as false-positives.  
As dependent variable for the Digit Span Task, the length of the longest span answered 
correctly over the 12 trials was used.  
Processing of data from self-reported questionnaires 
All data from questionnaires were entered manually in SPSS. All data were cross-checked for 
accuracy. Scale sub-scores and total scores were calculated using published algorithms.  
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Data analyses 
Analyses of covariance (ANCOVA) models were employed, in which the dependent variable 
was the change pre-post intervention for each of the primary and secondary outcomes (all 
scales were coded as continuous variables); and in which group membership (control or 
intervention) was a fixed factor. The covariates and their coding status were:  
- marital status (categorical variable, 2 categories: Married/With partner; and Not 
married /Widowed/Single) 
- education (categorical variable, 2 categories: No formal education/Primary/Secondary; 
and College/University/Higher) 
- Body mass index (BMI) (continuous variable) 
- Health index (EQ5D-Visual Analogue Scale - continuous variable) 
- Beck Depression Inventory score (continuous variable) 
- Light exposure (min/day of light exposure over 1000 lux – continuous variable) 
- Baseline value of the primary (or secondary outcome) in the respective model. 
Independence of the covariates and intervention effects, and homogeneity of regression slopes 
was checked.  
Logistic regression models were used to characterize the relationship between changes in 
scores on the Insomnia Severity Index (ISI) (from baseline to 6 months post-intervention) and 
outcomes/anchors from the Beck Depression Inventory, State-Trait Anxiety Inventory - Trait, 
and psychomotor tasks. 
Effect sizes and confidence intervals were computed using the Effect Size Generator 
Professional Edition software (v. 4.1, ClinTools Software, Melbourne, Australia), by inputting 
adjusted means and standard deviations from SPSS for the respective variables.   
 87 
 
Data protection 
All data from the trial was stored according to the current data Protection Act 1998 
obligations, and in conformity to Loughborough University’s Code of Practice on 
Investigations Involving Human Participants (available here: 
http://www.lboro.ac.uk/committees/ethics-approvals-human-
participants/additionalinformation/codesofpractice/).  
Personal data is as defined by the Act as data relating to a living individual who can be 
identified from that information or from that data and other information in possession of the 
data controller. Sensitive data is defined by the Act as data which covers racial or ethnic 
origin, political opinions, religious beliefs, trade union membership, health, sex life, and 
criminal convictions.   
Personal data (name, address, date of birth) collected from participants was stored in written 
format, and not transferred into electronic format. The data were stored in a fire-proof locked 
cabinet, inside a locked office, within Loughborough University. Only the writer (trial main 
investigator), and the supervisors of the project (Kevin Morgan and Clare Stevinson, both 
based at Loughborough University), had access to it.  
Sensitive data (ethnic origin and health-related data) were stored in electronic format, and 
were coded and anonymised i.e. devoid of any features which could have led to the 
identification of the participants. Participants were electronically allocated a number at the 
beginning of the trial, and all data were entered against the chosen number. The published 
results of the present research are anonymised, and no information is published that would 
allow individuals to be identified. 
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4.3 Results 
4.3.1 Recruitment and selection of participants 
The full CONSORT diagram is presented in Figure 22. In response to advertisements, 320 
enquiries were received from potential volunteers. After telephone screening, 261 people were 
sent screening questionnaires. Based on the responses, 93 people were considered eligible for 
participation in the trial.  
Of those potential participants excluded at screening stage, 89% were considered ineligible on 
the basis that they reported engaging in more than 60 minutes per week of physical activity. 
The remaining exclusions pertained to present diagnosed psychiatric disorder, or declined 
randomisation. 
Following randomisation to group, six potential participants withdrew or were excluded: three 
in the intervention group, and 3 in the control group. The reasons given for their withdrawal 
by the three in the control group were: that they wanted to be in the physical activity condition 
(n=2), and worsening health (n=1). The reasons given for withdrawal by the three in the 
intervention group were: unexpected lifestyle demands making time commitment to the trial 
difficult (n=1); and worsening health (n=2). 
One participant from the control group was unavailable for measures within the allocated time 
at 3 months from baseline.  
4.3.2 Participants characteristics 
Participants’ socio-demographic characteristics at baseline are shown in Table 9. Briefly, the 
sample consisted of 41 adults (of whom 30 were females), with a mean age of 60 years. The 
mean weekly volume of MVPA was 57 minutes. The sample was just above the normal 
weight range, with a mean BMI score of 26.  
There were no significant differences between the two groups at baseline on any of the 
variables of interest. None of the variables violated the equality of variance assumption, or 
normality of distributions assumption (for the t-tests).  
Table 10 shows the self-reported sleep and health characteristics within the sample at baseline. 
The depression and anxiety scores place the sample within the subclinical range. Table 11 
presents participants’ sleep characteristics from wrist actigraphy at baseline. 
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At baseline, there were no significant differences between the two groups in these respects. 
The mean ISI score placed this sample in the moderately severe range of insomnia severity. In 
terms of the development of the disorder, participants reported an average of 11 years of 
chronic persistence of insomnia, with a wide range, from 1 year to 25 years. 
24% of participants reported present use of non-pharmalogical and of pharmacological 
treatment to improve sleep. Participants reported on average having one chronic disease in 
addition to insomnia. 
Insomnia duration, medication use and number of other chronic diseases did not significantly 
differ between groups at baseline.   
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CONSORT Diagram 
 
Figure 22. Participant flow diagram  
Randomised (n=41) 
Analysed  (n=17) 
 Excluded from analysis (n=0) 
 
    Analysed  (n=18) 
 Excluded from analysis (n=0) 
 
Analysis 
 Lost to follow-up (n= 0) 
Discontinued intervention (n= 0) 
Lost to follow-up (n= 0) 
Discontinued intervention (n= 0) 
Assessed for eligibility (n=93) 
Screening  
Lost to follow-up (n= 0) 
Discontinued intervention (n= 0) 
Allocated to intervention (n=20) 
Received allocated intervention (n=17) 
Did not receive allocated intervention 
(withdrawn) (n=3) 
Lost to follow-up (n= 1) 
Not available for measures at the time 
Discontinued intervention (n= 0) 
Allocated to control (n= 21) 
Received allocated intervention (n=18) 
Did not receive allocated intervention 
(withdrawn) (n=3) 
Allocation 
3 months 
 
Enrolment 
Post-intervention 
(6 months) 
Excluded  (n=52) 
   Not meeting inclusion criteria 
(n=48) 
   Declined to participate (n=2) 
   Other reasons (n=2) 
Lost to follow-up (n= 0) 
Discontinued intervention (n= 0) 
 
 Lost to follow-up (n= 0) 
Discontinued intervention (n= 0) 
 
Follow-up            
(12 months) 
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Table 9 
 
Participants’ socio-demographic characteristics at baseline 
Variable Sample                           
N = 41 
Control group   
N = 21  
Intervention 
group N = 20 
p* 
 Mean (SD) or frequency 
Age 59.80 (9.46) 60.10 (8.51) 59.50 (10.59) 0.84 
Gender (female/male)† 30/11  15/6 15/5 0.76 
Education (high/low)† 17/24  9/12 8/12 0.85 
Marital status (married/not) † 36/15 12/9 14/6 0.39 
Income groups (median) ‡ 7.00 6.50 9.00 0.34 
Body mass index 26.29 (4.18) 26.58 (4.77) 25.99 (3.55) 0.65 
MVPA§ min/week 57.50 (30.07) 48.95 (27.84)  66.50 (30.37) 0.16 
*t-tests between groups; †χ2 between groups; ‡ Mann-Whitney-U; § MVPA= Moderate to 
vigorous physical activity 
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Table 10 
 
Participants’ self-reported sleep and health characteristics at baseline 
Variable Sample                           
N = 41 
Control group   
N = 21  
Intervention 
group N = 20 
p* 
 Mean (SD)** 
ISIa 16.11 (4.93) 16.37 (5.58) 15.82 (4.23) 0.41 
PSQIb Global 10.37 (2.76) 10.61 (2.94) 10.10 (2.61) 0.55 
BDIc 11.87 (6.51) 12.95 (6.84) 10.75 (6.13) 0.28 
STAId-Trait 39.95 (8.73) 40.14 (9.68) 39.74 (8.09) 0.88 
STAId-State 34.75 (7.98) 35.71 (8.52) 33.68 (7.41) 0.42 
EQ-5D (VAS) 77.63 (16.53) 75.24 (20.82) 80.15 (10.28) 0.35 
FSSe 3.96 (1.51) 3.88 (1.53) 4.04 (1.54) 0.74 
*t-tests between groups; **Equality of variance tested, all non-significant 
a ISI= Insomnia Severity Index; b PSQI=Pittsburgh Sleep Quality Index; c BDI=Beck 
Depression Inventory; d STAI=State/Trait Anxiety Inventory; e FSS=Fatigue Severity Scale 
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Table 11 
 
Baseline sleep characteristics from sleep actigraphy 
Variable Sample                 
N = 41 
Control group     
N = 21  
Intervention 
group N = 20 
p* 
  Mean (SD) †   
Total sleep time – min‡ 403.58 (59.63) 405.23 (71.52) 401.85 (45.79) 0.85 
Time in bed – min 519.93 (56.62) 516.04 (66.66) 524.03 (45.16) 0.65 
Sleep onset latency – min§ 25.76 (17.26) 24.96 (15.94) 26.62 (18.94) 0.68 
Wake after sleep onset – 
min§ 
67.51 (51.71) 64.40 (58.81) 70.79 (44.35) 0.60 
Sleep efficiency (%)§ 78.01 (8.63) 79.03 (9.50) 76.95 (7.71) 0.22 
Sleep Fragmentation Index§ 17.66 (5.04) 17.74 (5.41) 17.58 (4.76) 0.83 
*t-tests between groups; †Equal variance tested, all non-significant, apart from ‡. 
‡ Equal Variance not assumed, p-value displayed; §Wilcoxon Rank Sum Test  
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4.3.3 Missing data: attrition analyses 
Logistic regression was employed to see whether key variables at baseline predicted 
‘missingness’ of data at subsequent follow-up time of 3 months and 6 months. A dichotomous 
adherence variable was created that represented the status of ‘missing’ or ‘non-missing’ data 
at 3 months follow up, and post-intervention. Predictive relationships were examined between 
these adherence categories and key independent variables: group allocation, insomnia 
severity, sleep quality, health status, and mood.  
The analyses revealed no significant association between key variables and ‘missingness’ of 
data at 3 months and 6 months (Tables 12 and 13). 
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Table 12 
 
Logistic regression output for data attrition analyses at 3 months 
Variables predictors df 
                       
Sig. Exp(B) 
95% C.I.for                        
Exp(B) 
Lower Upper 
Group membership (control or 
intervention) 
1 0.96 1.07 0.10 11.45 
ISIa 1 0.20 1.31 0.87 1.99 
PSQI GLOBALb 1 0.41 0.72 0.33 1.57 
BDIc 1 0.81 1.04 0.76 1.42 
FSSd 1 0.50 1.41 0.52 3.80 
ESSe 1 0.22 0.74 0.46 1.20 
MVPAf min/week 1 0.25 0.98 0.94 1.02 
EQ5D-DL Health Index Value 1 0.98 1.11 0.00 4960.80 
Body Mass Index 1 0.41 0.81 0.49 1.33 
STAI-Traitg 1 0.51 1.09 0.84 1.41 
STAIT-Stateg 1 0.50 0.91 0.69 1.19 
Constant 1 0.73 40.18     
a ISI= Insomnia Severity Index; b PSQI=Pittsburgh Sleep Quality Index; c BDI=Beck 
Depression Inventory; d FSS=Fatigue Severity Scale; e ESS=Epworth Sleepiness Scale; f 
MVPA=Moderate to vigorous physical activity; g STAI=State/Trait Anxiety Inventory. 
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Table 13 
 
Logistic regression output for data attrition analyses at 6 months 
Variables predictors df  Sig. 
 
Exp(B) 
95% C.I.for 
Exp(B) 
Lower Upper 
Group membership (control or 
intervention) 
1 0.34 3.53 .27 46.65 
ISIa 1 0.34 1.23 .80 1.89 
PSQI GLOBALb 1 0.42 .72 .32 1.60 
BDIc 1 0.79 1.05 .75 1.45 
FSSd 1 0.89 .93 .30 2.82 
ESSe 1 0.42 .83 .53 1.31 
MVPAf min/week 1 0.40 .98 .94 1.03 
EQ5D-DL Health Index Value 1 0.70 5.10 .00 19460.46 
Body Mass Index  1 0.61 .86 .49 1.52 
STAIg-Trait 1 0.66 1.06 .82 1.37 
STAITg-State 1 0.71 .95 .73 1.24 
Constant 1 0.86 7.04   
a ISI= Insomnia Severity Index; b PSQI=Pittsburgh Sleep Quality Index; c BDI=Beck 
Depression Inventory; d FSS=Fatigue Severity Scale; e ESS=Epworth Sleepiness Scale; f 
MVPA=Moderate to vigorous physical activity; g STAI=State/Trait Anxiety Inventory. 
 
It was concluded that the missing data was missing at random, thus data left in the analyses 
would not be biased. No data imputation for missing data was performed.  
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4.3.4 Adherence 
Adherence to intervention 
Over the trial, the participants in the intervention group engaged on average in 219 minutes 
per week of moderate to vigorous intensity physical activity (MVPA) (SD=99.75). The 
participants in the control group engaged on average in 74.38 minutes per week of MVPA 
(SD = 67.36).  
During the 6 month period of the intervention, the participants in the intervention group 
(N=17) were aiming to reach at least 30 minutes of MVPA, over 5 days, per week, leading to 
at least 150 minutes of MVPA per week. When using this threshold to calculate regular 
compliance (monitored with continual use of pedometers with accelerometers), out of 442 
total reported weeks for the 17 participants, there were 4.75% weeks achieving less than 150 
minutes MVPA per week. Thus, there was 95% continuous adherence to the intervention.  
Three participants in the intervention group (18%) were found to have achieved less than 150 
minutes per week of MVPA per week, at 6-months follow-up. One participant in the control 
group was found to have engaged in more than 150 minutes per week of MVPA (293 
min/week) at 6-month follow up. 
The majority of the MVPA reported comprised walking or jogging, with 10% of participants 
reporting additional swimming sessions, or cycling. Those activities that could not be captured 
by accelerometers i.e. swimming, or cycling, were not included in the activity figures 
reported. All the figures reported are from the actigraphy activity monitoring. 
 Tolerability to intervention 
There was one adverse event reported due to the intervention (mild sprained ankle). With 
adequate rest and treatment, the participant returned to her usual walking levels within 2 
weeks.  
Over the 26 weeks of walking intervention, with participants engaging in an average of 5 
walking sessions a week, this represents a 0.03% risk of injury over the course of the study. 
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4.3.5 Effect of intervention on physical activity levels    
Independent t-tests between groups separately performed at 3 months follow up, and at 6 
months follow up, showed significant differences in physical activity levels, as recorded by 
accelerometers, between the two groups. The intervention group performed significantly more 
minutes of moderate to vigorous physical activity per week than the control group (Table 14).  
Using multivariate mixed models, there was a significant main effect of group membership on 
amount of weekly physical activity performed at 6 months, F(1,32)=19.08, p<0.001. Group 
membership affected the degree of change in physical activity levels performed over time, 
(F(1,32)=15.45, p<0.001), with those participants in the intervention group performing 
significantly more PA over time than those in the control group (Figure 23).  
In the intervention group, participants increased their mean MVPA from 66.50 (SD = 30.37) 
min/week at baseline, to 213 (SD = 109.31) min/week at 6 months. In the control group, on 
average participants increased their MVPA from 48.95 (SD = 27.84) min/ week at baseline, to 
79.66 (SD = 64.73) at 6 months. 
 
Table 14 
 
Means and standard deviations for weekly minutes of moderate to vigorous physical activity 
at 3 months and post-intervention 
 Control Intervention p* 
MVPA† 3 months 66.47 ± 73.72 225.62 ± 97.71 0.001 
MVPA post-
intervention 
79.66 ± 64.73 213.00 ± 109.31 0.001 
*Independent t-tests; † MVPA=Moderate to vigorous physical activity (min/week) 
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Figure 23. Weekly mean physical activity change from baseline to 6-month follow-up 
4.3.6 Insomnia symptoms severity and sleep quality 
The main outcome measure of the trial was severity of insomnia symptoms, as measured by 
Insomnia Severity Index (ISI). The secondary outcome measures were sleep quality, as 
assessed with Pittsburgh Sleep Quality Index (PSQI); and sleep structure/quantity, as assessed 
with actigraphy.  
At baseline, the average ISI and PSQI scores in the whole sample were 16, and 10, 
respectively, placing the sample in the moderate range of insomnia severity.  
Changes in insomnia severity symptoms and sleep quality at 3 months, and post-intervention 
(at 6 months) were assessed using analyses of covariance (ANCOVA) models.  
Means and standard deviations on these variables for the groups at baseline, 3 months and 
post-intervention are presented in Table 15.  
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Assumptions for the ANCOVA models were checked. Independence of the covariates and 
treatment effect were ensured through random allocation of participants to the two groups; in 
addition baseline levels of covariates used did not significantly differ between the two groups 
(Table 9). Homogeneity of regression slopes was tested through a series of interaction 
univariate models (controlling for the main effects) between the dependent variable (ISI 
change score) and the covariates. None of the interaction models were significant, indicating 
that the homogeneity assumption was met. 
Table 15 
 
Means and standard deviations for self-reported sleep variables at baseline, 3 months and 
post-intervention 
 All sample Control Intervention 
Mean ± SD 
ISI* (Baseline) 16.11 ± 4.93 16.37 ± 5.58 15.82 ± 4.23 
ISI (3 months) 13.24 ± 5.33 14.35 ± 5.61 12.12 ± 4.96 
ISI (Post-intervention) 13.44 ± 5.60 14.95 ± 5.02 11.76 ± 5.88 
PSQI† Global (Baseline) 10.33 ± 2.90 10.26 ±  3.12 10.41 ± 2.71 
PSQI Global (3 months) 9.11 ± 3.15 9.47 ± 2.93 8.76 ± 3.40 
PSQI Global (Post-
intervention) 
8.69 ± 3.62  9.37 ± 3.93 7.94 ± 3.17 
*ISI=Insomnia Severity Index; †PSQI=Pittsburgh Sleep Quality Index 
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3 months sleep variables 
In ANCOVA models, with Insomnia Severity Index difference score as dependent variable 
(baseline - 3 months score), and marital status, education, body mass index, health index 
value, Beck Depression Inventory score, light exposure, and baseline value of Insomnia 
Severity Index, there was a significant effect of group allocation on insomnia severity change, 
F(8,25)=4.42, p=.04. Pre-post comparisons within each group revealed that there was a 
significant improvement in Insomnia Severity Index score in the intervention group, 
t(16)=4.68, p<0.001; but no significant change in the control group, t(16)=2.06, p=.06.  
Looking at secondary outcomes, in ANCOVA models with Pittsburgh Sleep Quality Index 
difference score as dependent variable, and the same covariates as in the model above, there 
was no significant effect of group membership on change in sleep quality, F(8,25)=.31, p=.58. 
Means and standard deviations for actigraphy-derived sleep variables are presented in Table 
16; there were no significant changes in any of these sleep variables at 3 month measures.  
Table 16 
 
Means, standard deviations, and ANCOVA models outputs for actigraphy sleep variables at 3 
months 
Variable Sample                 
N = 34 
Control group       
N = 17  
Intervention 
group    N = 17 
F(8,24) p 
Mean ±SD 
Total sleep time – min 415.80 ± 53.25 407.92 ± 63.52 423.68 ± 41.00 .02 0.89 
Time in bed – min 510.00 ± 55.88 501.76 ± 66.73 518.24 ± 42.94 .02 0.90 
Sleep onset latency – min 26.25 ± 17.69 22.57 ± 16.09 29.94 ± 18.91 .65 0.42 
Wake after sleep onset – 
min 
42.96 ± 19.62 44.66 ± 21.32 41.26 ± 18.26 .06 0.80 
Sleep efficiency (%)  81.62 ± 7.26 81.30 ± 8.10 81.94 ± 6.55 .01 0.98 
Sleep Fragmentation 
Index  
19.68 ± 8.11 20.95 ± 9.16 18.41 ± 6.97 .08 0.77 
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Post-intervention (6 months) sleep variables 
The covariates were not significantly related to change in the main outcome – insomnia 
symptoms severity (Table 17). There was a significant effect of group membership on change 
scores in ISI, after controlling for appropriate variables: F(8,26)=5.16, p=.03 (Table 18). Pre-
post comparisons for each group showed a significant improvement in the ISI score in the 
physical activity group (t(16)=3.35, p<0.01), but no significant change in the control group 
(t(17)=1.81, p=0.21).  
In order to determine the clinical significance of the change in ISI, a series of comparisons 
were performed within sample groups. The ISI was categorised as subthreshold insomnia 
(<14) and moderate to severe (15 and over) (Morin et al, 2011). Upon comparing the change 
in the two categories within the groups over time, there was a reduction of 67% in the 
moderate to severe category of the intervention group, compared to a 14% reduction within 
the same category in the control group (Figure 24). Overall, in the intervention group, there 
was a 4-point reduction in the ISI score.  
Considering as responders to physical activity treatment those who improved their insomnia 
Severity Index score with 4 points or more, 47% of participants in the intervention group were 
responders at 3 months, and 53% were responders to treatment at 6 months.  
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Table 17 
 
Assumptions for covariates significance interaction in the ANCOVA ISI model at 6 months 
Covariate  F(1,28)   p 
Marital status 0.30 0.58 
Education 0.25 0.61 
Body Mass Index 0.54 0.46 
Health index 0.003 0.95 
Light exposure 0.04 0.84 
Beck Depression Inventory 1.28 0.26 
ISI* (Baseline value) 1.07 0.30 
*ISI=Insomnia Severity Index
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Table 18 
 
Main models for pre-post intervention outcomes, adjusted means and effect sizes in the RCT 
 Intervention group Control group    
Comparison of mean 
change pre-post 
intervention 
 
Mean ± SD (n) 
p Adjusted mean difference 
± SE (95% CI) 
Adjusted Cohen d 
(95% CI) 
Main outcome: Sleep*       
ISIa -4.06 ± 4.99 (17) -1.42 ± 3.42 (19) 0.03 3.67 ± 1.48 (.33–6.4) .78 (.10–1.45) 
Secondary outcomes†      
PSQIb -2.47 ± 3.26 (17) .89 ± 3.43 (19) 0.27 1.36 ± 1.22 (-1.1–3.87) .38 (-.27–1.04) 
FSSc .64 ± 1.48 (17) -.16 ± .63 (17) 0.18 6.13 ± 4.6 (-.32–1.59) .49 (-.17–1.15) 
BDId -4.35 ± 4.44 (17) 1.31 ± 9.26 (19) 0.02 5.99 ± 2.52 (.82 – 11.15) .87 (.19 –1.56) 
STAI-Te -4.93 ± 5.40 (17) .38 ± 8.95 (19) 0.05 -4.76 ± 2.35 (-9.6 – 0.7) .72 (.03–1.42) 
Attention‡      
Simple RTf(ms) -31.98 ± 35.85 4.61 ± 31.25 0.001 -33.58 ± 8.68 (-51.47– -
15.70) 
-1.3 (-2.07 – -0.62) 
Complex RT(ms) -13.58 ± 30.56 -8.18 ± 28.01 0.62 -4.58 ± 9.18 (-23.50–
14.32) 
-.17 (-0.82–0.48) 
Ratio SRT/CRT(ms) .09 ± .12 -.04 ± .07 0.003 -.11 ± .03 (-.18 – -.04) 1.09 (0.35 - 1.83) 
aISI=Insomnia Severity Index; bPSQI=Pittsburgh Sleep Quality Index; cFSS=Fatigue Severity Scale; dBDI=Beck Depression 
Inventory; eSTAI-T=State-Trait Anxiety Inventory (Trait only); fRT=Reaction Time (ms) 
 
*Covariates: Marital status, Education, Body Mass Index, Health Index, Beck Depression Inventory, Light exposure, Baseline value 
of comparison variable; †Covariates: Marital status, Education, Body Mass Index, Health Index, Beck Depression Inventory, Light 
exposure, Baseline value of comparison variable; ‡Covariates: Marital status, Education, Body Mass Index, Health Index, Beck 
Depression Inventory, Fatigue Severity Scale, Baseline value of attention task/ratio (ms)
 105 
 
 
Figure 24. ISI categories at baseline (above) and post-intervention (below) 
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There was no significant effect of group membership on the change score on global PSQI, 
F(8,26)=1.24, p=.27. Speculative pre-post comparisons for each group showed significant 
improvement in the PSQI global score in the intervention group t(16)=3.12, p<0.01, but 
not in the control group, t(17)=1.13, p=0.27 (Figure 25).  
 
 
Figure 25. Means and standard deviations for PSQI Global scores in the intervention and 
control groups 
Additional analyses on the PSQI subscales change scores revealed a significant effect of 
group membership on the daytime dysfunction subscale, F(8,26)=10.83, p<0.01, with 
follow-up pre-post comparisons for each group showing a significant improvement in the 
physical activity group, t(16)=3.05, p<0.01, but no significant change in the control group, 
t(17)=-1.75, p=0.24.  
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Means and standard deviations for the actigraphy-derived sleep variables post-intervention 
are presented in Table 19. There was no significant effect of treatment condition on the 
change score post-intervention in any of the actigraphy sleep variables (Table 20). 
Table 19 
 
Means and standard deviations of actigraphy sleep variables post-intervention 
Variable Sample                 
N = 35 
Control group     
N = 18  
Intervention 
group N = 17 
  Mean (SD)  
Total sleep time – min 426.35 (41.96) 418.68 (50.03) 434.48 (30.74) 
Time in bed – min 518.87 (51.66) 509.74 (58.43) 528.54 (43.01) 
Sleep onset latency – min 26.38 (18.17) 24.55 (16.73) 28.32 (19.91) 
Wake after sleep onset – 
min 
41.63 (19.84) 41.96 (18.76) 41.28 (21.50) 
Sleep efficiency (%)  82.61 (7.21) 82.57 (7.35) 82.65 (7.28) 
Sleep Fragmentation Index  18.99 (7.84) 19.39 (7.25) 18.56 (8.63) 
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Table 20 
 
Post-intervention ANCOVA models for actigraphy sleep variables 
Comparison of mean change        
pre-post intervention 
F(8,26) p 
Total sleep time 0.62 0.43 
Sleep onset latency 0.14 0.71 
Wake after sleep onset 0.06 0.80 
Time in bed 1.42 0.24 
Sleep efficiency 0.02 0.90 
Sleep fragmentation index 0.01 0.91 
 
4.3.7 Mood 
3 months mood variables 
Beck Depression Inventory and STAI-Trait and State were used to measure mood 
outcomes. In ANCOVA models with depression scores change from baseline to 3 months 
follow up as dependent variable, and marital status, education, body mass index, health 
index value, light exposure, and baseline value of Beck Depression Inventory score as 
covariates; there was a trend towards a significant effect of intervention condition on 
depression change scores, F(7,27)=3.66, p=0.06.  
Both state and trait anxiety sub-scales showed no significant difference based on group 
allocation at 3 months measuring point, F(7,27)=.42, p=0.51, and F(7,27)=.13, p=0.72, 
respectively.  
Post-intervention (6 months) mood variables 
At post-intervention, using the same models as above, there was a significant effect of 
group membership on change in depression scores: F(6,28)=5.61, p=0.02. In pre-post 
comparisons for each group, participants in the physical activity group demonstrated 
significant improvement in the BDI scores, t(16)=4.03, p<0.001 (Figure 26). Participants 
in the control group did not show significant improvement, t(17)=-.61, p=0.54.  
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Figure 26. Means and standard deviations for BDI scores in the intervention and control 
groups 
Using the same models as at 3 months, but with STAI-Trait change scores, there was a 
significant effect of group membership on trait anxiety outcomes post-intervention, 
F(6,28)=4.41, p=0.05 (Figure 27). Follow-up comparisons for each group revealed that 
participants in the intervention group had significant improvement in their trait anxiety 
scores, whilst participants in the control group did not show the same pattern (t(16)=3.71, 
p<0.01, and t(17)=-.18, p=0.34, respectively).  
When repeating the models for STAI-State, there was no significant effect of group 
membership on state anxiety score change, F(6,28)=0.78, p=0.38.  
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Figure 27. Mean STAI-Trait scores at baseline and post-intervention, in the physical 
activity and control groups 
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4.3.8 Daytime sleepiness and fatigue 
There was also no significant effect of group membership on the change score on Fatigue 
Severity Scale at the two measuring time points, with covariates marital status, education, 
body mass index, Health Index value, Beck Depression Inventory score, light exposure and 
baseline values of fatigue F(8,25)=2.83, p=0.10 at 3 months; and F(8,26)=1.84, p=0.18 at 
post-intervention (Figure 28). Daytime sleepiness followed the same trend, with no 
significant effect of group membership on change scores at post-intervention, F(8,26)=.04, 
p=0.83.  
Employing an ANCOVA model for the 6-months data only, with fatigue severity scale as 
dependent variable, group membership as fixed factor, and insomnia severity index as 
covariate, there was a main effect of ISI on fatigue, F(3,32)=8.54, p=.006, but no 
significant effect of group membership in this model, F(3.32)=.60, p=0. 44.  
 
Figure 28. Means and standard deviations of Fatigue Severity index at baseline and post-
intervention, in the physical activity and control groups 
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4.3.9 Health-related quality of life 
The EQ5D-5L was used to measure quality of life. There was no significant condition 
effect on the health scale change score at 3 months or 6 months, with covariates marital 
status, education, body mass index , Beck Depression Inventory score, light exposure and 
baseline values of Health Index, F(7,26)=2.39, p=0.13, and  F(7,27)=1.28, p=0.26, 
respectively.  
4.3.10 Psychomotor performance 
The group mean maximum digit span at baseline was 6; this remained unchanged at 6 
month follow up. The lowest length of the maximum digit span was 4, both at baseline and 
post-intervention; therefore none of the participants met the criteria (maximum digit span 
length of 3) to be eliminated from the analyses. There was no significant effect of group 
membership on performance on the digit span task, F(6,25)=.05, p=0.82.  
Across all participants and conditions (baseline and post-intervention), the complex 
vigilance task required approximately 137 ± 12.2ms more than the simple vigilance task to 
perform. Independent t-tests showed no significant difference between groups at baseline 
(Table 21).  
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Table 21 
 
Means and standard deviations for the psychomotor tests variables at baseline and post-
intervention 
 All sample Control Intervention p* 
 Mean ± SD  
Simple Reaction 
Task (ms) at 
baseline 
365.97 ± 42.73 369.89 ± 70.97 362.04 ± 45.12 0.56 
Simple Reaction 
Task (ms) post-
intervention 
378.38 ± 35.75 365.66 ± 29.67 389.75 ± 38.92  
Complex Reaction 
Task (ms) baseline 
487.92 ± 41.23 482.42 ± 44.46 493.43 ± 38.07 0.40 
Complex Reaction 
Task (ms) post-
intervention 
499.78 ± 32.86 498.39 ± 32.42 501.25 ± 34.25  
No. of lapses at 
SRT at baseline 
7.27 ± 4.04 7.05 ± 4.35 7.50 ± 3.80 0.88 
No. of lapses at 
SRT post-
intervention 
8.00 (3.95) 7.88 ± 3.80 8.11 ± 4.22  
No. of lapses at 
CRT at baseline 
10.42 ± 9.07 9.10 ± 7.25 11.75 ± 10.62 0.68 
No. of lapses at 
CRT post-
intervention 
9.11 ± 4.26 8.55 ± 3.69 9.70 ± 4.83  
*Independent t-tests between groups at baseline; equality of variance tested and n/s in all 
tests   
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Table 21 (Cont’d/..) 
 
Means and standard deviations for the psychomotor tests variables at baseline and post-
intervention 
 All sample Control Intervention p* 
 Mean ± SD  
No. of false 
positives at CRT 
baseline 
2.15 ± 1.29 2.30 ± 1.39 2.00 ± 1.07 0.42 
No. of false 
positives at CRT 
post-intervention 
1.65 ± 1.23 1.16 ± .98 2.17 ± 1.28  
Ratio SRT/CRT at 
baseline 
1.34 ± .14 1.31 ± .11 1.37 ± .16 0.12 
Ratio SRT/CRT 
post-intervention 
1.33 ± .14 1.36 ± .11 1.29 ± .16  
*Independent t-tests between groups at baseline; equality of variance tested and n/s in all 
tests 
There was a significant effect of treatment condition on the change score of the Simple 
Reaction Task, F(6,25)=14.96, p<0.01. Further examination of the groups’ means revealed 
that the intervention group had significantly slower reaction time post-intervention, 
compared to their baseline performance, t(15)=-3.67, p<0.01. There was no significant 
effect of treatment condition on the performance on the Complex Reaction Task, 
F(6,25)=.24, p=0.62 (Table 18). 
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When performance was calculated as a ratio between the simple reaction task and the 
complex reaction task, there was a significant effect of treatment condition on the ratio of 
performance, F(6,25)=10.41, p<0.01 (Figure 29). Follow-up comparisons for each group 
revealed a significant decrease in performance ratio time in the intervention group, t(16)=-
2.74, p=0.01; whilst participants in the control group displayed an increase in their ratio 
performance time, t(15)=-2.5, p=0.04. There was no significant differences in ratio 
performance time at baseline, F(1,38)=2.25, p=0.14.  
 
 
Figure 29. Mean performance ratio change between baseline and 6-month follow up in the 
two groups 
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4.3.11 Light exposure 
Using data from wrist worn actiwatches, in ANCOVA models with change scores in 
average light exposure over 1000 lux as the dependent variable, and health, marital status, 
BMI, education, and baseline values of light exposure as covariates, there was no 
significant effect of treatment condition on this outcome at 3 months, or post-intervention: 
F(6,28)=.08, p=0.77; and F(6,28)=.47, p=0.49, respectively (Figure 30).  
 
Figure 30. Mean light exposure (min/day) at baseline and post-intervention, in the physical 
activity and control groups 
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4.3.12 Relationship between insomnia severity index and daytime variables post-
intervention 
For those daytime variables hypothesised to change with the intervention, Pearson-product 
moment correlations analyses were conducted with the ISI score, for the intervention 
group. Higher Insomnia Severity Index scores were associated with larger Fatigue Severity 
Scale scores (r=.58, p=0.01, 2-tailed). Fatigue was also positively correlated with trait 
anxiety scores (r=.52, p=0.03, 2-tailed). When analysed as change scores (baseline – post-
intervention), there was a significant positive association between changes in insomnia 
severity symptoms and changes in fatigue scores (r=.50, p=0.04, 2-tailed).  
A series of stepwise linear regression models for the whole sample was employed, to find 
the best model predicting the change in ISI scores. The best predictors resulting in a 
significant model were group membership, depression scores and fatigue scores, r2=.30, 
F(3,32)=4.48, p=0.01. 
4.3.13 12-month follow up change 
Analyses of self-reported data at the follow up period (12 months since baseline, and 6 
months after the physical activity intervention had ceased) were conducted for sleep 
outcomes (Insomnia Severity Index and Pittsburgh Sleep Quality Index) and mood 
outcomes (Beck Depression Inventory and State-Trait Anxiety Inventory). Means and 
standard deviations of these variables are presented in Table 22.  
Employing ANCOVA models with Insomnia Severity Index change scores from baseline 
to 12-month follow up as dependent variable, and covariates:  marital status, education, 
body mass index, Health Index value, Beck Depression Inventory score, light exposure and 
baseline values of sleep severity index, there was a non-significant trend of improvement 
in insomnia severity symptoms by group membership, F(8,26)=3.24 , p= 0.08. Similarly, 
there was no effect of group membership on the change in PSQI score at 12-month follow 
up: F(8,26)=1.49, p=0.23. 
In the self-reported measures of weekly physical activity levels, the intervention group 
reported a mean of 1796 MET-minutes per week, whilst the control group reported a mean 
of weekly MET-minutes of 1751 (p=0.07).  
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Table 22 
 
Means and standard deviations for self-reported sleep and mood variables at 12-month 
follow up 
 All sample Control Intervention 
              Mean ± SD 
ISIa 11.57 ± 5.40 13.06 ± 4.53 10.00 ± 5.93 
PSQIb 8.71 ± 3.12 9.27 ±  2.69 8.11 ± 3.49 
BDIc 10.28 ± 7.31 12.66 ± 7.80 7.76 ± 5.97 
STAI-Sd 33.80 ± 8.96 36.05 ± 10.15 31.41 ± 7.01 
STAI-Te 38.62 ± 9.18 42.61 ± 9.03 34.41 ± 7.46 
aISI=Insomnia Severity Index; bPSQI=Pittsburgh Sleep Quality Index; cBDI=Beck 
Depression Inventory;  dSTAI-S=State-Trait Anxiety Inventory – State; eSTAI-T=State-
Trait Anxiety Inventory – Trait. 
In ANCOVA models with Beck Depression Inventory change scores from baseline to 12-
month follow up as dependent variable, and covariates:  marital status, education, body 
mass index, Health Index value, light exposure and baseline values of Beck Depression 
Inventory score, there was a non-significant effect of group membership, F(7,27)=2.38, 
p=0 .13. Similarly, there was no effect of group membership on the change in the state 
sub-scale of the STAI score at 12-month follow up: F(7,27)=1.07, p=0.30. 
When employing the same models with the change in STAI-Trait sub-scale change scores, 
there was a significant effect of group membership on anxiety score change at 12 months: 
F(7,27)=8.16, p<0.01. Subsequent comparisons for each group revealed significant 
changes pre-post intervention in the intervention group, T(16)=2.52, p=0.02, but not in the 
control group, t(17)=-.97, p=0.34. 
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4.4 Summary 
Activity assessments at baseline indicated an inactive sample, and did not differ between 
the intervention and control group. In addition, self-reported and objective sleep measures, 
as well as other health-related measures, did not differ at baseline either. At 6 months post 
baseline the intervention group engaged in 213 min/week of moderate intensity PA, 
compared to the control group (82 min/week). Following the physical activity treatment, 
the intervention group showed significant improvement in insomnia severity symptoms 
score at 6 months F(1,28) = 5.16, p=0.03), adjusted means difference = 3.37, with an 
adjusted Cohen's d =.78 (95% CI 0.10–1.45). There were also significant improvements in 
trait anxiety, and depression outcomes in the intervention group at 6 months, F(6,28)=4.41, 
p=0.05, and F(6,28)=5.61, p=0.02, respectively. These results demonstrate that increasing 
activity in line with current guidelines could deliver clinically significant improvements in 
sleep quality, and mood outcomes, among inactive adults with insomnia. These trial 
results, and the overall thesis conclusions, will be discussed in Chapter 5.  
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CHAPTER 5 
5.0 Discussion and conclusions 
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5.1 Discussion of RCT findings  
Using a randomised controlled design, the present trial sought to determine whether a 
physical activity intervention to the level of the recommended guidelines would reduce the 
severity of night-time insomnia symptoms, and impact daytime functioning among a 
sample of physically inactive people aged 40 years or over meeting diagnostic criteria for 
insomnia.   
The results broadly supported the research hypotheses. A 6-month period of increased 
physical activity (moderate intensity walking for at least 150 minutes per week), monitored 
objectively by actigraphy, was associated with: a reduction in the severity of insomnia 
symptoms, as measured by the Insomnia Severity Index (ISI); with a reduction in 
symptoms of depression and anxiety, as measured by the Beck Depression Inventory 
(BDI) and the State-Trait Anxiety Inventory (STAI); and with an improvement in daytime 
function, as measured by selected tests of psychomotor performance. These significant 
improvements in sleep, mood indicators and psychomotor performance associated with the 
physical activity intervention were independent of participants' health status, body mass 
index, marital status, education, light exposure, insomnia severity, mood and psychomotor 
performance measured at baseline. In interpreting the improvements resulting from the 
physical activity intervention, there was no confounding effect of increased exposure to 
light. 
Insomnia severity symptoms, as measured by the ISI, showed a significant reduction from 
baseline to post intervention. The size of this effect (.78) was ‘large’, with the 
improvement in the intervention group representing an average 4-point reduction on the 
ISI scale. Over the 6 month period, the majority of participants in the intervention group 
(67%) reduced the severity of their symptoms by one sub-scale on the ISI.  Changes in 
psychomotor performance were characterised by significant slowing on the simple reaction 
task among participants in the physical activity intervention group. The ratio of simple to 
complex reaction times also showed a significant reduction over time in the intervention 
group, but not in the control group. 
In terms of lasting effects of the intervention, analyses of self-reported sleep and mood 
variables at 12 months (6 months after treatment cessation) showed a continuing trend in 
the reduction of severity of insomnia symptoms in the intervention group; and still a highly 
significant improvement in trait anxiety scores in the intervention group.  
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5.1.1 Validity of the findings  
Given the known reliability and validity of the measures used, the rigorous procedures 
employed in sample selection, the power delivered by the sample size, and the relatively 
high adherence rates obtained at baseline, post intervention and follow up, the present trial 
offers a robust test of the hypothesis that physical activity at or above the level of the 
recommended guidelines can positively impact sleep outcomes, and associated daytime 
experiences in people with insomnia. 
The selection of a participant sample typical of health seeking patients with insomnia 
symptoms is a particular strength of the present trial.  All participants in the sample 
fulfilled the research diagnostic criteria for insomnia disorder4. There were no exclusions 
for present chronic conditions, save where such conditions interfered with informed 
consent (gross cognitive impairment), or created potential health risks as a result of 
increased physical activity (for example, uncontrolled heart problems). The mean duration 
of insomnia symptoms in the sample was 11 years (with a range of 1 year to 25 years).  
In the present trial the majority of the sample was female, consistent with the higher 
prevalence of insomnia among women (Morin et al, 2006). Apart from insomnia, the mean 
number of existing chronic conditions in the sample was 1.02, with diabetes, arthritis, liver 
disease, renal disease and asthma among those conditions. These characteristics of the 
sample are also representative of the national pattern: in the UK almost half of those 
reporting chronic conditions have more than one such condition, and this rises to 70% in 
those aged 65 and over (Department of Health, 2012).  
Similarly, 14% of participants were taking over the counter sleep aids, or prescribed sleep 
medication, with some taking medication for other chronic conditions, a proportion in line 
with other studies of insomnia in older sub-groups.  In a nationally representative sample 
of people aged between 55- 64 years meeting DSV-IV criteria for insomnia, for example, 
Stewart et al (2006) found that 14.9% were taking anxiolytic or hypnotic medication.  
  
                                                 
4 These subsumed the DSM-IV-TR and ICSD-2 manual criteria, and comprised: predominant difficulties in 
initiating or maintaining sleep, or non-restorative sleep, whilst having adequate opportunity to sleep, for at 
least 6 months, accompanied by clinically significant distress and/or impairment in important areas of daily 
functioning. These criteria are compatible with the updated DSM-V (2013) manual, published after the start 
of the present research programme).  
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5.1.2 Adherence to the intervention and extent of behaviour change 
The trial dropout rate was minimal (equal in both intervention and control groups, at 15%). 
This is less than the average dropout rate encountered in randomised controlled trials 
reported in major medical journals, of an average of 20% (Wood, White, & Thompson, 
2004). Adherence to the requirements of the intervention was also high, with 95% of those 
in the intervention group achieving weekly MVPA of 150 minutes or more. Given that 
adherence rates in physical activity trials have been estimated at between 50% - 78% 
(Dishman, 2001; Martin & Sinden, 2001), the adherence rate of 95% in the present trial 
indicates the high quality methodology employed in delivering the intervention. The 
present trial used a combination of cognitive and behavioural strategies to ensure and 
enhance individual adherence: goal-setting, self-monitoring, feedback, and support. These 
strategies have been associated with effective physical activity interventions for health 
(King, Rejenski, & Buchner, 1998). Previous research has suggested that it takes around 6 
months for physical activity change to be realised effectively (Bock, Marcus, Pinto, & 
Forsyth, 2001).  Given this, the results from the present trial indicate that, in public health 
terms, the sustained behavioural change at 6-month post intervention was particularly 
remarkable. At the commencement of the trial, participants were habitually physically 
inactive, yet the intervention group continued to engage in an average of 213 minutes 
moderate intensity physical activity per week after 6 months, a finding suggestive of a 
robust lifestyle change.  
5.1.3 Significance of findings as to the impact of intervention on insomnia symptoms  
The baseline characteristics of the sample placed participants in the range of those with 
moderately severe insomnia symptoms, as scored on the ISI (the average score was 16). 
The change in sleep severity symptoms was evident at 3 months from the start of 
intervention, though the magnitude of change on the ISI reached statistical significance at 
6 months.  The average 4-point reduction in ISI scores found in the present study falls in 
the lower range of reported ISI outcomes for more specific insomnia interventions.   
Lankford et al (2012), for example, report a significant 5-point reduction in ISI scores 
following 4 weeks of pharmacological treatment, while more recently Gellis, Arigo and 
Elliott (2013) reported a significant 4-point reduction in ISI scores following a cognitive 
behavioural intervention.  
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The clinical significance of changes in scores on the Insomnia Severity Index has been 
examined in further recent large randomised control trials. One such study examined the 
probabilities of people with insomnia experiencing significantly better health-related 
quality of life, increased productivity and reduced fatigue, after a six month 
pharmaceutical intervention. The study identified that a reduction of 6 points on the ISI 
was associated with these clinically significant indicators (Yang et al, 2009).  
Another such study examined significance of changes in scores on the ISI following 
intervention with CBT-I, either alone or combined with medication, in people with 
insomnia (Morin et al, 2011). The clinical meaningful change was determined through 
global improvement ratings by an independent clinical assessor, who marked those 
changes as slight, moderate and markedly improved. The authors found that a moderate 
clinical change was associated with a reduction in ISI scores of 8 points. The reduction in 
ISI scores by on average 4 points following the physical activity intervention in the present 
trial corresponds to slight clinical improvement, according to Morin et al’s (2011) method. 
To put these results in context, the size of effects of interventions can reflect such factors 
as the characteristics of the sample; the methods of intervention, and the setting of the 
intervention (Rothwell, 2005). It is important to note that Yang et al (2009) and Morin et al 
(2011) both used homogeneous clinical samples. They excluded co-morbid chronic 
diseases, as well as present use of sleeping medication. While such sampling procedures 
can improve the interpretability of explanatory trials, they also serve to reduce external 
validity, in that the sample characteristics depart from the heterogeneous insomnia 
populations routinely found in the community, or in primary care.  It is reasonable to 
conclude, therefore, that in relations to insomnia severity, the present study delivered 
modest, but clinically significant changes.  
5.1.4 Changes in psychomotor performance 
Trial condition was associated with an interesting pattern of results for psychomotor 
performance, with those in the intervention group showing a significant post-treatment 
decrease in simple reaction time, and a reduced ratio of performance between simple and 
complex reaction tasks when compared with the control group (indicative of a reduced 
magnitude of difference between simple and complex RT).  These results are similar to 
those reported by Altena et al (2008) who administered the same psychomotor tests to a 
sample of people with insomnia who then underwent various combined insomnia therapies 
(CBT, bright light exposure, body temperature manipulation, and physical activity) over a 
6 week intervention period.  
 125 
 
One possible explanation for the present findings is that a perceived improvement in sleep 
quality led to a change in task performance strategy post intervention, whereby people 
feeling more rested took more time to respond to stimuli, in order to increase their 
precision. If that were the case, those in the intervention group should have recorded 
significantly fewer lapses (errors) post-treatment. However, the results of the present trial 
showed no significant difference in lapses pre- and post-treatment. Thus, the changes in 
performance appear to be independent of any perceived improvement in sleep quality by 
participants.   
An alternative explanation concerns the state of cognitive arousal, a key proposed 
mechanism in perpetuating insomnia (Harvey, 2002).  Espie, Broomfield, MacMahon, 
Macphee, and Taylor (2006) provide a comprehensive cognitive explanation which builds 
on the Harvey’s (2002) model: the attention-intention-effort (A-I-E) pathway. According 
to the A-I-E pathway model sleep onset is initially delayed by the automatic processes of 
hyperarousal selective attention to sleep-related stimuli. When an extended sleep latency is 
experienced as a consequence, the individual explicitly ‘intends’ to fall sleep, and deploys 
a conscious (and counterproductive) ‘sleep effort’. Thus, people with insomnia show 
evidence of both hyperarousal (Harvey, 2002) and an attentional bias towards processing 
sleep-related, threatening stimuli (Harvey, 2002; Espie et al, 2006). Support for this theory 
comes from research in other areas of pathological behaviour, such as anxiety-related 
disorders. People with specific phobias, for example, selectively attend to threat-related 
stimuli in the environment with a thematic specificity to their disorder (Williams, Watts, 
MacLeod, & Mathews, 1997).    
Levels of performance adopt a U-shaped function in relation to arousal, with hyperarousal 
often associated with faster reaction times.  Given this, a further possibility is that reaction 
times increased because the exercise intervention reduced levels of hyperarousal arousal in 
the treated group.  The research literature of other conditions in which hyperarousal is a 
central feature, such as generalised anxiety disorders and Post-Traumatic Stress Disorder, 
shows that physical activity reduces symptoms commonly associated with hyperarousal 
(Stathopoulou, Powers, Berry, Smits, & Otto, 2006). The present results are therefore 
consistent with the hypothesis that the physical activity intervention contributed to the 
restoration of effective attention regulation mechanisms, resulting in reduced arousal and 
improved sleep. 
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While the presents results for simple RT accord with those reported by Altena et al (2008), 
they differ in that Altena also found a post-treatment improvement for complex RT.  That 
the present study showed no differences in complex RT may be attributable, at least in 
part, to methodology. Unlike previous studies (e.g. Altena et al, 2008) where testing is 
conducted under laboratory conditions, in the present study all the psychomotor tests were 
administered in the participant’s own home.  While it has been argued that the laboratory 
environment may lack ecologically validity and, as a result, mask real deficits apparent 
when cognitive, behavioural and environmental factors interact (Shekleton et al, 2010), it 
is also the case that less controlled conditions may compromise the sensitivity of the test.  
It is possible, therefore, that when administered in such an environment, any improvement 
in a complex reaction task time might have been undetectable.  
A final possibility is that the complex reaction time task used may have been too simple to 
elicit deficits in higher cognitive processes in this heterogeneous sample of people with 
insomnia (the task required differentiating between letters ‘p’ and ‘d’).  Recent reviews of 
cognitive deficits in people with insomnia suggest that more complex tests may be needed 
to clearly elicit these impairments in various samples of people with insomnia (Fortier-
Brochu et al, 2012).  Significant impairment in people with insomnia, for example, is more 
apparent with tests of working and episodic memory, and problem-solving (Fortier-
Brochu, 2012). These impairments better correspond to complaints of daytime 
performance from people with insomnia: poor concentration, memory difficulties, and 
inability to maintain attention on tasks (Ohayon & Lemoine, 2004).  
5.1.5 Changes in mood  
The finding that the present physical activity intervention was associated with significant 
post-intervention reductions in depression and anxiety (as reflected in BDI and STAI 
scores) is consistent with both the physical activity, and the emerging physical activity and 
sleep literature. In a systematic review of five RCTs, Stanton & Reaburn (2013) concluded 
that moderate intensity aerobic activities, continued for at least 9 weeks, can be effective in 
the treatment of depression. Exercise also acts as a buffer against emotional stressors’ 
negative responses in people who have suffered with depression in the past (Mata, Hogan, 
Joormann, Waugh, & Gotlib, 2013).  Using the CES-D short self-report scale of Radloff 
(1977), a recent sleep trial (Reid et al, 2010), showed significant reductions in depressive 
symptoms among sedentary adults with chronic insomnia following a 16 week programme 
of aerobic activity (although this study lacked sufficient power to demonstrate mood 
outcomes in its main analyses).  
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In both activity and sleep studies, effects seem to be dependent on the level of depression 
present in participants pre-treatment.  In studies of the impact of activity on mood, for 
example, those in the moderate to severe range appear to receive the greatest gain from 
physical activity interventions (Steffens, 2013). Similarly, Irwin et al’s (2008) study of a 
Tai Chi intervention for insomnia found no change in post-treatment depression scores, but  
recorded only minimal baseline scores of depression at baseline (the mean baseline BDI 
score was 4).  In contrast, the baseline mean score on BDI of the sample in the present trial 
was 12, introducing the possibility that the baseline scores in Irwin et al’s (2008) sample 
were such as to have left very little room for improvement.    
It is particularly interesting that post-treatment changes in anxiety in the present study 
were found in the trait anxiety measures, as opposed to state anxiety measures. Trait 
anxiety is conceptualised as a relatively stable characteristic of an individual (Spielberger 
et al, 1983). State anxiety, on the other hand, reflects a transitory emotional state that is 
characterised by subjective, consciously perceived feelings of tension and apprehension, 
and by heightened autonomic nervous system activity; this may fluctuate and can vary in 
intensity (Spielberger et al, 1983). Whilst state anxiety generally correlates with trait 
anxiety, state anxiety is also dependent on situational factors (Endler & Kocovski, 2001). 
A large number of sleep-related variables could affect an individual’s state score at any 
one time, such as caffeine (Alsene, Deckert, Sand, de Wit, 2003), light exposure 
(Youngstedt & Kripke, 2007), or circadian timing (Monteleone & Maj, 2008). 
Nevertheless, changes in trait anxiety are not uncommon. 
Only 30-50% of variability in vulnerability to anxiety disorders can be explained by 
genetic factors, the remainder being attributed to complex environmental and genetic 
interactions, which are susceptible to change (Clément, Calatayud, & Belzung, 2002). 
Many forms of behavioural intervention result in a reduction in trait anxiety scores (Jorm, 
1989; Manzoni, Pagnini, Castelnuovo, & Molinari, 2008). Physical activity interventions 
have previously shown a significant effect on trait anxiety when the period of the activity 
programme is longer than 10 weeks in duration (Petruzzello, Landers, Hatfield, Kubitz, & 
Salazar, 1991). Indeed, measurements of the effect of such interventions show a larger 
effect on trait anxiety than on state anxiety (Herring, O’Connor, & Dishman, 2010), as was 
also found in the present study.   
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Different mechanisms have been hypothesised as to how depression and anxiety might be 
affected by increased physical activity. At a physiological level, a number of 
neurochemical changes occur as a direct result of physical activity which confers 
neuroprotective and neurotorphic effects (Seifert et al, 2010; Knaepen, Goekint, Heyman, 
& Meeusen, 2010). Increased physical activity may downregulate the physiological 
inflammatory response system and increase resilience to stress (Kohut et al, 2006; 
Starkweather, 2007). Psychological mediational hypotheses include changes in self-
efficacy, and the interruption of negative thoughts. These particular mechanisms have 
resonance in cognitive mechanisms by which insomnia may act (Harvey, 2002; Espie et al, 
2006).   
Self-efficacy   
Self-efficacy has been defined as self-belief in one’s abilities to succeed in dealing with 
prospective situations, and a determinant of how people think, feel and act (Bandura, 
1977). A sub-construct of self-efficacy is coping efficacy, which reflects the confidence of 
a person to perform a task, despite challenges in doing so (Bandura, 1977). People with 
depression and anxiety often feel inefficacious in dealing with challenges or stress 
(Sawatzki et al, 2012). Similarly, people with insomnia describe an inability to 
concentrate, and feelings of fatigue during the day (Ohayon, 2002) and, as a clinical group, 
show significantly higher levels of depression and anxiety when compared to healthy 
controls (Taylor et al, 2007).  
Craft and Perna (2004) hypothesised that engaging in a physical activity program may 
provide participants with a meaningful mastery experience necessary to improve perceived 
ability to cope with depression and stress, and thereby, improve mood. In her quasi-
experimental study, Craft (2005) found that women who exercised had significantly lower 
depression scores, and significantly higher coping self-efficacy, compared to the control 
group in the study. Significantly higher coping ability and decreased anxiety has also been 
observed in a randomised controlled trial of physical activity program in anxious inactive 
participants (Steptoe, Edwards, Moses, & Mathews, 1989).  
Using a similar design, Bodin and Martinsen (2004) found that a session of exercise 
targeting self-efficacy (45 minutes of martial arts) induced significantly greater 
improvements in positive affect and anxiety compared to exercise that did not target self-
efficacy (45 min of stationary bike exercise).  
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In the present trial, the physical activity intervention (moderately brisk walking) was not 
designed to target self-efficacy as was the case in Craft’s (2005) study. Yet it still required 
motivation, planning and investment of time from the participants. Whilst self-efficacy 
was not a variable measured in this study, the hypothesis described above is compatible 
with the notable improvement in depression scores found.  
Distraction   
An alternative psychological mechanism which might explain the relationship between 
physical activity and mood is the distraction hypothesis, proposed by Barkhe and Morgan 
(1978). The hypothesis postulates that physical activity may provide a distraction from 
accessing, or reduces the perceived intensity of, ruminations, worries and anxieties.  
Craft’s (2005) study found that exercise was associated with a decrease in rumination 
throughout the intervention, and greater use of distraction techniques early in the 
intervention period. Similar distraction techniques, only of cognitive nature, are 
successfully used as therapeutic strategies in cognitive behavioural therapy for insomnia 
(Harvey & Payne, 2002). 
Harvey (2002) described how people with insomnia constantly monitor the internal and 
external environment for sleep-related daytime consequences, a key mechanism identified 
in perpetuating insomnia symptoms (Neitzert Semler & Harvey, 2007). Physical activity 
may break the vicious cycle of negatively toned daytime cognitive activity, by providing a 
targeted distraction which may limit accessibility to such thoughts.  
Anxiety sensitivity   
An additional psychological mechanism, which might break constant monitoring and 
rumination which people with insomnia often experience, is anxiety sensitivity 
reconditioning. Anxiety sensitivity comprises of the belief that anxiety experiences have 
negative implications, and at behavioural level of a dispositional tendency to respond 
fearfully to anxiety-related bodily sensations (Reiss, Peterson, Gursky, & McNally, 1986). 
Anxiety sensitivity has received a lot of attention in the anxiety literature (for a review, see 
Naragon-Gainey, 2010). A recent study investigating anxiety sensitivity in people with 
insomnia found this variable moderated the relationship between insomnia severity and 
dysfunctional beliefs, and insomnia severity and daytime fatigue (Fairholme, Carl, 
Farchione, & Schonwetter, 2012). Findings from the anxiety literature suggest that 
physical exercise programs can result in significant changes in anxiety sensitivity 
(Broman-Fulks, Berman, Rabian, & Webster, 2004; Smits, Otto, Powers, & Utschig, 
2005).  
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Physical activity intervention can be conceptualized as an interoceptive (internal sensation) 
exposure procedure, as it provides repeated confrontation with feared bodily sensations 
(e.g., racing heart, physical fatigue), but, crucially, in the absence of anticipated negative 
consequences (Stathopoulou et al, 2006). Thus, interoceptive exposure through physical 
activity may be beneficial in reducing insomnia severity symptoms, at least in those people 
with insomnia and high anxiety.   
Additional clinical effectiveness   
Physical activity may also act as an adjuvant to other therapies for depression and anxiety. 
In an augmentation study of participants partially respondent to anti-depressive 
medication, compared with a health education control group, moderate intensity physical 
activity (Tai Chi) was associated with greater reductions in depressive symptoms and 
decreased depression remission after 10 weeks (Lavretsky et al, 2011). Another study 
looking at the efficacy of physical activity as an adjutant to pharmacological treatment for 
depression found similar positive results (Mather et al, 2002), shown to extend long-term 
(Hoffman et al, 2011).  
5.1.6 Daytime fatigue and sleepiness  
Fatigue  In the present trial, post-treatment comparisons of fatigue and daytime sleepiness 
scores showed no significant differences between groups. Nevertheless, additional 
analyses provided several lines of evidence indicating that changes in sleep quality may 
have positively impacted fatigue experiences.  First, insomnia severity changes were 
positively and significantly correlated with change scores in Fatigue Severity Scale. 
Second, multiple regression analyses showed that the physical activity intervention, 
depression scores and fatigue scores were the best combined variables to predict 
significant changes in the severity of insomnia symptoms. And third, analyses of PSQI 
component scores showed a significant improvement on the daytime dysfunction sub-scale 
following physical activity intervention. This component contains two items: one 
addressing daytime sleepiness, and the other addressing stamina and enthusiasm through 
the day. It is interesting, therefore, that this pattern of results, indicative of significant 
change in daytime experience related to insomnia symptom severity, was not captured by 
the specific fatigue (FSS) measure employed.  
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As sleep is usually an effective remedy for fatigue in the healthy population (Aaronson, 
Pallikkathayil, & Crighton, 2003), it is often assumed that the cause of fatigue lies in the 
disturbed sleep pattern of people with insomnia, with some cross-sectional studies 
supporting such a relationship (e.g. Alapin et al, 2000). However, a more detailed 
consideration of both the fatigue construct, and the assumptions underlying its 
measurement, can provide insights into the apparent inconsistencies found in the present 
study. The FSS, for example, was developed to identify common features of fatigue in 
people with multiple sclerosis and systemic lupus erythematosus (Krupp et al, 1989). The 
scale measures the impact of fatigue on specific types of functioning, i.e. the behavioural 
consequences of fatigue, rather than intensity of fatigue symptoms (Taylor, Jason, & 
Torres, 2000). All but one of the nine items measure physical aspects of fatigue. More 
recent evidence shows that FSS is not a reliable instrument for measuring cognitive levels 
of fatigue (Amtmann et al., 2012). 
People with insomnia describe difficulties with cognitive, emotional and physical 
functioning during the day (Kyle, Espie, & Morgan, 2010). And while a central complaint 
in people with insomnia is ‘daytime fatigue’ (Carey, Moul, Pilkonis, Germain, & Buysse, 
2005), analyses show that  people with chronic illness in which fatigue forms a central part 
of the symptomology describe their present fatigue as qualitatively different from the 
fatigue they experienced before they became sick (Glause, Crow, & Hammond, 1996). 
More in-depth analyses of sleep, fatigue and other daytime functioning indicators in people 
with insomnia also suggest that poorer sleep, as objectively measured by 
polysomnography, is not systematically associated with more severe fatigue; there are 
complex interactions between fatigue, subjectively-reported sleep quality, health related 
quality of life and mood variables (Fortier-Brochu et al, 2012). Collectively, these results 
indicate that in people with insomnia, disturbed sleep duration and continuity may not be 
the only pathways leading to high levels of fatigue, and that sleep and fatigue can vary 
independently.  As a result, some daytime experiences of people with insomnia may be 
best captured by a multidimensional approach, enquiring into the physical, cognitive and 
emotional domains (Dittner, Wessely, & Brown, 2004).  
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Sleepiness  Daytime sleepiness is one of the criteria (relating to daytime impairments) 
used for the diagnosis of insomnia in the DSM-5 (APA, 2013) manual and the ICSD-2 
(AASM, 2005) manual. Despite this, people with insomnia rarely complain of daytime 
sleepiness, their complaints relating more to fatigue and exhaustion (Singareddy, Bixler, & 
Vgontzas, 2010).  In the present study, the sample’s mean daytime sleepiness scale score 
was relatively low and stable throughout the trial, with a mean around 6 on Epworth 
Sleepiness Scale. The mean in the general population without chronic sleep disorder is 
around 5, and the ‘normal’ range of sleepiness in the general population has been validated 
in trials to be from 0 to 10 on the scale (Johns & Hocking, 1997).  
Reid et al (2010), in their trial of physical activity and sleep in people with insomnia, 
found a significant improvement in daytime sleepiness, as measured by the Epworth 
Sleepiness Scale, in their sample. In Reid et al’s study, the baselines values were higher 
than in the present trial’s sample (with a mean of around 10 on the scale). It is a reasonable 
assumption, therefore, that opportunities for improvement in the present sample were 
reduced due to ceiling effects (i.e. there was little room for significant improvement).  
5.1.7 Activity-related sleep outcomes and light exposure 
No earlier study of the effects of a physical activity intervention on sleep outcomes has 
tested, or controlled for increased exposure to light potentially arising from increased time 
spent outdoors. One of the strengths of the present trial, therefore, is its measurement of, 
and analysis of the effect of light exposure when interpreting the results of the 
intervention. While light exposure values did increase within the intervention group (see 
Figure 30, p137), this increase did not reach statistical significance, and did not 
significantly contribute to the relationship between physical activity and sleep outcomes in 
this sample. Furthermore, analyses of the moderating effects of season showed no 
difference, when looking at all participants spread throughout the year. Thus, in 
interpreting the improvements resulting from the intervention, there appears to have been 
no confounding effect of increased light exposure.   
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Nevertheless, several factors should be considered when interpreting these findings. It is 
not known, for example, at what point in the day or night participants took their exercise, 
as these measures were not recorded in the trial. It is also the case that light exposure 
might only (or mainly) affect those groups of people whose insomnia was related to 
circadian dysfunction. This has been shown before in people with non-seasonal depression 
treated with light exposure (Even, Schröder, Friedman, & Rouillon, 2008). The authors of 
this extensive meta-analytical review on that subject hypothesised that only a defined 
group of people with depression, whose characteristics relate to circadian dysfunction, 
would be responsive to light treatment. Given the multi-factorial nature of insomnia, it is 
possible the same processes apply to insomnia disorders.  
It is also possible that the objective means by which light was recorded in this study may 
not have adequately captured actual light exposure. Illumination was recorded through a 
light sensor on the actiwatch participants wore at the wrist. Illuminations at eye level and 
at the wrist are correlated generally at around the 0.76 level (Okudaira, Kripke, & Webster, 
1983). The instructions for the participants specified that the actiwatch should be worn on 
top of clothing i.e. participants to avoid the placement of actiwatches under sleeves. Even 
so, it cannot be determined whether the device was worn on top or underneath clothing. If 
the device is worn under clothing, it can underestimate the intensity of light exposure 
(Figueiro, Hamner, Higgins, Hornick, & Rea, 2012). This may have introduced an 
unsystematic error into the light exposure data.  
5.1.8 Changes in sleep quality and sleep quantity  
As recommended in international guidelines, a combination of self-report and objective 
measures (including actigraphy) was used in the design of the present trial (Buysse et al, 
2006). The use of multiple methods of assessment maximised the possibility of recording 
changes of small or moderate magnitude in a sample of those with moderately severe 
symptoms of chronic insomnia, over the period of the trial.  
Sleep quality As measured by the Pittsburgh Sleep Quality Index (PSQI), the baseline 
sample characteristics of the sample placed the participants in the range of those with 
‘clinically disturbed sleep’, with an average global score of 10.33. In contrast to the 
significant changes in the scores recorded on the ISI, there was no statistically significant 
change in global scores on the PSQI following the physical activity intervention (with a 
mean reduction of 2.4 points post-intervention). Earlier randomised controlled studies of 
physical activity and sleep quality have found statistically significant mean reductions in 
average PSQI scores post intervention of 1.8 points (Irwin et al, 2008), 3.4 points (King et 
al, 2008), and 4.8 points (Reid et al, 2010).  
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A recent systematic review of physical activity interventions in adults with sleeping 
problems noted a moderate effect of the PA intervention, when measures by the PSQI 
(Yang et al, 2012). However, none of these earlier studies also used the ISI as an outcome 
measure. 
In explaining the apparent differential sensitivity of PSQI scores to activity interventions it 
is relevant to note that the samples used in the earlier studies were also differently selected, 
and of different characteristics, as compared to the present sample. Irwin et al (2008) 
excluded from their sample people with syndromal insomnia, and only included 
participants with mild, or moderate sleep complaints. (In addition, their analyses looked at 
group differences over time between multiple groups, so the changes which they reported 
may reflect type I error). King et al (1997) included in their sample participants with mild 
to moderate sleep complaints. Both samples may have captured a few people with 
insomnia; if so, it is not clear, as the researchers did not employ sufficiently precise 
selection criteria in their samples. It is possible, then, that those with only mild sleep 
disturbance, or a sleep disturbance of simple causation, may be more responsive to 
physical activity interventions. Finally, while Reid et al (2010) used a sample comprising 
people with thoroughly assessed chronic insomnia, they also augmented their activity 
intervention with a programme of ‘sleep hygiene therapy’, which may have amplified 
treatment effects.  Studies looking exclusively at the effects of sleep hygiene education on 
sleep quality have found significant changes in sleep quality following therapy (Hauri, 
1993), and an incremental effect of sleep hygiene when used in conjunction with other 
sleep therapies (Guilleminault et al, 1995).  
The PSQI and ISI scales also show structural differences which help to explain differential 
sensitivity.  For the measurement of self-perceived severity of insomnia, the ISI is the most 
frequently used disease specific instrument (Morin & Espie, 2003). The seven items on the 
scale each describe insomnia-related health impairments. The content of the items on the 
scale yield 3 components: impact, severity and satisfaction. These map onto the DSM-IV-
TR criteria for primary insomnia (Bastien et al, 2001). In contrast, the PSQI provides an 
assessment tool for diverse self-reported sleep disorders (Buysse et al, 1989). The 19 items 
on the scale assess a broad range of sleep-related domains. These domains include sleep-
wake patterns; sleep duration and latency; the frequency of specific sleep problems; other 
specific behaviours or environmental factors which may contribute to poor sleep (snoring, 
urinary frequency, temperature change etc). The scale yields a global score, and 7 
component scores. Global scores below and above 5 have the main dichotomous 
application of discriminating between poor and good sleepers.   
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Due to its wide remit of enquiry, and dichotomous application of its global score, it may be 
that the global PSQI score does not adequately capture small changes to treatment. This is 
particularly likely if the change is confined to discrete questions within its many 
dimensions.  
The retrospective nature of the PSQI (over the last 1 month) may also be less sensitive to 
differences in sleep averaged over such large portions of time, and participants may be 
weighing up the worst nights over the last 1 month when forming global sleep impressions. 
The instructions specifically ask for ‘usual’ sleep patterns, which may not cater for the 
variability in sleep pattern encountered by the majority of people with insomnia. 
Anecdotally, several participants in the present study reported difficulties with summing 
up their sleep pattern over the last month. The ISI, on the other hand, has a recall period of 
two weeks, and places emphasis on the ‘current’ perceived insomnia-related impairment.  
Changes in sleep structures  Wrist actigraphy showed baseline sleep characteristics of the 
trial participants typical of people with insomnia, with long sleep onset latencies, and long 
periods of wake after sleep onset. The sample had an average of 78% sleep efficiency. 
Following the physical activity intervention, there were no significant changes in sleep 
outcomes as measured by actigraphy. Reid et al (2010) used actigraphy to screen 
participants at baseline, but did not report actigraphic sleep outcomes following the 
physical activity intervention.  
However, an earlier systematic review of clinical trials of psychological and behavioural 
treatments for insomnia found that in most trials, actigraphy was insensitive to change 
following intervention (Morin et al, 2006b). In contrast, polysomnography and self-
reporting questionnaires and diaries recorded significant changes following intervention 
(Morin et al, 2006b). These differences in outcomes probably reflect fundamental 
differences in the sensitivity and specificity of the two instrumental measures.  Studies 
comparing actigraphy to polysomnography, for example, show that actigraphy tends to 
underestimate periods of wake time during the night, scoring as ‘sleep’ those periods when 
people with insomnia may lie awake but still in bed (Ancoli-Israel et al, 2003; Brooks, 
Friedman, Bliwise, & Yesavage, 1993). Such studies also show that actigraphy 
overestimates total sleep time (Hauri & Wisbey, 1992).   
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Recently, Baron, Reid and Zee (2012) monitored sleep through actigraphy in a group of 11 
women with insomnia, and found significant changes in total sleep time as well as in sleep 
efficiency after 16 weeks of physical activity intervention. That study was not controlled, 
and the small number of participants precludes firm conclusions as to the ability of 
actigraphy to capture activity-related changes in sleep structure.  
Given that: changes recorded in subjective sleep quality in the present study were modest; 
actigraphy frequently fails to capture improved sleep quality in clinical trials; and it is also 
possible that over the 6 month period of the study, changes in subjective sleep quality did 
not significantly alter underlying sleep structure, the present actigraphy results are not 
inconsistent with reasonable expectations.   
5.1.9 Limitations  
Whilst successful in answering the hypotheses posed, there are some limitations to the 
present trial to consider when interpreting these results. The number of participants in the 
trial was small, which did not allow for more complex analyses of trends of change in 
insomnia symptoms over the course of the trial, or interaction effects which could have 
revealed the mechanisms responsible for the change in the main outcome. Further larger 
trials should be set up to test these additional hypotheses separately. The inclusion criteria 
test of inactivity was self-reported (less than 60 minutes of moderate intensity activity a 
week), introducing the possibility of participants over-reporting their physical activity 
levels, and therefore becoming ineligible for entering the study. Objectively-measured 
physical activity levels at recruitment stage could maximise the number of participants 
allowed on the study.  
The present trial employed an intervention testing the transition from inactivity, to activity 
levels to the current guidelines, as this was the state of physical activity in the majority of 
the adult population. Current evidence indicates that the most significant effects of 
physical activity on health outcomes is achieved by transitioning from no activity, to 
activity to the current recommended guidelines. Current evidence also indicates a dose-
response relationship between physical activity and health outcomes, with increased doses 
of physical activity accompanied by increased significant improvements in health 
outcomes. The present trial did not test for additional higher thresholds of increased 
activity, to test whether there would be accompanying increased benefits in sleep quality 
outcomes. It is also not known what the effects on sleep quality would be if existing levels 
of physical activity in adults already meeting the current guidelines would be increased 
even further. Future trials should help elucidate the physical activity and sleep quality dose 
response relationship. 
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5.2 Conclusions: explaining the present results 
The literature identifies three plausible mechanisms through which physical activity may 
impact sleep structure and quality. 
1. Physical activity acts upon cognitive processes known to be involved in the normal 
sleep, such as the effective regulation of attention. Both the internal circadian 
clock, and the sleep/wake homeostasis can be influenced by conscious decisions 
and increased levels of vigilance. These may be altered due to the vigilance-
induced hyperarousal and/or accompanying altered light exposure. The attention-
intention-effort pathway (Espie et al, 2006) attributes the disruption of the 
automatic process of sleep to dysfunctions of normal attention. This is 
accompanied by physiological arousal which may interfere with the circadian clock 
self-regulation, and synchronization with the normal time pattern. There is 
emerging new evidence pointing to the role of physical fitness and regular physical 
activity in the maintenance and recovery of cognitive function, by reducing atrophy 
in critical brain regions (Weinstein et al, 2012). Physical activity may therefore 
contribute to restoration of effective attention regulation mechanisms, resulting in 
improved sleep.  
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2. Physical activity may also act upon sleep quality through alleviating symptoms of 
depression and anxiety (Youngstedt, 2005). There are numerous studies showing 
that physical activity has beneficial effects on symptoms of depression and anxiety 
(Strohle, 2009). There is a strong, bi-directional relationship between 
depression/anxiety and insomnia; depressed mood and anxiety is associated with 
risk of developing insomnia (Johnson, Roth, & Breslau, 2006); non-depressed 
people with insomnia have a two-fold increase in risk of developing depression, 
compared with people with no sleeping difficulties (Baglioni et al, 2011).                                                                                         
The study by Reid et al (2010), looking at the effects of physical activity and sleep 
hygiene on people with insomnia, found that sleep quality improvement was 
associated with significant improvement in depressive symptoms. Therefore, it is 
possible that physical activity may improve sleep quality of people with insomnia 
through improved mood. 
3. Finally, physical exercise may influence sleep quality by better entraining the 
circadian rhythm to the wake/sleep schedule (Van Someren & Van der Lek, 2007). 
Under natural environments, the internal body clock is synchronized to the 
geophysical day/night cycle by environmental time cues (Zeitgebers). The most 
powerful zeitgeber for our bodies is the pattern of light exposure over 24 hours.  
Indeed, light therapy, which consists of regular light exposure at certain times in 
the 24 hour period, significantly improves sleep quality in people with insomnia 
(Guilleminault et al, 1995). Other social zeitgebers are meal times, activity 
patterns, work schedule etc. When habitual time pattern is disrupted, such as when 
we travel through time zones, these zeitgebers act upon the body clock to bring it 
back into synchronization with the new time pattern. Physical activity is one such 
zeitgeber, shown to have influence upon the entrainment of the circadian rhythm to 
the environmental time pattern (Youngstedt et al, 2002). Presuming that insomnia 
results from a disruption in the circadian rhythm, physical activity could contribute 
to the restoring of sleep quality by entraining the body to the desired sleep/wake 
schedule.  
Results from the present randomised controlled trial are consistent with the view that the 
physical activity intervention likely improved sleep quality through the restoration of 
effective attention regulation mechanisms, and through improvements in mood.  The 
evidence from the trial does not support the view that improvements in sleep quality (as 
measured here) were due to light-dependent improvements in circadian entrainment.   
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GENERAL CONCLUSIONS 
Large population studies have consistently found that moderate intensity physical activity 
levels at or above a threshold value of 150 minutes per week reliably deliver 
cardiovascular, metabolic, psychological and musculo-skeletal health benefits.  This 
threshold value has been widely adopted in public health practice and research as an 
aspirational, public health goal throughout the world.  However, while epidemiological 
and laboratory studies had established clear links between physical activity and sleep 
outcomes, the evidence base did not provide guidelines on minimum levels of exercise 
likely to reduce insomnia symptoms and improve sleep quality. Such guidelines, if 
evidence based, could have greatly clarified advice, and accelerated the use of physical 
activity goals to improve sleep outcomes in behavioural sleep medicine and public health.   
This thesis examined the current public-health recommendation of 150 minutes of 
moderate intensity activity per week in relation to sleep outcomes. First, it established a 
population-level pattern describing the relationship between levels of physical activity and 
sleep quality by reviewing relevant epidemiological evidence. Exploratory analyses were 
then conducted using data from a longitudinal study of physical activity and health 
outcomes among older people (age = 65+), the Nottingham Longitudinal Study of Active 
Ageing (NLSAA). Respondents in the study were classified as walking at or above, or 
below the recommended threshold of 150 minutes per week. In regression models 
controlling for health and demographic factors, these analyses showed that higher levels of 
walking were significantly and independently associated with a lower likelihood of either 
reporting insomnia symptoms (OR = 0.67 (95% CI = 0.45 – 0.91) p<0.05), or experiencing 
poor sleep efficiency (OR = 0.70 (95% CI = 0.52 – 0.94 p<0.05). Using the same data, the 
predictive validity of this activity threshold was then confirmed in a 27-year survival 
analysis. The analysis showed a significantly decreased all-cause mortality risk associated 
with the higher level of walking (HR = 0.75 (95% CI = 0.65 - 0.86) p<0.01).  These 
findings offered ‘proof of concept’ that physical activity and sleep relationships operate on 
a continuum, with sleep benefits evident at relatively low levels of activity.   
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Experimental evidence on the acute and sustained effects of physical activity on sleep 
quality were then analysed and discussed. Outcomes from the review of evidence, together 
with the NLSAA preliminary analyses, were then used to inform the design of a 
randomised controlled trial to investigate the effects on sleep quality of increasing physical 
activity to currently recommended levels among sedentary people with insomnia. A total 
of 41 sedentary adults meeting DSM-IV criteria for insomnia (30 female; mean age 
59.8±9.5) were randomised to a physical activity group (≥150 minutes moderate intensity 
activity/week) or a waiting list control group.  The principal outcome was Insomnia 
Severity Index (ISI) change 6 months post baseline; secondary outcomes were anxiety 
(using the State Trait Anxiety Inventory; Spielberger et al, 1983) and depression (Beck 
Depression Inventory II; Beck et al, 1996). Sleep and physical activity were objectively 
measured. Outcomes were assessed in univariate general linear models, adjusted for 
baseline confounders. 
Results of the RCT showed that activity and sleep assessments did not differ at baseline. 
At 6 months post baseline the intervention group engaged in 213 min/week of moderate 
intensity PA, compared to the control group (82 min/week). Compared to the control 
group, the intervention group showed significant improvement in the ISI score at 6 months 
F(1,28) = 5.16, p<0.05), adjusted means difference = 3.37, with an adjusted Cohen's d =.78 
(95% CI .10–1.45). There was a significant improvement in trait anxiety, and depression 
outcomes post-intervention, F(6,28)=4.41, p=0.05, and F(6,28)=5.61, p=0.02, respectively. 
The results showed that increasing activity in line with current guidelines could deliver 
clinically significant improvements in sleep quality and mood outcomes among sedentary 
people with insomnia, independent of possible confounders.  
The pattern of results reported here allow for two conclusions with clear implications for 
public health: 1) measures to increase levels of physical activity above the currently 
recommended threshold of  150 minutes per week could usefully be added to the other 
tools available for insomnia management; and 2) the likelihood of improved sleep quality 
should be routinely added to those evidence-based cardiovascular and metabolic benefits 
most frequently associated with increased physical activity in behaviour change initiatives. 
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Sear strategy: Key words  
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PHYSICAL ACTIVITY 
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METHODOLOGY 
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Exercise movement technique 
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Exercise movement technique (MeSH) 
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Jadad Scale for scoring methodology quality of randomised controlled trials 
(Jadad et al, 1996) 
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Methodological Quality Assessment of RCTs of physical activity and sleep quality in populations with mild to severe insomnia complaints, using the Jadad 
Scale (Jadad et al, 1996) 
Trial Randomisation Blinding Participants Total Score 
 Randomisation 
mentioned 
Randomisation 
appropriate 
Blinding 
mentioned 
Blinding 
appropriate 
All participants 
accounted for 
 
Reid et al, 2010 1 0 0 0 1 2 
King et al, 1997 1 1 0 0 1 3 
Li et al, 2004 1 1 1 1 1 5 
Irwin et al, 2008 1 1 1 1 1 5 
King et al, 2008 1 1 1 1 0 4 
 
 
  
 183 
 
Appendix 2: Intervention group material 
 
2.1 Walking advice booklet  
2.3 Pedometer diary 
  
 184 
 
Walk your way to health and better sleep 
Whatever your age, size or physical condition, you are likely to benefit from being 
more active. The people who can benefit the most are inactive people who start to 
take regular, moderate activity. 
Walking is one of the best ways to get your dose of healthy activity: just 30 
minutes of walking spread throughout the day (in bouts of at least 10 minutes) will 
help to keep you healthy. It’s easy, and you can do it anywhere, at any time and 
either alone or with friends. Physical activity doesn’t have to mean exhausting 
runs, buying fancy equipment or joining an expensive health club.  
 
We’ve produced this walking guide, adapted from the British Heart Foundation’s 
‘Put Your heart Into Walking’ booklet, with practical tips and a personal walking 
plan to help you succeed in living your life as actively as possible, for the rest of 
your study.  
What walking can do for you 
 
Regular walking can help reduce your risk of coronary heart disease. It can also 
reduce your risk of stroke, diabetes, obesity and osteoporosis (thinning of the 
bones). Walking can also help lift your mood, increase energy levels, improve your 
sleep quality, manage your weight and enjoy the environment.  
How much should I do? 
You should aim to be active daily. To keep your heart, lungs, muscles and bones 
in good working order, you should do a total of at least 30 minutes of at least 
moderate-intensity physical activity a day, on five or more days a week. 
Moderate-intensity physical activity means working hard enough to make you 
breathe more heavily than normal and become slightly warmer, but not so hard 
that you are unable to talk and exercise at the same time, or that you become 
exhausted. Brisk walking is a good example of moderate-intensity activity. 
If 30 minutes a day sounds a lot, don’t worry 
You can split the 30 minutes up into two bouts of 15 minutes, or three bouts of 10 
minutes. If you’re not used to walking, start slowly and build up gradually. To 
receive the health benefits, the activity needs to be continuous for at least ten 
minutes. 
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Taking the first step 
The first step towards being more active is the most important one. Don’t be over-
ambitious. Just set yourself small achievable goals to start with. 
Start slowly 
If you’re not used to walking 30 minutes a day, start slowly and at a level that suits 
you. Below are some examples of simple changes you could make to get into a 
healthy habit: 
• Get off the bus a stop earlier and then walk. 
• Walk up the stairs. If you’re going up or down fewer than three flights, walk 
instead of using the lift, or walk up or down the escalator. 
• Reduce the time you spend sitting down. Get up and move around during 
television advert breaks.  
Build up gradually 
Once you’re used to taking the stairs and reducing the time you spend sitting 
down, it’s time to gradually build up your activity. Vary the time you spend walking 
and how often you go for a walk. 
For example, you could start by walking for five minutes, three times a day, on 
three days a week. Walk at a slightly faster pace than usual, without it being 
uncomfortable. As you get fitter, you’ll be able to do more. 
After a few weeks, you can gradually increase your walking, by adding a few more 
minutes to each walk and going out for a walk on more days of the week. 
 
You should aim to build up to doing brisk walking for at least 30 
minutes a day in bouts of ten minutes or more on at least five days a 
week. 
 
Build more walking into your daily routine 
If you’re not used to walking every day, look into ways of building walking into your 
daily life. It’s easier than you think. Make sure your goals are measurable. For 
example, it’s better to say ‘I’ll walk to the shop to get a newspaper on Saturday 
and Sunday instead of taking the car,’ rather than ‘I’ll walk to the shop more often.’ 
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Tips to get you started 
• Walk to your local shop instead of taking the car or the bus. 
• Build a walk into your journey to work. Try different routes to add variety. 
• Make walking part of your social life. Go for a walk at lunchtime with 
colleagues instead of staying at work. Walk to the cinema or library, or 
walk round to see friends. 
• Plan a walk with a friend instead of just meeting for a chat. Keeping 
each other company can keep you both motivated. Arrange regular 
walks so that they become a habit. 
• Involve the whole family so you can support each other. Walking is good 
for children too, and a great way of exploring your local area or the 
countryside. 
• Walk the children to school and save the expense of driving or going on 
the bus. 
• Try letting something go. Are there any low-priority ‘in-activities’ that you 
can stop doing to make time for your health? 
• Take your children, grandchildren, neighbours children, or your partner 
or siblings, for a walk in the park at the weekend. It will give you quality 
time with a loved one, and an opportunity to keep active.  
 
Take care – be safe 
You will want to make sure that your first steps are safe and enjoyable. 
Here’s how you can achieve this: 
• Stop exercising if you feel pain, discomfort or dizziness, or if you feel unwell 
or very tired, and get advice from your doctor. 
• Choose comfortable, supportive shoes, such as running, walking, or cross-
training shoes. 
• Practise correct posture – head upright, arms bent at the elbow and 
swinging as you stride. 
• If you’re going for a longer walk, start slowly for the first few minutes and 
build up gradually. At the end, spend some time slowing down gradually. 
• Drink plenty of water before, during and after your walk, to keep your body 
hydrated. 
• Tell others if you are walking alone and take a mobile phone with you in 
case of emergencies. 
• Walk in well-lit areas where it is fairly busy. 
• Be careful of traffic and wear reflective clothing in the dark. 
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Take the pedometer challenge 
One way of helping you to achieve the recommended 30 minutes a day is to aim 
to take 10,000 steps a day. On average, people only take between 3,000 and 
5,000 steps a day.  
You can use a pedometer to count the number of steps you take each day. A 
pedometer is fun, and easy to use. It’s a small device that you clip onto your 
waistband. Set it at zero at the beginning of the day, and at the end of the day it 
tells you how many steps you have taken. 
A person who walks 10,000 steps a day burns between 1,750 and 2,450 extra 
calories a week (about 250 to 350 calories a day), compared with the average 
person who takes between 3,000 and 5,000 steps a day. This is the energy 
equivalent of gaining or losing half a pound (0.25 kilo) each week. 
Walk 10,000 steps a day 
When you begin walking, to avoid feeling the strain of a new routine, start out 
slowly and build up gradually. You can keep a Pedometer record sheet (attached) 
to see the progress you are making. 
Tips to keep you going 
• Try to walk every day and build a healthy habit.  
• Plan a time in your day when you will walk. Use your diary or calendar if it 
helps. 
• Use reminders. Put a note where you will see it – by the front door, on the 
fridge or by the kettle – to remind you to do some walking. And keep your 
walking shoes by the door. 
• If you’re struggling for motivation, think of how walking makes you feel: 
fitter, energised, relaxed, self-confident, toned and happy. 
• Don’t give up. If you miss a day – just start again tomorrow. Your health is 
worth working for. 
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PEDOMETER DIARY 
TIMELINE STEPS MINUTES 
Week 1   
Week 2   
Week 3   
Week 4   
Week 5   
Week 6   
Week 7   
Week 8   
Week 9   
Week 10   
Week 11   
Week 12   
 
Email:   sleepstudy@lboro.ac.uk  
Telephone:  01509 223 021 
Text:   07977 790 622 
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Appendix 3: Telephone screening standardised script  
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Telephone Script (First time contact) 
Greeting. Do you have 15 minutes now, I can call you back and we can discuss 
the study in detail.  
No – send information in the post? Get address, and post information sheet and 
screening questionnaire.  
Yes – proceed with script as below.  
This is a 1-year study looking at the relationship between sleep problems and 
lifestyle habits. In the course of the study, two approaches will be compared: 
regular physical activity, and continuous health monitoring whilst not engaged in 
physical activity. We need to find out if either of these two approaches makes any 
difference to sleep. To make sure the comparison is fair, each participant is 
allocated to the two groups by chance (randomly).   
During the study, we will monitor your sleep, and will give you health-related tests 
and questionnaires (none of them invasive, uncomfortable or requiring any bodily 
fluids from you. For example, we will give you a computerised task involving you 
watching a screen and pressing a key as symbols appear on a screen).  
However, the study will involve some of your time. You will complete a brief 
questionnaire booklet four times during the year, at regular intervals. You will also 
receive brief computerised tasks at the beginning and at the end of the study.  
Depending on what group you are allocated by chance, one group may need to 
engage in a regular walking activity. If you are in the second group, you will have 
your sleep and health monitored for a year, at regular intervals.  
The study will include men and women who:  
1. Are aged over 40 years,  
2. have problems with their sleep (for example, cannot go to sleep, or wake up 
too early),  
3. and who are not engaged in regular physical activity.  
There are other criteria, but these are the main requirements.  
Do you think you fulfil these basic criteria?  
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If you would like to, I can send you some further information in the post. I will also 
send you a screening questionnaire for you to complete, to see whether you can 
participate in the study. The screening asks more questions about your sleep and 
lifestyle habits. If you think you may want to join, please complete the screening 
questionnaire and send it back to me in the envelope provided. We will then 
assess your answers, and contact you further.  
Please be aware that just because you send us the screening questionnaire back, 
it does not mean that you signed up for the study. You will only be signed up for 
the study once you sign a Consent Form, which we will send you at a later stage. 
You can change your mind at any time.  
Do you have any other questions now? 
No – take address and contact number. Ask if it possible to call back in a couple of 
days to check whether they received the information.  
Yes – refer them to the information they will be receiving in the post. Then take 
address and contact number. Ask if it possible to call back in a couple of days to 
check whether they received the information. 
Input details in the telephone enquiries booklet.  
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Appendix 4: Detailed screening material 
4.1 Brief Participant Information Sheet 
4.2 Health Screening Questionnaire 
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Loughborough University Sleep and Lifestyle Study 
Information Sheet  
What is this study all about? 
The aim of this study is to find out how much sleep patterns change over time, and whether lifestyle factors 
(like physical activity) can influence these changes.  To do this, we are monitoring the sleep of 2 groups of 
people with sleep problems.  One group will be asked to go about their lives as usual, and the other will be 
asked to walk regularly every week (in line with Government guidelines).  Although regular physical activity 
can offer benefits, it is not known whether regular physical activity can help people with sleep problems. To 
find out, we will closely monitor the sleep of both groups. 
During the study we will ask you to complete some brief questionnaires and health- related tests.  These 
questionnaires will be completed at the start of the study and then again, 3 months, 6 months and 12 months 
later.  At periods throughout the study we will also ask you to wear special electronic devices which record 
your activity and sleep patterns.   We cannot promise that the study will benefit you personally, but the 
information from this study will help us to better understand disturbed sleep.   At the end of the study, 
however, we will provide all the participants with a detailed personal sleep profile and expert sleep advice. 
What happens next? 
If you are willing to participate, please complete the enclosed screening questionnaire.  Your answers to 
these questions will help us to include the most appropriate people for this study.  If, on the basis of your 
questionnaire results, you are eligible to participate, we will arrange to visit you at home and explain the 
trial.  Or we could arrange for you to come to our research office and explain the trial. If, on the other hand, 
you are not eligible to participate, we will explain why.   
If you have any queries or would just like to discuss the project further 
please telephone Iuliana in the research office on: 01509 223 021 
(or please leave a message on the answerphone and we will call you 
back at a convenient time to you). 
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Name/Number   ...............…….  
 
Health Screen Questionnaire for Study Volunteers 
As a volunteer participating in a research study, it is important that you are currently in 
good health and have had no significant medical problems in the past.  This is (i) to 
ensure your own continuing well-being and (ii) to avoid the possibility of individual health 
issues confounding study outcomes. All answers will be kept in strict confidence.  
 
 
Please complete this brief questionnaire to confirm your fitness to participate 
Source 
How did you find out about the study? 
(e.g. advert in the library) 
 
 
 
Personal Details 
Your Name: Date of birth:   Age: 
Telephone(s): Address: 
 
 
Usually available to talk: 
Distance from Lboro University (please 
approximate): 
 
 
 
 
 
How much do you weigh?         _________    (kg/stones/pounds)  
                                                                               Delete as applicable. 
 
How tall are you?                      _________    (feet/metres/cm) 
                 Delete as applicable. 
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1. At present, do you have any health problem for which you are: 
(a) on medication, prescribed or otherwise ...........  Yes  No  
(b) attending your general practitioner ..................  Yes  No  
(c) on a hospital waiting list ...................................  Yes  No  
 
If Yes, please give details (e.g. name of medication, for how long have you been taking 
medication etc): 
 
……………………………………………………………………………………………………… 
 
……………………………………………………………………………………………………… 
 
……………………………………………………………………………………………………… 
 
2. Have you ever had any of the following: 
(a) Convulsions/epilepsy  ........................................ Yes  No  
(b) Asthma  ............................................................. Yes  No  
(c) Eczema  ............................................................ Yes  No  
(d) Diabetes  ........................................................... Yes  No  
(e) A blood disorder  ............................................... Yes  No  
(f) Head injury  ....................................................... Yes  No  
(g) Digestive problems  ........................................... Yes  No  
(h) Heart problems  ................................................. Yes  No  
(i) Problems with bones or joints     ........................ Yes  No  
(j) Disturbance of balance/coordination  ................. Yes  No  
(k) Numbness in hands or feet  ............................... Yes  No  
(l) Disturbance of vision  ........................................ Yes  No  
(m) Ear / hearing problems  ..................................... Yes  No  
(n) Thyroid problems  .............................................. Yes  No  
(o) Kidney or liver problems  ................................... Yes  No  
(p) Allergy to nuts  ................................................... Yes  No  
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3. Have you ever had any of the following: 
(a) Anxiety disorder  ................................................ Yes  No  
(b) Bipolar disorder  ................................................ Yes  No  
(c) Delirium  ............................................................ Yes  No  
(d) Dementia  .......................................................... Yes  No  
(e) Depression, dysthymia  ..................................... Yes  No  
(f) Schizophrenia  ................................................... Yes  No  
(g) Substance abuse  .............................................. Yes  No  
 
If YES to any question, please describe briefly if you wish (e.g. to confirm problem was/is 
short-lived, insignificant or well controlled.) 
............................................................................................................................................... 
 
............................................................................................................................................... 
 
………………………………………………………………………………………………………... 
 
4.  Do you regularly consume: 
             How 
much/day? 
(a) Caffeine  ......................................................   Yes  No    
(b) Alcohol  ........................................................   Yes  No    
(c) Nicotine  ......................................................   Yes  No    
(d) Excessive fluid in the evening  .....................   Yes  No    
 
 
5. Has any, otherwise healthy, member of your family under the 
age of 35 died suddenly during or soon after 
exercise?  ................................................................. 
Yes  No  
 
 
  
 197 
 
6. Allergy Information 
(a) are you allergic to any food products? Yes  No  
(b) are you allergic to any medicines? Yes  No  
(c) are you allergic to plasters? Yes  No  
 
If YES to any of the above, please provide additional information on the allergy: 
 
…………………………………………………………………………………………………… 
 
7. Additional questions for female participants 
(d) are you taking hormone replacement therapy 
(HRT)? 
Yes  No  
 
If YES, please state when you commenced the hormone replacement therapy:  
 
............................................................................................................................................... 
 
8. Are you currently involved in any other research studies at the University or 
elsewhere? 
 Yes  No  
 
If yes, please provide details of the study 
………………………………………………………………………………………………….. 
………………………………………………………………………………………………….. 
 
9. How many minutes a week do you spend doing exercise/physical activity (such as 
brisk walking, swimming, jogging etc)? 
 
………………………………………… minutes/week 
 
10. On an average week, on how many days a week do you exercise/are physically 
active? 
 
………………………………………… days per week 
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Sleep problems  
Q1. Have you been told that you have a sleep 
problem/condition by your GP or another healthcare 
professional? ......................................................................   
Yes  No   If No, go 
to Q3.  
 
If Yes, please describe the diagnosis  
………………………………………………………………………………………………………... 
Q2. Please tell us when you were diagnosed  
…………………………………………………………………….. 
Q2. Are you currently taking medication/any other 
treatment for this condition? ............................................   
Yes  No  
 
If yes, please provide details – what medication/treatment are you taking, when have you started 
………………………………………………………………………………………………………………… 
………………………………………………………………………………………………………………… 
How 
many 
nights/ 
week 
Q3. Do you have problems falling alseep? ......................   Yes  No    
 
Q4. Do you have problems staying alseep? ....................   Yes  No    
 
Q5. Do you wake up in the morning before the desired 
time? ....................................................................................   
Yes  No    
 
Q6. Do you wake up feeling unrefreshed, despite 
adequate opportunity to sleep? ........................................   
Yes  No    
 
Q7. Do you consider your sleep problems interfere 
with your daytime functioning, for example memory, 
concentration, ability to work/daily chores, mood? .......   
Yes  No    
 
Q8. Are you concerned about your sleep problems? ....   Yes  No    
 
Q9. How long have you been having these sleep problems?  
 
………………………………………………………………………………………………………………… 
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Q10. Are you currently taking medication, prescribed 
or over the counter, for your sleep problems? ...............   
Yes  No  
 
If Yes, please provide details – what medication/treatment are you undertaking, when have you 
started 
………………………………………………………………………………………………………………… 
………………………………………………………………………………………………………………… 
 
Q11. Have you ever had unpleasant sensations in your legs, combined with an urge to move 
your legs? 
 Yes  No  
 
Q12. Do/did these feelings occur mainly or only at rest and do/did they improve with 
movement? 
 Yes  No  
 
Q13. Are/were these feelings worse in the evening or night than in the morning? 
 Yes  No  
 
Q14. How often do/did these feelings occur? 
 Less than one time per year 
 At least one time a year but less than one time/month 
 2–4 times per month 
 2–3 times per week 
 4–5 times per week 
 6–7 times per week 
How 
many 
nights/we
ek 
Q15. Do you have problems falling asleep at the 
desired time? ......................................................................   
Yes  No    
 
Q16. Do you have problems waking up at the desired 
time? ....................................................................................   
Yes  No    
 
Q17. Do you feel very sleepy during the daytime? .........   Yes  No    
 
 
Q18. How long have you been having these sleep problems?     
..........................……………………… 
 
  
 200 
 
 
Q19. How likely are you to doze off or fall asleep in the following situations, in contrast to 
just feeling tired? This refers to your usual way of life in recent times. Even if you have not 
done some of these things recently, try to work out how they would have affected you.  
 
 I would 
never 
doze 
I would have a 
slight chance 
of dozing 
I would have a 
moderate 
chance of 
dozing 
I would have 
a high 
chance of 
dozing 
 
Sitting & reading     
 
    
Watching TV 
 
    
Sitting, inactive in a  
public place 
(e.g. cinema) 
    
As a passenger in a  
car for an hour  
without a break 
    
Lying down to rest in  
the afternoon when 
given the chance       
    
Sitting and talking to  
someone  
    
Sitting quietly after 
lunch without alcohol 
    
In a car, while  
stopped for a few 
minutes in traffic  
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Q20. Please tick () the most 
appropriate response to the questions 
below. Please answer all questions. 
 
1. Sadness 
 
I do not feel sad  
I feel sad much of the time  
I am sad all of the time  
I am so sad or unhappy that I 
can’t stand it  
 
 
2. Pessimism 
 
I am not discouraged about 
my future   
I feel more discouraged about 
my future than I used to be  
I do not expect things to work 
out for me  
I feel my future is hopeless 
and will only get worse  
 
 
3. Past Failure 
 
I do not feel like a failure  
I have failed more than I 
should have  
As I look back, I see a lot of 
failures   
I feel I am a total failure as a 
person  
 
 
 
 
 
 
 
4. Loss of Pleasure 
 
I get as much pleasure as I 
ever did from things I enjoy  
I don’t enjoy things as much 
as I used to  
I get very little pleasure from 
the things I used to enjoy  
I can’t get any pleasure from 
the things I used to enjoy  
 
5. Guilty Feelings 
 
I don’t feel particularly guilty  
I feel guilty over many things I 
have done or should have 
done 
 
I feel quite guilty most of the 
time  
I feel guilty all of the time  
 
 
6. Punishment Feelings 
 
I don’t feel I am being 
punished  
I feel I may be punished  
I expect to be punished  
I feel I am being punished  
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7. Self-Dislike 
 
I feel the same about myself 
as ever  
I have lost confidence in 
myself  
I am disappointed in myself  
I dislike myself  
 
 
 
 
 
 
 
 
 
8. Self-Criticalness 
 
I don’t criticise or blame 
myself more than usual  
I am more critical of myself 
than I used to be  
I criticise myself for all of my 
faults  
I blame myself for everything 
bad that happens  
 
 
 
9. Suicidal Thoughts or Wishes 
 
I don’t have any thoughts of 
killing myself  
I have thoughts of killing 
myself, but I would never 
carry them out 
 
I would like to kill myself  
I would kill myself if I had the 
chance  
 
 
 
 
 
 
 
 
 
 
 
 
 
10. Crying 
 
I don’t cry anymore than I 
used to  
I cry more than I used to  
I cry over every little thing  
I feel like crying, but I can’t  
 
 
11. Agitation  
 
I am no more restless or 
wound up than usual  
I feel more restless or wound 
up than usual  
I am so restless or agitated 
that it’s hard to stay still   
I am so restless or agitated 
that I have to keep moving or 
doing something 
 
 
 
 
12. Loss of interest 
 
I have not lost interest in other 
people or activities  
I am less interested in other 
people or things than before  
I have lost most of my interest 
in other people or things  
It’s hard to get interested in 
anything  
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13. Indecisiveness  
 
I make decisions about as 
well as ever  
I find it more difficult to make 
decisions than usual  
I have much greater difficulty 
in making decisions than I 
used to 
 
I have trouble making any 
decisions  
 
14. Worthlessness 
 
I do not feel I am worthless  
I don’t consider myself as 
worthwhile and useful as I 
used to 
 
I feel more worthless as 
compared to other people  
I feel utterly worthless  
 
15. Loss of Energy 
 
I have as much energy as 
ever  
I have less energy than I used 
to have  
I don’t have enough energy to 
do very much  
I don’t have enough energy to 
do anything  
 
 
 
 
 
 
 
 
 
16. Irritability 
 
I am no more irritable than 
usual  
I am more irritable than usual  
I am much more irritable than 
usual  
I am irritable all of the time  
 
17. Concentration Difficulty 
 
I can concentrate as well as 
ever  
I can’t concentrate as well as 
usual  
It’s hard to keep my mind on 
anything for very long  
I find I can’t concentrate on 
anything  
 
18. Tiredness or Fatigue 
 
I am not more tired or fatigued 
than usual  
I get more tired or fatigued 
more easily than usual  
I am too tired or fatigued to do 
a lot of the things I used to do  
I am too tired or fatigued to do 
most of the things I used to do  
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19. Loss of Interest in Sex 
 
I have not noticed any recent 
change in my interest in sex  
I am less interested in sex 
than I used to be  
I am much less interested in 
sex now  
I have lost interest in sex 
completely  
 
 
20. Changes in Appetite 
 
I have not experienced any 
change in my appetite  
My appetite is somewhat less 
than usual  
My appetite is somewhat 
greater than usual  
My appetite is much less than 
before  
My appetite is much greater 
than usual  
I have no appetite at all  
I crave food all the time  
 
 
 
 
 
 
 
 
 
 
 
 
21. Changes in Sleeping Pattern 
 
I have not experienced any 
change in my sleeping pattern  
I sleep somewhat more than 
usual   
I sleep somewhat less than 
usual  
I sleep a lot more than usual   
I sleep a lot less than usual   
I sleep most of the day  
I wake up 1-2 hours early and 
can’t get back to sleep   
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THANK YOU FOR COMPLETING ALL QUESTIONS 
 
PLEASE RETURN THE SCREENING QUESTIONNAIRE IN THE 
FREEPOST ENVELOPE PROVIDED 
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Appendix 5: Standardised letter for ineligibility for the RCT  
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PRIVATE & CONFIDENTIAL 
Volunteer 
 
 
15 February 2012 
Dear Mr/Mrs …, 
Re: Loughborough University Sleep and Lifestyle Study 
Thank you for returning the screening questionnaire to the Clinical Sleep 
Research Unit. We are very grateful for taking the time to do it.  
Your screening questionnaire indicates that you engage in moderate to vigorous 
physical activity of 250 to 300 minutes per week. This specific trial is aimed at 
people who are currently engaged in less than 60 minutes of physical activity in a 
week. We are sorry therefore that you cannot participate in this study.  
We understand sleep problems are very distressing, and we hope our research 
leads to better understanding of sleep-related conditions, and expand the 
knowledge base on treatment options. Whilst it is disappointing that you cannot 
participate in this study, we can keep your contact details on our database, with 
your express permission. Should suitable future sleep-related studies take place in 
our department, we can invite you to take part.  
If you would like to discuss this further, please do not hesitate to contact me. 
I thank you for the time taken to write to us, and complete the screening process.  
Kind regards, 
 
Iuliana Hartescu 
 
Sleep Research Centre 
Tel: 01509 223021 (direct line) 
Fax: 01509 223940 
i.hartescu@lboro.ac.uk 
Clinical Sleep Research Unit: 
http://www.lboro.ac.uk/departments/ssehs/research/behavioural-medicine/sleep/clinical-sleep-
search-unit/index.html.  
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Appendix 6: Full Participant Information Sheet and Consent Form  
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Number:   
Date:   May 2011 
Information Sheet  
Our invitation to you 
Thank you for expressing interest in participating in our study.  We are currently running a study on 
monitoring lifestyle, health and sleep quality. We would like to invite you to take part in this research study.  
Before you decide you need to understand why the research is being done and what it would involve for you.  
Please take time to read the following information carefully.  Talk to others about the study if you wish, or 
call the number provided at the bottom of this sheet.   
What is this study all about? 
The aim of this study is to find the best way of helping people with sleep problems to get the most out of 
their sleep.  In the course of this study, two approaches to physical activity habits are being compared: 
regularly walking to the prescribed governmental guidelines; and continuous health monitoring whilst not 
engaged in regular physical activity.   While regular physical activity can offer benefits, it is not known 
whether physical activity habits can help people with sleep problems. To find out, we need to compare these 
two approaches.   
To do this we invite people to join different groups and give each group a different treatment.  In the present 
study we are calling these groups the ‘Regular Walking’ group and the ‘Regular Health Monitoring’ group.  At 
the end of the study results from both groups are compared to see if one is better.  To try to make sure the 
comparison is fair, each participant is allocated to a group by chance (randomly).  In this case you have a 50-
50 (evens) chance of joining one of the two groups.  We cannot promise the study will help you, but the 
information we get from this study will help to improve the treatment of people who cope with long-term 
health conditions, and experience disturbed sleep.  This trial is financially supported by Government funded 
Research Councils, and is being managed by Loughborough University’s Sleep Research Centre. 
What will happen to me if I take part? 
If you are being invited to participate in the Regular Walking group.  This means that we will support you in 
engaging in regular walking (of 30 minutes per day, on at least 5 days of the week).  
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If you are being invited to participate in the Regular Health Monitoring group.  This means that we will 
regularly monitor your health and sleep, whilst you continue your lifestyle as usual.    
For all participants. We will give you a booklet of questionnaires, monitor your sleep and conducts health 
tests at the beginning of the study.   We will give you the same questionnaires and tests after 3 months, 6 
months, and one year later.   
And that’s it; all together you will be involved in the study for approximately 12 months.   
 What do the questionnaires ask?   In order to assess your regular health and sleep, we need to ask you for 
information on your health, your sleeping patterns, and the amount of fatigue you experience.  These 
questionnaires take approximately half an hour to complete.  You can take breaks whilst completing the 
questionnaires. You will be provided with pre-paid envelopes to return the questionnaires to Loughborough 
University.    
What do other tests involve?    In order to assess the contribution of other factors to your sleep problems, 
we will also test your attention.  There are two computerised attention tests, each lasting approximately 15 
minutes. The tests involve watching a screen, and pressing a button when certain targets appear on the 
screen. You will be given ample opportunity to first familiarise yourself with the tests.  We can conduct these 
tests either in the comfort of your home, or you can visit our University (your choice). After that, we will 
repeat the same tests after 6 months, and one year later.  
What happens to this information?  All the questionnaires and tests are anonymous (we will place a number 
on the form).  The information will also be stored anonymously and securely, and only people with correct 
authority will have access. If you decide to withdraw from the study we will destroy your personal (contact) 
information, but we will need to use the questionnaire data collected up to your withdrawal.  At all times we 
will follow strict codes of ethical and legal practice.  
What if I want to complain? 
If you have concerns about any aspect of this study, you can bring this to the attention of the researchers 
(office number below) who will do their best to address the matter.  If you remain unhappy and wish to 
complain formally, you can do directly to the University authorities.  The person to contact for complaints is 
Mrs Zoë Stockdale, Secretary to the Ethical Avisory Committee, Research office, Loughborough University, 
Tel: 01509222423, email: z.c.stockdale@lboro.ac.uk. 
Do I have to take part?  Participation is, of course, entirely voluntary.  If, after reading this information, you 
decide to participate, we will ask you to sign a consent form to show you have agreed to take part.  We will 
then inform your GP so that they know what is going on.  You are also free to withdraw at any time, without 
giving a reason. 
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Full contact details of the Investigators: 
Ms Iuliana Hartescu 
Clinical Sleep Research Unit 
Loughborough University 
Leicestershire 
LE11 3TU 
Tel: 01509223021 
Email: i.hartescu@lboro.ac.uk 
Professor Kevin Morgan 
Clinical Sleep Research Unit 
Loughborough University 
Leicestershire 
LKE11 3TU 
Tel: 01509222472 
Email: k.morgan@lboro.ac.uk 
Doctor Clare Stevinson 
School of Sports, Exercise and Health Scien  
Loughborough University 
LE11 3TU 
Tel: 01509222472 
Email: C.D.Stevinson@lboro.ac.uk 
   
 
If you have any queries, or would just like to discuss the project further, please 
telephone the project office on: 01509 223 021. 
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Number:   
Date:   May 2011 
 
CONSENT FORM 
 
Title of Project: Sleep and lifestyle factors 
 
Name of Researcher:  IULIANA HARTESCU 
                
                                     Please initial box 
1. I confirm that I have read and understand the information sheet for the 
above study.  I have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to withdraw 
at anytime without giving any reason, without my legal rights being affected. 
 
3. I agree to take part in the above study 
 
 
 
 
_____________________  _____________ _________________ 
Name of Participant    Date    Signature 
 
Iuliana Hartescu 
_____________________   _____________ __________________ 
Name of Person     Date    Signature 
taking consent  
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Appendix 7: RCT Attrition Management Strategy 
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RCT Attrition management 
1. Offer incentives 
a. Sleep profile 
b. A free personal consultation with a sleep specialist at the end. 
c. Pedometer 
 
2. Offer attention and support 
a. Weekly reminder text 
b. Monthly progress letter 
c. Mobile number for continuous support 
d. Monthly update on local walking opportunities 
 
3. Run procedure 
a. Identify personal walking opportunities 
b. Have milestones set (3 months, 6 months, one year) and agreed 
with participants 
 
4. Exit interview 
a. Have early exit interview ready 
b. Try and identify, and overcome, obstacles to continuing 
c. Test participants at whatever point they wish to terminate 
 
5. Get specialist support from the Department 
a. Clare Stevinson 
b. Stacy Clemes 
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Appendix 8: Standard letter to General Practitioner, for intervention and control 
groups  
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Surgery 
 
 
10 December 2011 
 
 
Dear Sir or Madam, 
 
Re: Participant, DOB, Address:  
 
I am writing to inform you that Mr/Mrs ..  has volunteered to participate in a 
research study at Loughborough University. The study is examining the 
relationship between lifestyle factors and insomnia symptoms, and has been 
approved by Loughborough University Ethics Committee Reference Number R11-
P68.  
 
During the 12-month study, participants will undertake regular physical activity 
(brisk walking) to governmental guidelines (150 minutes per week), and wear an 
accelerometer. They will also complete cognitive tests, questionnaires on their 
lifestyle habits, perceived physical and mental health, and sleep, on four 
occasions.  
 
If you require any more information, or if you have any comments or concerns 
about the study, please do not hesitate to contact me.  
 
Kind regards, 
 
 
 
Iuliana Hartescu 
 
Sleep Research Centre 
Loughborough University 
 
Direct line: 01509 223 021 
Email: i.hartescu@lboro.ac.uk 
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Appendix 9: Booklet of self-reported questionnaires, administered at baseline, 3 
months, 6 months and 12 months 
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Loughborough 
University Sleep and 
Lifestyle Study 
 
 
 
 
Please complete ALL questions  
 
 
THANK YOU 
 
 
 
 
           
 
 
 
 
 
 
 
 
                 
 
School of Sport, Exercise and Health Sciences 
Loughborough University 
Loughborough 
Leicestershire LE11 3TU 
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   Please answer the following questions about you and your 
health 
All responses will be kept confidential. 
 
About you 
 
 
Please tick () the appropriate boxes where indicated : 
 
1. Are you : 
 
Male  Female  
 
2. What is your age?      _________ 
 
 
3.  What is your ethnic background? 
 
i) White – British, Irish, Other White background                                                     
 
  
ii) Mixed – White and Black Caribbean, White and Black African, White 
and Asian, other mixed background 
 
  
iii) Asian or Asian British- Indian, Pakistani, Bangladeshi, other Asian 
background 
 
  
iv) Black or Black British – Caribbean, African, Other Black background 
jkjkj                                    
 
  
v) Chinese or other ethnic group – Chinese, any other                       
hjhjhhj                         
 
 
4. Would you describe your work as:  
 
       Day time work (e.g. 9am – 5pm)  
 
       Shift work – day time only  
 
       Shift work – including nights  
 
       I am currently unemployed/retired  
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About your health 
 
By placing a tick () in ONE box in each group below, please indicate which 
statements best describe your own health state TODAY. 
 
1. MOBILITY 
I have no problems in walking about       
I have slight problems in walking about      
I have moderate problems in walking about      
I have severe problems in walking about      
I am unable to walk about        
 
2. SELF-CARE 
I have no problems washing or dressing myself     
I have slight problems washing or dressing myself     
I have moderate problems washing or dressing myself    
I have severe problems washing or dressing myself    
I am unable to wash or dress myself      
 
3. USUAL ACTIVITIES (e.g. work, study, housework,  
family or leisure activities) 
I have no problems doing my usual activities     
I have slight problems doing my usual activities     
I have moderate problems doing my usual activities    
I have severe problems doing my usual activities     
I am unable to do my usual activities      
 
4. PAIN / DISCOMFORT 
I have no pain or discomfort        
I have slight pain or discomfort       
I have moderate pain or discomfort       
I have severe pain or discomfort       
I have extreme pain or discomfort       
 
5. ANXIETY / DEPRESSION 
I am not anxious or depressed       
I am slightly anxious or depressed       
I am moderately anxious or depressed      
I am severely anxious or depressed       
I am extremely anxious or depressed      
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6.  We would like to know how good or bad your health is  
TODAY. 
 
• This scale is numbered from 0 to 100. 
• 100 means the best health you can imagine. 
0 means the worst health you can imagine. 
• Mark an X on the scale to indicate how your health is 
TODAY.  
• Now, please write the number you marked on the 
scale in the box below.  
                     
 
 
 
YOUR HEALTH TODAY  = 
10 
0 
20 
30 
40 
50 
60 
80 
70 
90 
100 
5 
15 
25 
35 
45 
55 
75 
65 
85 
95 
The best health        
 you can imagine 
 
The worst health        
 you can imagine 
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7.        Over the past 4 weeks, how often have 
you: 
 
  How often? (enter 
number of times) 
i Visited your local surgery for a consultation with a 
doctor (include ‘out-of hours’ consultations at 
special centres)? 
 
 
ii Visited your local surgery for an appointment with 
a nurse, a counsellor, or any other member of the 
team? 
 
 
iii Visited an Accident and Emergency department 
in a hospital? 
 
 
iv Taken sleep medicine prescribed by your doctor 
(please enter the name of the medicine below)? 
 
 
_____________________________________ 
 
 
v Taken sleep medicine that you bought yourself 
from a chemist or health shop (please enter the 
name of the medicine below)? 
 
 
_____________________________________ 
 
 
vi Contacted NHS direct? 
 
  
 
 
 
 
What is your current weight?     How tall are you? 
 
 
___________________stone/ lb / kg    _______________ ft/ cm  
 
 
 
What is your annual household income, before taxes? 
 
£5,000 - £9,999    £30,000 - £34,999    £55,000 - £59,999  
£10,000 - £14,999   £35,000 - £39,999    £60,000 - £64,999  
£15,000 - £19,999   £40,000 - £44,999    £65,000 - £69,999 
£20,000 - £24,999   £45,000 - £49,999    £70,000 – £74,999  
£25,000 - £29,999   £50,000 - £54,999    More than £75,000  
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Instructions: 
 
The following questions relate to your usual sleep habits during the past month 
only. Your answers should indicate the most accurate reply for the majority of days 
and nights in the past month. Please answer all the questions. 
 
 
1. During the past month, when have you usually gone to bed at night?  
     
   usual bed time              _____________  
    
 
2. During the past month, how long (in minutes) has it usually taken you to fall 
asleep each night?    
 
                             number of minutes     _____________  
 
 
3. During the past month, when have you usually got up in the morning?  
      
   usual getting up time    _____________     
 
4. During the past month, how many hours of actual sleep did you get at night? 
(This may be different than the number of hours you spend in bed).  
       
    hours of sleep per night _____________ 
 
 
 
5. During the past month, how often have you had trouble sleeping because you…
         
 
For each of the remaining questions, tick () the most relevant response. Please 
answer all questions. 
 
 Not during 
the past 
month 
Less than 
once a 
week 
Once or 
twice a week 
Three or 
more times a 
week 
Cannot get to sleep 
within 30 minutes 
    
Wake up in the 
middle of the night 
or early morning 
    
Have to get up to 
use the bathroom 
    
Cannot breathe 
comfortably 
    
Cough or snore 
loudly 
    
About your sleep quality 
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 Not during 
the past 
month 
Less than 
once a 
week 
Once or 
twice a week 
Three or 
more times a 
week 
Feel too cold 
 
    
Feel too hot 
 
    
Had bad dreams 
 
    
Have pain 
 
    
 
If there are any other reason(s) you have had trouble sleeping please describe: 
   
 
 
6. If you provided other reasons for having trouble sleeping in the box above, 
please indicate how often this has affected your sleep over the past month.  
 
Not during 
the past 
month 
 Less than 
once a week 
 Once or twice a 
week 
 Three or more 
times a week 
 
        
 
 
7. During the past month, how would you rate your sleep quality overall? 
 
Very good  Fairly good  Fairly bad  Very bad  
        
 
 
8. During the past month, how often have you taken medicine (prescribed or 
“over the counter”) to help you sleep? 
 
Not during 
the past 
month 
 Less than 
once a week 
 Once or twice a 
week 
 Three or more 
times a week 
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9. During the past month, how often have you had trouble staying awake 
 while driving, eating meals or engaging in social activity? 
 
Not during 
the past 
month 
 Less than 
once a week 
 Once or twice a 
week 
 Three or more 
times a week 
 
        
 
10. During the past month, how much of a problem has it been for you to 
 keep up enough enthusiasm to get things done? 
 
No problem at 
all 
 Only a very 
slight problem 
 Somewhat of a 
problem 
 A very big 
problem 
 
        
 
 
11. Over the past month have you consumed any of the following to  help 
you sleep?  Please tick all that apply. 
 
Alcohol      
 
Medicines purchased from a pharmacy e.g. Nytol    
 
Medicines purchased from the internet    
 
Herbal tablets or compounds e.g. valerian, Nytol Herbal     
 
Herbal teas e.g. camomile      
 
Milk drinks e.g. Horlicks, milk, hot chocolate      
 
 
Is the anything else you consume to help you sleep? (Please specify)  
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12. Over the past month have you consumed any of the following to  reduce 
feelings of sleepiness? Please tick all that apply.  
 
Caffeinated drinks e.g. tea, coffee      
 
“Energy” drinks, e.g. Red Bull  
 
High sugar drinks e.g. cola      
 
Sugary snack e.g. chocolate, sweets       
 
Over the counter stimulants e.g. Pro Plus       
 
Is the anything else you consume to reduce daytime sleepiness? (Please specify)  
 
  
 
 
13. For each question, please CIRCLE the number that best describes your 
answer. 
 
Please rate the CURRENT (i.e. LAST 2 WEEKS) SEVERITY of your insomnia 
problem(s). 
 
Insomnia problem None Mild Moderate Severe Very severe 
1) Difficulty falling asleep 0 1 2 3 4 
2) Difficulty staying asleep 0 1 2 3 4 
3) Problems waking up too early 0 1 2 3 4 
 
4) How satisfied/dissatisfied are you with your current sleep pattern? 
Very satisfied Satisfied Moderately satisfied Dissatisfied Very dissatisfied 
0 1 2 3 4 
 
5) How NOTICEABLE to others do you think your sleep problem is in terms of impairing 
the quality of your life? 
Not at all 
noticeable 
A little Somewhat Much Very much 
noticeable 
0 1 2 3 4 
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6) How WORRIED/DISTRESSED are you about your current sleep problem? 
Not at all 
worried 
A little Somewhat Much Very much 
worried 
0 1 2 3 4 
 
7) To what extent do you consider your sleep problem to INTERFERE with your daily 
functioning (e.g. daytime fatigue, mood, ability to function at work/daily chores, 
concentration, memory, mood etc) CURRENTLY? 
Not at all 
interfering 
A little Somewhat Much Very much 
interfering 
0 1 2 3 4 
 
 
About your daytime functioning and mood 
 
Instructions: 
 
We are interested in finding out about the kinds of physical activities that people 
do as part of their everyday lives.  The questions will ask you about the time you 
spent being physically active in the last 7 days.  Please answer each question 
even if you do not consider yourself to be an active person.  Please think about 
the activities you do at work, as part of your house and yard work, to get from 
place to place, and in your spare time for recreation, exercise or sport. 
 
Think about all the vigorous activities that you did in the last 7 days.  Vigorous 
physical activities refer to activities that take hard physical effort and make you 
breathe much harder than normal.  Think only about those physical activities that 
you did for at least 10 minutes at a time. 
 
1. During the last 7 days, on how many days did you do vigorous physical 
activities like heavy lifting, digging, aerobics, or fast bicycling?  
 
_____ days per week  
 
   No vigorous physical activities  Skip to question 3 
 
 
2. How much time did you usually spend doing vigorous physical activities on 
one of those days? 
 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
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Think about all the moderate activities that you did in the last 7 days.  Moderate 
activities refer to activities that take moderate physical effort and make you 
breathe somewhat harder than normal.  Think only about those physical activities 
that you did for at least 10 minutes at a time. 
 
 
3. During the last 7 days, on how many days did you do moderate physical 
activities like carrying light loads, bicycling at a regular pace, or doubles 
tennis?  Do not include walking. 
 
_____ days per week 
 
   No moderate physical activities  Skip to question 5 
 
 
 
4. How much time did you usually spend doing moderate physical activities 
on one of those days? 
 
_____ hours per day 
_____ minutes per day 
 
  Don’t know/Not sure  
 
 
Think about the time you spent walking in the last 7 days.  This includes at work 
and at home, walking to travel from place to place, and any other walking that you 
might do solely for recreation, sport, exercise, or leisure. 
 
5. During the last 7 days, on how many days did you walk for at least 10 
minutes at a time?   
 
_____ days per week 
  
   No walking     Skip to question 7 
 
 
6. How much time did you usually spend walking on one of those days? 
 
_____ hours per day 
_____ minutes per day  
 
  Don’t know/Not sure  
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The last question is about the time you spent sitting on weekdays during the last 
7 days.  Include time spent at work, at home, while doing course work and during 
leisure time.  This may include time spent sitting at a desk, visiting friends, 
reading, or sitting or lying down to watch television. 
 
7. During the last 7 days, how much time did you spend sitting on a week 
day? 
 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
 
 
Instructions: 
 
Read each statement and circle a number from 1 to 7, based on how accurately it 
reflects your condition during the past week and the extent to which you agree or 
disagree that the statement applies to you.  
• A low value (e.g., 1) indicates strong disagreement with the statement, whereas 
a high value (e.g., 7) indicates strong agreement.  
• It is important that you circle a number (1 to 7) for every question. 
 
 
During the past week, I have found that:  Disagree <--------> Agree  
My motivation is lower when I am fatigued.  1  2  3  4  5  6  7  
Exercise brings on my fatigue.  1  2  3  4  5  6  7  
I am easily fatigued.  1  2  3  4  5  6  7  
Fatigue interferes with my physical functioning. 1  2  3  4  5  6  7  
Fatigue causes frequent problems for me.  1  2  3  4  5  6  7  
My fatigue prevents sustained physical 
functioning.  1  2  3  4  5  6  7  
Fatigue interferes with carrying out certain duties 
and responsibilities.  1  2  3  4  5  6  7  
Fatigue is among my three most disabling 
symptoms.  1  2  3  4  5  6  7  
Fatigue interferes with my work, family, or social 
life.  1  2  3  4  5  6  7  
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Instructions: 
 
How likely are you to doze off or fall asleep in the following situations, in contrast 
to just feeling tired? This refers to your usual way of life in recent times. Even if 
you have not done some of these things recently, try to work out how they would 
have affected you.  
 
 I would 
never 
doze 
I would have a 
slight chance 
of dozing 
I would have a 
moderate 
chance of 
dozing 
I would have 
a high 
chance of 
dozing 
 
Sitting & reading     
 
    
Watching TV 
 
    
Sitting, inactive in a  
public place 
(e.g. cinema) 
    
As a passenger in a  
car for an hour  
without a break 
    
Lying down to rest in  
the afternoon when 
given the chance       
    
Sitting and talking to  
someone  
    
Sitting quietly after 
lunch without alcohol 
    
In a car, while  
stopped for a few 
minutes in traffic  
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Instructions: 
Please tick () the circle that best indicates how you feel right now, that is, at this 
moment.  There are no right or wrong answers.   
  Not at all Somewhat Moderately Very much so 
1.  I feel calm      
2.  I feel secure     
3.  I am tense     
4.  I fell strained     
5.  I feel at ease     
6.  I feel upset     
7.  
I am presently 
worrying over 
possible misfortunes 
    
8.  I feel satisfied     
9.  I feel frightened     
10.  I feel comfortable     
11.  I feel self-confident     
12.  I feel nervous     
13.  I am jittery     
14.  I feel indecisive     
15.  I am relaxed     
16.  I feel content     
17.  I am worried     
18.  I feel confused     
19.  I feel steady     
20.  I feel pleasant     
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Instructions: 
Now please tick () the circle that best indicates how you generally feel.    
  Almost never Sometimes Often 
Almost 
always 
1.  I feel pleasant     
2.  I feel nervous and restless     
3.  I feel satisfied with myself     
4.  
I wish I could be as 
happy as others 
seem to be 
    
5.  I feel like a failure     
6.  I feel rested     
7.  I am “calm, cool and collected”     
8.  
I feel that difficulties 
are piling up so that I 
cannot over them 
    
9.  
I worry too much 
over something that 
really doesn’t matter 
    
10.  I am happy     
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  Almost never Sometimes Often 
Almost 
always 
11.  I have disturbing thoughts     
12.  I lack self confidence     
13.  I feel secure     
14.  I make decisions easily     
15.  I feel inadequate     
16.  I am content     
17.  
Some unimportant 
thoughts runs 
through my mind and 
bothers me 
    
18.  
I take 
disappointments so 
keenly that I can’t put 
them out of mind 
    
19.  I am a steady person     
20.  
I get in a state of 
tension or turmoil as I 
think over my recent 
concerns and 
interests 
    
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Please tick () the most appropriate 
response to the questions below. 
Please answer all questions 
 
1. Sadness 
 
I do not feel sad  
I feel sad much of the time  
I am sad all of the time  
I am so sad or unhappy that 
I can’t stand it  
 
 
2. Pessimism 
 
I am not discouraged about 
my future   
I feel more discouraged 
about my future than I used 
to be 
 
I do not expect things to 
work out for me  
I feel my future is hopeless 
and will only get worse  
 
 
3. Past Failure 
 
I do not feel like a failure  
I have failed more than I 
should have  
As I look back, I see a lot of 
failures   
I feel I am a total failure as 
a person  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4. Loss of Pleasure 
 
I get as much pleasure as I 
ever did from things I enjoy  
I don’t enjoy things as 
much as I used to  
I get very little pleasure 
from the things I used to 
enjoy 
 
I can’t get any pleasure 
from the things I used to 
enjoy 
 
 
5. Guilty Feelings 
 
I don’t feel particularly 
guilty  
I feel guilty over many 
things I have done or 
should have done 
 
I feel quite guilty most of 
the time  
I feel guilty all of the time  
 
6. Punishment Feelings 
 
I don’t feel I am being 
punished  
I feel I may be punished  
I expect to be punished  
I feel I am being punished  
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7. Self-Dislike 
 
I feel the same about 
myself as ever  
I have lost confidence in 
myself  
I am disappointed in myself  
I dislike myself  
 
 
8. Self-Criticalness 
 
I don’t criticise or blame 
myself more than usual  
I am more critical of myself 
than I used to be  
I criticise myself for all of 
my faults  
I blame myself for 
everything bad that 
happens 
 
 
9. Suicidal Thoughts or Wishes 
 
I don’t have any thoughts of 
killing myself  
I have thoughts of killing 
myself, but I would never 
carry them out 
 
I would like to kill myself  
I would kill myself if I had 
the chance  
 
10. Crying 
 
I don’t cry anymore than I 
used to  
I cry more than I used to  
I cry over every little thing  
I feel like crying, but I can’t  
 
 
 
 
 
11. Agitation  
 
I am no more restless or 
wound up than usual  
I feel more restless or 
wound up than usual  
I am so restless or agitated 
that it’s hard to stay still   
I am so restless or agitated 
that I have to keep moving 
or doing something 
 
 
12. Loss of interest 
 
I have not lost interest in 
other people or activities  
I am less interested in other 
people or things than 
before 
 
I have lost most of my 
interest in other people or 
things 
 
It’s hard to get interested in 
anything  
 
13. Indecisiveness  
 
I make decisions about as 
well as ever  
I find it more difficult to 
make decisions than usual  
I have much greater 
difficulty in making 
decisions than I used to 
 
I have trouble making any 
decisions  
 
14. Worthlessness 
 
I do not feel I am worthless  
I don’t consider myself as 
worthwhile and useful as I 
used to 
 
I feel more worthless as 
compared to other people  
I feel utterly worthless  
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15. Loss of Energy 
 
I have as much energy as 
ever  
I have less energy than I 
used to have  
I don’t have enough energy 
to do very much  
I don’t have enough energy 
to do anything  
 
 
16. Irritability 
 
I am no more irritable than 
usual  
I am more irritable than 
usual  
I am much more irritable 
than usual  
I am irritable all of the time  
 
 
17. Concentration Difficulty 
 
I can concentrate as well 
as ever  
I can’t concentrate as well 
as usual  
It’s hard to keep my mind 
on anything for very long  
I find I can’t concentrate on 
anything  
 
 
18. Tiredness or Fatigue 
 
I am not more tired or 
fatigued than usual  
I get more tired or fatigued 
more easily than usual  
I am too tired or fatigued to 
do a lot of the things I used 
to do 
 
I am too tired or fatigued to 
do most of the things I used 
to do 
 
 
 
19. Loss of Interest in Sex 
 
I have not noticed any 
recent change in my 
interest in sex 
 
I am less interested in sex 
than I used to be  
I am much less interested 
in sex now  
I have lost interest in sex 
completely  
 
20. Changes in Sleeping Pattern 
 
I have not experienced any 
change in my sleeping 
pattern 
 
I sleep somewhat more 
than usual   
I sleep somewhat less than 
usual  
I sleep a lot more than 
usual   
I sleep a lot less than usual   
I sleep most of the day  
I wake up 1-2 hours early 
and can’t get back to sleep   
 
 
21. Changes in Appetite 
 
I have not experienced any 
change in my appetite  
My appetite is somewhat 
less than usual  
My appetite is somewhat 
greater than usual  
My appetite is much less 
than before  
My appetite is much 
greater than usual  
I have no appetite at all  
I crave food all the time  
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Thank you for completing the questionnaires. 
 
 
